Rescuing the Last-Line Polymyxins: Achievements and Challenges
Antibiotic resistance is a major global health challenge and, worryingly, several key Gram negative pathogens can become resistant to most currently available antibiotics. Polymyxins have been revived as a last-line therapeutic option for the treatment of infections caused by multidrug-resistant Gra...
Saved in:
| Published in | Pharmacological reviews Vol. 73; no. 2; pp. 679 - 728 |
|---|---|
| Main Authors | , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Elsevier Inc
01.04.2021
The American Society for Pharmacology and Experimental Therapeutics |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0031-6997 1521-0081 1521-0081 |
| DOI | 10.1124/pharmrev.120.000020 |
Cover
Loading…
| Abstract | Antibiotic resistance is a major global health challenge and, worryingly, several key Gram negative pathogens can become resistant to most currently available antibiotics. Polymyxins have been revived as a last-line therapeutic option for the treatment of infections caused by multidrug-resistant Gram negative bacteria, in particular Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacterales. Polymyxins were first discovered in the late 1940s but were abandoned soon after their approval in the late 1950s as a result of toxicities (e.g., nephrotoxicity) and the availability of “safer” antibiotics approved at that time. Therefore, knowledge on polymyxins had been scarce until recently, when enormous efforts have been made by several research teams around the world to elucidate the chemical, microbiological, pharmacokinetic/pharmacodynamic, and toxicological properties of polymyxins. One of the major achievements is the development of the first scientifically based dosage regimens for colistin that are crucial to ensure its safe and effective use in patients. Although the guideline has not been developed for polymyxin B, a large clinical trial is currently being conducted to optimize its clinical use. Importantly, several novel, safer polymyxin-like lipopeptides are developed to overcome the nephrotoxicity, poor efficacy against pulmonary infections, and narrow therapeutic windows of the currently used polymyxin B and colistin. This review discusses the latest achievements on polymyxins and highlights the major challenges ahead in optimizing their clinical use and discovering new-generation polymyxins. To save lives from the deadly infections caused by Gram negative “superbugs,” every effort must be made to improve the clinical utility of the last-line polymyxins.
Antimicrobial resistance poses a significant threat to global health. The increasing prevalence of multidrug-resistant (MDR) bacterial infections has been highlighted by leading global health organizations and authorities. Polymyxins are a last-line defense against difficult-to-treat MDR Gram negative pathogens. Unfortunately, the pharmacological information on polymyxins was very limited until recently. This review provides a comprehensive overview on the major achievements and challenges in polymyxin pharmacology and clinical use and how the recent findings have been employed to improve clinical practice worldwide.
▪ |
|---|---|
| AbstractList | Antibiotic resistance is a major global health challenge and, worryingly, several key Gram negative pathogens can become resistant to most currently available antibiotics. Polymyxins have been revived as a last-line therapeutic option for the treatment of infections caused by multidrug-resistant Gram negative bacteria, in particular
,
, and Enterobacterales. Polymyxins were first discovered in the late 1940s but were abandoned soon after their approval in the late 1950s as a result of toxicities (e.g., nephrotoxicity) and the availability of "safer" antibiotics approved at that time. Therefore, knowledge on polymyxins had been scarce until recently, when enormous efforts have been made by several research teams around the world to elucidate the chemical, microbiological, pharmacokinetic/pharmacodynamic, and toxicological properties of polymyxins. One of the major achievements is the development of the first scientifically based dosage regimens for colistin that are crucial to ensure its safe and effective use in patients. Although the guideline has not been developed for polymyxin B, a large clinical trial is currently being conducted to optimize its clinical use. Importantly, several novel, safer polymyxin-like lipopeptides are developed to overcome the nephrotoxicity, poor efficacy against pulmonary infections, and narrow therapeutic windows of the currently used polymyxin B and colistin. This review discusses the latest achievements on polymyxins and highlights the major challenges ahead in optimizing their clinical use and discovering new-generation polymyxins. To save lives from the deadly infections caused by Gram negative "superbugs," every effort must be made to improve the clinical utility of the last-line polymyxins. SIGNIFICANCE STATEMENT: Antimicrobial resistance poses a significant threat to global health. The increasing prevalence of multidrug-resistant (MDR) bacterial infections has been highlighted by leading global health organizations and authorities. Polymyxins are a last-line defense against difficult-to-treat MDR Gram negative pathogens. Unfortunately, the pharmacological information on polymyxins was very limited until recently. This review provides a comprehensive overview on the major achievements and challenges in polymyxin pharmacology and clinical use and how the recent findings have been employed to improve clinical practice worldwide. Antibiotic resistance is a major global health challenge and, worryingly, several key Gram negative pathogens can become resistant to most currently available antibiotics. Polymyxins have been revived as a last-line therapeutic option for the treatment of infections caused by multidrug-resistant Gram negative bacteria, in particular Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacterales. Polymyxins were first discovered in the late 1940s but were abandoned soon after their approval in the late 1950s as a result of toxicities (e.g., nephrotoxicity) and the availability of “safer” antibiotics approved at that time. Therefore, knowledge on polymyxins had been scarce until recently, when enormous efforts have been made by several research teams around the world to elucidate the chemical, microbiological, pharmacokinetic/pharmacodynamic, and toxicological properties of polymyxins. One of the major achievements is the development of the first scientifically based dosage regimens for colistin that are crucial to ensure its safe and effective use in patients. Although the guideline has not been developed for polymyxin B, a large clinical trial is currently being conducted to optimize its clinical use. Importantly, several novel, safer polymyxin-like lipopeptides are developed to overcome the nephrotoxicity, poor efficacy against pulmonary infections, and narrow therapeutic windows of the currently used polymyxin B and colistin. This review discusses the latest achievements on polymyxins and highlights the major challenges ahead in optimizing their clinical use and discovering new-generation polymyxins. To save lives from the deadly infections caused by Gram negative “superbugs,” every effort must be made to improve the clinical utility of the last-line polymyxins. Antimicrobial resistance poses a significant threat to global health. The increasing prevalence of multidrug-resistant (MDR) bacterial infections has been highlighted by leading global health organizations and authorities. Polymyxins are a last-line defense against difficult-to-treat MDR Gram negative pathogens. Unfortunately, the pharmacological information on polymyxins was very limited until recently. This review provides a comprehensive overview on the major achievements and challenges in polymyxin pharmacology and clinical use and how the recent findings have been employed to improve clinical practice worldwide. ▪ Antibiotic resistance is a major global health challenge and, worryingly, several key Gram negative pathogens can become resistant to most currently available antibiotics. Polymyxins have been revived as a last-line therapeutic option for the treatment of infections caused by multidrug-resistant Gram negative bacteria, in particular Acinetobacter baumannii , Pseudomonas aeruginosa , and Enterobacterales. Polymyxins were first discovered in the late 1940s but were abandoned soon after their approval in the late 1950s as a result of toxicities (e.g., nephrotoxicity) and the availability of “safer” antibiotics approved at that time. Therefore, knowledge on polymyxins had been scarce until recently, when enormous efforts have been made by several research teams around the world to elucidate the chemical, microbiological, pharmacokinetic/pharmacodynamic, and toxicological properties of polymyxins. One of the major achievements is the development of the first scientifically based dosage regimens for colistin that are crucial to ensure its safe and effective use in patients. Although the guideline has not been developed for polymyxin B, a large clinical trial is currently being conducted to optimize its clinical use. Importantly, several novel, safer polymyxin-like lipopeptides are developed to overcome the nephrotoxicity, poor efficacy against pulmonary infections, and narrow therapeutic windows of the currently used polymyxin B and colistin. This review discusses the latest achievements on polymyxins and highlights the major challenges ahead in optimizing their clinical use and discovering new-generation polymyxins. To save lives from the deadly infections caused by Gram negative “superbugs,” every effort must be made to improve the clinical utility of the last-line polymyxins. Antibiotic resistance is a major global health challenge and, worryingly, several key Gram negative pathogens can become resistant to most currently available antibiotics. Polymyxins have been revived as a last-line therapeutic option for the treatment of infections caused by multidrug-resistant Gram negative bacteria, in particular Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacterales. Polymyxins were first discovered in the late 1940s but were abandoned soon after their approval in the late 1950s as a result of toxicities (e.g., nephrotoxicity) and the availability of "safer" antibiotics approved at that time. Therefore, knowledge on polymyxins had been scarce until recently, when enormous efforts have been made by several research teams around the world to elucidate the chemical, microbiological, pharmacokinetic/pharmacodynamic, and toxicological properties of polymyxins. One of the major achievements is the development of the first scientifically based dosage regimens for colistin that are crucial to ensure its safe and effective use in patients. Although the guideline has not been developed for polymyxin B, a large clinical trial is currently being conducted to optimize its clinical use. Importantly, several novel, safer polymyxin-like lipopeptides are developed to overcome the nephrotoxicity, poor efficacy against pulmonary infections, and narrow therapeutic windows of the currently used polymyxin B and colistin. This review discusses the latest achievements on polymyxins and highlights the major challenges ahead in optimizing their clinical use and discovering new-generation polymyxins. To save lives from the deadly infections caused by Gram negative "superbugs," every effort must be made to improve the clinical utility of the last-line polymyxins. SIGNIFICANCE STATEMENT: Antimicrobial resistance poses a significant threat to global health. The increasing prevalence of multidrug-resistant (MDR) bacterial infections has been highlighted by leading global health organizations and authorities. Polymyxins are a last-line defense against difficult-to-treat MDR Gram negative pathogens. Unfortunately, the pharmacological information on polymyxins was very limited until recently. This review provides a comprehensive overview on the major achievements and challenges in polymyxin pharmacology and clinical use and how the recent findings have been employed to improve clinical practice worldwide.Antibiotic resistance is a major global health challenge and, worryingly, several key Gram negative pathogens can become resistant to most currently available antibiotics. Polymyxins have been revived as a last-line therapeutic option for the treatment of infections caused by multidrug-resistant Gram negative bacteria, in particular Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacterales. Polymyxins were first discovered in the late 1940s but were abandoned soon after their approval in the late 1950s as a result of toxicities (e.g., nephrotoxicity) and the availability of "safer" antibiotics approved at that time. Therefore, knowledge on polymyxins had been scarce until recently, when enormous efforts have been made by several research teams around the world to elucidate the chemical, microbiological, pharmacokinetic/pharmacodynamic, and toxicological properties of polymyxins. One of the major achievements is the development of the first scientifically based dosage regimens for colistin that are crucial to ensure its safe and effective use in patients. Although the guideline has not been developed for polymyxin B, a large clinical trial is currently being conducted to optimize its clinical use. Importantly, several novel, safer polymyxin-like lipopeptides are developed to overcome the nephrotoxicity, poor efficacy against pulmonary infections, and narrow therapeutic windows of the currently used polymyxin B and colistin. This review discusses the latest achievements on polymyxins and highlights the major challenges ahead in optimizing their clinical use and discovering new-generation polymyxins. To save lives from the deadly infections caused by Gram negative "superbugs," every effort must be made to improve the clinical utility of the last-line polymyxins. SIGNIFICANCE STATEMENT: Antimicrobial resistance poses a significant threat to global health. The increasing prevalence of multidrug-resistant (MDR) bacterial infections has been highlighted by leading global health organizations and authorities. Polymyxins are a last-line defense against difficult-to-treat MDR Gram negative pathogens. Unfortunately, the pharmacological information on polymyxins was very limited until recently. This review provides a comprehensive overview on the major achievements and challenges in polymyxin pharmacology and clinical use and how the recent findings have been employed to improve clinical practice worldwide. |
| Author | Zhou, Qi (Tony) Nang, Sue C. Azad, Mohammad A.K. Li, Jian Velkov, Tony |
| Author_xml | – sequence: 1 givenname: Sue C. surname: Nang fullname: Nang, Sue C. – sequence: 2 givenname: Mohammad A.K. surname: Azad fullname: Azad, Mohammad A.K. – sequence: 3 givenname: Tony surname: Velkov fullname: Velkov, Tony – sequence: 4 givenname: Qi (Tony) surname: Zhou fullname: Zhou, Qi (Tony) email: tonyzhou@purdue.edu – sequence: 5 givenname: Jian surname: Li fullname: Li, Jian email: jian.li@monash.edu |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33627412$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkUFv1DAQhS1URLeFX4CEcuSSxZPYcYxEpWrVAtJKVBWcLXcy2Rgl9mJnV-y_x9W2FXCAufgw73sznnfGTnzwxNhr4EuASrzbDjZOkfZLqPiS56r4M7YAWUHJeQsnbMF5DWWjtTplZyl95xyEbOULdlrXTaUEVAt2cUsJd85vinmgYm3TXK6dp-ImjIfp8NP59L64xMHRnibycyqs74rVYMeR_IbSS_a8t2OiVw_vOft2ffV19alcf_n4eXW5LlFIPZd9K5Ql7LSARtdaoWqxQtFCr-6oJ6F133BLHPtONla2FhBlr1qJ-SMgu_qcXRx9t7u7iTrMq0Q7mm10k40HE6wzf3a8G8wm7I3SAFxDNnj7YBDDjx2l2UwuIY2j9RR2yVRC10I2CkSWvvl91tOQx6NlQX0UYAwpReqfJMDNfTTmMRqTozHHaDKl_6LQzXZ24X5hN_6H_XBkKd947yiahI48Uuci4Wy64P7J_wLAVqyW |
| CitedBy_id | crossref_primary_10_3892_etm_2023_11908 crossref_primary_10_3389_fphar_2022_880352 crossref_primary_10_23838_pfm_2023_00184 crossref_primary_10_1016_j_cmi_2023_05_018 crossref_primary_10_1016_j_ijbiomac_2024_138233 crossref_primary_10_1080_1120009X_2024_2405355 crossref_primary_10_1016_j_cmi_2024_03_015 crossref_primary_10_2147_IDR_S501632 crossref_primary_10_1016_j_celrep_2024_114161 crossref_primary_10_1016_j_ijantimicag_2022_106593 crossref_primary_10_1038_s41598_024_67777_1 crossref_primary_10_1016_j_bioorg_2024_108015 crossref_primary_10_3390_antibiotics11030307 crossref_primary_10_1080_14740338_2024_2348610 crossref_primary_10_1007_s00203_024_04133_x crossref_primary_10_1016_j_micpath_2024_107021 crossref_primary_10_3390_pathogens10111485 crossref_primary_10_1007_s10928_024_09916_9 crossref_primary_10_1186_s12951_024_02906_6 crossref_primary_10_1038_s41570_023_00532_8 crossref_primary_10_1073_pnas_2201460119 crossref_primary_10_1186_s13568_023_01634_8 crossref_primary_10_1186_s40779_024_00510_1 crossref_primary_10_3390_microorganisms11061459 crossref_primary_10_1002_ange_202408360 crossref_primary_10_3389_fvets_2024_1466690 crossref_primary_10_1016_j_ijantimicag_2021_106505 crossref_primary_10_1016_j_ijantimicag_2024_107326 crossref_primary_10_3389_fcimb_2024_1382145 crossref_primary_10_1016_j_bpj_2022_08_007 crossref_primary_10_1016_j_matdes_2022_111284 crossref_primary_10_1007_s10337_021_04091_2 crossref_primary_10_3390_antibiotics13020119 crossref_primary_10_3390_pharmaceutics14020446 crossref_primary_10_2147_IDR_S474191 crossref_primary_10_1016_j_heliyon_2023_e15774 crossref_primary_10_1016_j_jcis_2025_02_107 crossref_primary_10_1093_jac_dkae193 crossref_primary_10_1002_smll_202305052 crossref_primary_10_1016_j_ejmech_2024_116924 crossref_primary_10_1016_j_jcrc_2021_09_006 crossref_primary_10_1080_17425255_2025_2473439 crossref_primary_10_1128_aac_00139_22 crossref_primary_10_1016_j_ijantimicag_2024_107232 crossref_primary_10_3389_fphar_2022_1019411 crossref_primary_10_1016_j_ijantimicag_2024_107233 crossref_primary_10_3389_fphar_2023_1183332 crossref_primary_10_3389_fcimb_2024_1470891 crossref_primary_10_3390_antibiotics12050918 crossref_primary_10_1021_acsinfecdis_3c00630 crossref_primary_10_3389_fphar_2022_975066 crossref_primary_10_1016_j_ijantimicag_2023_107065 crossref_primary_10_3389_fbioe_2021_704077 crossref_primary_10_3390_antiox13070827 crossref_primary_10_1016_j_jgar_2024_04_006 crossref_primary_10_12677_acm_2024_14123242 crossref_primary_10_12998_wjcc_v10_i31_11466 crossref_primary_10_1007_s11033_024_09979_4 crossref_primary_10_3390_antibiotics11060731 crossref_primary_10_1016_j_ijantimicag_2024_107346 crossref_primary_10_1016_j_ijantimicag_2024_107106 crossref_primary_10_1007_s00294_024_01307_4 crossref_primary_10_1128_aac_00505_23 crossref_primary_10_1016_j_jare_2024_12_044 crossref_primary_10_1155_2024_8917136 crossref_primary_10_1371_journal_ppat_1010308 crossref_primary_10_1002_anie_202408360 crossref_primary_10_1016_j_micres_2025_128083 crossref_primary_10_1007_s12035_024_04577_8 crossref_primary_10_1016_j_csbj_2021_12_039 crossref_primary_10_1016_j_ejmech_2025_117440 crossref_primary_10_1016_j_aquaculture_2023_740171 crossref_primary_10_1016_j_jddst_2023_104874 crossref_primary_10_1128_aac_00426_23 crossref_primary_10_1016_j_fct_2022_112966 crossref_primary_10_1016_j_micres_2024_127839 crossref_primary_10_1080_22221751_2024_2366354 crossref_primary_10_1073_pnas_2408315121 crossref_primary_10_1080_1040841X_2024_2429599 crossref_primary_10_3390_antibiotics11101406 crossref_primary_10_1016_j_isci_2023_106809 crossref_primary_10_1016_j_addr_2022_114171 crossref_primary_10_1016_j_celrep_2024_114410 crossref_primary_10_1097_QCO_0000000000000974 crossref_primary_10_1007_s12274_024_6828_6 crossref_primary_10_3390_antibiotics11010102 crossref_primary_10_1021_acs_jmedchem_2c01915 crossref_primary_10_1016_j_ijantimicag_2024_107393 crossref_primary_10_1007_s12038_021_00209_8 crossref_primary_10_1016_j_bmcl_2023_129535 crossref_primary_10_1111_bcp_15855 crossref_primary_10_1038_s41429_023_00606_1 crossref_primary_10_3389_fmicb_2022_961498 crossref_primary_10_3389_fmed_2022_913364 crossref_primary_10_3390_antibiotics12040670 crossref_primary_10_1016_j_biopha_2023_114965 crossref_primary_10_3390_pathogens11080874 crossref_primary_10_1021_acsinfecdis_3c00315 crossref_primary_10_1080_10408398_2024_2397462 crossref_primary_10_1128_spectrum_02293_23 crossref_primary_10_3389_fcimb_2024_1467607 crossref_primary_10_1021_acs_jmedchem_3c01497 crossref_primary_10_1021_acsomega_3c06719 crossref_primary_10_1128_spectrum_01854_22 crossref_primary_10_3389_fphar_2024_1466888 crossref_primary_10_1016_j_bioactmat_2022_09_021 crossref_primary_10_3390_futurepharmacol3040047 crossref_primary_10_1007_s12088_024_01392_6 crossref_primary_10_1016_j_ijantimicag_2025_107445 crossref_primary_10_1128_aac_00197_23 crossref_primary_10_3389_fcimb_2023_1118122 crossref_primary_10_1002_adma_202204065 crossref_primary_10_1016_j_foodchem_2024_138481 crossref_primary_10_3390_microorganisms11102484 crossref_primary_10_1038_s43856_025_00748_3 crossref_primary_10_3389_fmicb_2025_1553148 crossref_primary_10_1128_spectrum_04275_22 crossref_primary_10_1007_s00228_022_03415_x crossref_primary_10_1016_j_mtbio_2024_101365 crossref_primary_10_1093_jac_dkae130 crossref_primary_10_3390_microorganisms12081661 crossref_primary_10_2139_ssrn_4007181 crossref_primary_10_3389_fcimb_2024_1404404 crossref_primary_10_1007_s12035_022_03140_7 crossref_primary_10_1007_s00018_022_04316_z crossref_primary_10_1016_j_saa_2022_121781 crossref_primary_10_3389_fcimb_2021_756782 crossref_primary_10_1007_s00210_023_02884_w crossref_primary_10_2147_IDR_S363944 crossref_primary_10_1002_advs_202302182 crossref_primary_10_3389_fmicb_2022_907116 crossref_primary_10_3390_pharmaceutics16030389 crossref_primary_10_1016_j_mtbio_2025_101590 crossref_primary_10_1016_j_sbi_2023_102647 crossref_primary_10_1371_journal_ppat_1011946 crossref_primary_10_1186_s12929_022_00874_3 crossref_primary_10_1039_D3TB00723E crossref_primary_10_1016_j_talanta_2023_124576 crossref_primary_10_1021_acsbiomaterials_2c00783 crossref_primary_10_1016_j_ijantimicag_2024_107285 crossref_primary_10_1007_s11095_022_03344_5 crossref_primary_10_1038_s41467_024_54607_1 crossref_primary_10_1016_j_ijantimicag_2022_106643 crossref_primary_10_1016_j_eng_2024_02_009 crossref_primary_10_1080_21505594_2023_2180938 crossref_primary_10_1016_j_jconrel_2023_12_046 crossref_primary_10_1111_jcpt_13711 crossref_primary_10_1016_j_cej_2025_161122 crossref_primary_10_3389_fmicb_2021_738812 crossref_primary_10_3389_fmicb_2023_1226981 crossref_primary_10_1038_s41467_022_29234_3 crossref_primary_10_1016_j_ymben_2024_07_005 crossref_primary_10_1080_00498254_2024_2370051 crossref_primary_10_3390_antiox13101170 crossref_primary_10_1016_j_biopha_2023_115856 crossref_primary_10_3390_pharmaceutics16010070 crossref_primary_10_3390_antibiotics11101301 crossref_primary_10_1093_jac_dkae344 crossref_primary_10_3390_microorganisms12112115 crossref_primary_10_1021_acsinfecdis_3c00591 crossref_primary_10_3389_fimmu_2022_1088130 crossref_primary_10_62347_WBZU4331 crossref_primary_10_3389_fmicb_2022_1017488 crossref_primary_10_1002_jssc_202400583 crossref_primary_10_1097_FTD_0000000000001216 crossref_primary_10_3390_pathogens11121420 crossref_primary_10_1021_acsinfecdis_4c00115 crossref_primary_10_1038_s41579_022_00682_4 crossref_primary_10_1089_fpd_2023_0051 crossref_primary_10_1016_j_csbj_2021_06_051 crossref_primary_10_1002_jev2_70032 crossref_primary_10_1128_spectrum_05231_22 crossref_primary_10_1007_s40203_024_00292_3 crossref_primary_10_1080_14656566_2021_1961743 crossref_primary_10_3390_microorganisms10091708 crossref_primary_10_1631_jzus_B2200466 crossref_primary_10_1007_s10989_021_10358_x crossref_primary_10_1128_spectrum_02736_22 crossref_primary_10_3390_v15030673 crossref_primary_10_3390_antibiotics10121554 crossref_primary_10_1128_spectrum_02306_23 crossref_primary_10_1021_acs_jmedchem_2c00657 crossref_primary_10_1016_j_jpba_2024_116403 crossref_primary_10_1111_crj_13493 crossref_primary_10_1016_j_ijantimicag_2024_107099 crossref_primary_10_1038_s41429_022_00561_3 crossref_primary_10_1007_s42770_024_01438_3 crossref_primary_10_1016_j_jhazmat_2024_136641 crossref_primary_10_1111_1541_4337_13407 crossref_primary_10_3389_fmicb_2024_1397906 crossref_primary_10_1016_j_micres_2024_127679 crossref_primary_10_1128_spectrum_00334_23 crossref_primary_10_1016_j_ijantimicag_2023_107003 crossref_primary_10_2147_DDDT_S479329 crossref_primary_10_2174_1574886318666230905100924 crossref_primary_10_1093_jac_dkac021 crossref_primary_10_3390_antibiotics13060506 crossref_primary_10_1155_2023_4867817 crossref_primary_10_1128_aac_00762_24 crossref_primary_10_3389_fmicb_2021_778968 crossref_primary_10_3390_molecules27031085 crossref_primary_10_1016_j_heliyon_2024_e40893 crossref_primary_10_3389_fcimb_2025_1536058 crossref_primary_10_1016_j_jpha_2024_101117 crossref_primary_10_1016_j_engmic_2022_100021 crossref_primary_10_1128_mbio_00634_24 crossref_primary_10_3389_fmicb_2024_1454618 crossref_primary_10_2147_IDR_S354460 crossref_primary_10_3390_antibiotics11060799 crossref_primary_10_1016_j_ijantimicag_2022_106688 crossref_primary_10_1038_s41429_023_00659_2 crossref_primary_10_1128_spectrum_00191_24 crossref_primary_10_1038_s42003_025_07911_5 crossref_primary_10_1007_s10096_024_04881_0 crossref_primary_10_3390_microorganisms12112207 crossref_primary_10_3389_fcimb_2021_734578 crossref_primary_10_3389_fphar_2025_1413563 crossref_primary_10_1039_D3NJ01028G crossref_primary_10_1016_j_jcrc_2023_154466 crossref_primary_10_1016_j_jlr_2022_100251 crossref_primary_10_1016_j_tim_2023_10_006 crossref_primary_10_1073_pnas_2115669119 crossref_primary_10_1016_j_ijantimicag_2023_106856 crossref_primary_10_3389_fphar_2022_902054 crossref_primary_10_1038_s41429_023_00687_y crossref_primary_10_3389_fcimb_2022_829592 crossref_primary_10_2147_IDR_S409090 crossref_primary_10_3389_fmed_2024_1496086 crossref_primary_10_3390_antibiotics12020415 crossref_primary_10_1128_spectrum_03833_22 crossref_primary_10_3390_antibiotics13040354 crossref_primary_10_1016_j_jim_2024_113670 crossref_primary_10_1016_j_ejmech_2024_116454 crossref_primary_10_1128_spectrum_00852_23 crossref_primary_10_3389_fped_2021_564991 crossref_primary_10_1093_cid_ciad556 crossref_primary_10_1016_j_jmii_2022_07_012 crossref_primary_10_3389_fmicb_2021_780201 crossref_primary_10_3389_fphar_2022_967412 crossref_primary_10_1016_j_ijantimicag_2024_107427 crossref_primary_10_3390_antibiotics12061057 crossref_primary_10_1016_j_ijantimicag_2023_107011 crossref_primary_10_37489_0235_2990_2024_69_7_8_53_66 crossref_primary_10_1021_acs_jpcb_2c03827 crossref_primary_10_3389_fphar_2024_1424765 crossref_primary_10_1128_cmr_00008_23 crossref_primary_10_1016_j_jhazmat_2025_137808 crossref_primary_10_3389_fphar_2024_1363441 |
| Cites_doi | 10.1128/AAC.47.3.905-909.2003 10.1371/journal.pone.0151270 10.1038/160263a0 10.1007/s00134-010-2038-7 10.1021/acs.chemrestox.5b00262 10.1016/j.chest.2016.07.001 10.1006/bbrc.1996.1056 10.1097/CCM.0b013e318208ee26 10.1128/AAC.02445-15 10.1016/j.clinthera.2008.01.015 10.1007/978-3-030-16373-0_10 10.1128/AAC.05052-14 10.1086/592577 10.1016/j.jinf.2012.01.015 10.3390/molecules24020249 10.1681/ASN.2016060606 10.1056/NEJMoa0800394 10.1128/AAC.06426-11 10.1097/01.shk.0000159930.87737.8a 10.1007/s15010-013-0507-y 10.1021/la504407v 10.1128/AAC.02634-12 10.1016/j.pharmthera.2017.07.012 10.1128/jcm.11.2.193-195.1980 10.1007/978-3-030-16373-0_17 10.1128/AAC.01268-16 10.1021/acsinfecdis.9b00217 10.1016/j.cmi.2017.06.002 10.1007/s12035-016-0276-6 10.1128/AAC.01406-06 10.1002/ppul.20873 10.1128/AAC.01254-17 10.1128/AAC.01779-13 10.1021/acschemneuro.7b00323 10.1093/jac/dkx409 10.1002/phar.2209 10.1097/00003246-198811000-00001 10.1093/jac/dkl512 10.1086/674387 10.1128/AAC.00922-10 10.1099/00221287-10-3-491 10.1016/j.cell.2007.06.049 10.1111/pcmr.12468 10.4103/2319-4170.132879 10.1007/s00134-009-1554-9 10.1093/jac/dkq131 10.1128/AAC.01273-10 10.1016/S0021-9673(01)00585-4 10.1001/jama.281.1.61 10.1128/AAC.00256-11 10.1186/cc11462 10.1111/j.1365-2958.1995.tb02299.x 10.1128/AAC.00703-13 10.1177/1060028015595643 10.1006/bbrc.1995.1722 10.1128/AAC.01718-12 10.1093/jac/dku151 10.1080/14787210.2018.1483240 10.1016/S0140-6736(63)91694-5 10.1128/mSphere.00119-16 10.1128/IAI.72.6.3577-3583.2004 10.1164/rccm.2105141 10.1111/j.1749-6632.1949.tb27322.x 10.1146/annurev-physiol-022516-034234 10.1128/AAC.01735-17 10.1111/j.1476-5381.1952.tb00702.x 10.1007/s40265-014-0181-0 10.1128/AAC.04869-14 10.1128/AAC.00280-15 10.1016/S0140-6736(48)90090-7 10.7164/antibiotics.30.427 10.1016/S0022-3476(84)80566-1 10.1128/AAC.04809-14 10.1007/s00134-006-0304-5 10.1128/AAC.01699-19 10.1111/j.1365-2125.2011.03991.x 10.1111/j.1399-3062.2010.00543.x 10.1007/s00134-012-2628-7 10.1136/thoraxjnl-2012-202059 10.1021/acsinfecdis.6b00031 10.1002/advs.202000704 10.1111/j.2042-7158.1979.tb13463.x 10.1086/429323 10.1681/ASN.2012050469 10.1001/jama.2018.14618 10.1111/1469-0691.12195 10.1186/s13613-016-0127-7 10.1016/j.ijantimicag.2016.11.029 10.1046/j.1365-2672.2001.01293.x 10.1086/432583 10.1093/oxfordjournals.jbchem.a128082 10.1128/AAC.47.5.1766-1770.2003 10.1128/AAC.00242-10 10.1080/1040841X.2018.1492902 10.1093/cid/cit334 10.1016/j.diagmicrobio.2011.03.003 10.1111/j.1749-6632.1949.tb27317.x 10.1007/978-3-030-16373-0_7 10.1016/j.chembiol.2018.01.005 10.1007/s12035-015-9396-7 10.1111/j.1469-0691.2005.01351.x 10.1371/journal.pone.0101033 10.1016/j.diagmicrobio.2006.10.006 10.1016/j.ijantimicag.2017.12.025 10.1093/cid/civ717 10.1128/AAC.03510-14 10.1128/AAC.01790-17 10.1128/AAC.01439-09 10.1056/NEJM196405142702002 10.1007/s15010-010-0018-z 10.1128/AAC.49.11.4814-4815.2005 10.1017/S0950268810003055 10.1111/j.1749-6632.1949.tb27316.x 10.1016/j.ijantimicag.2017.01.007 10.1016/S1473-3099(06)70580-1 10.1016/j.ijantimicag.2006.08.024 10.1046/j.1365-2958.2000.01956.x 10.1128/AAC.02449-14 10.1128/AAC.05055-14 10.1128/AAC.01571-06 10.1128/AAC.00009-16 10.1021/acsinfecdis.0c00330 10.1128/AAC.01768-09 10.1007/s001340050314 10.1097/01.CCM.0000152224.01949.01 10.1016/j.ntt.2016.03.004 10.1111/j.1469-0691.2007.01708.x 10.15190/d.2019.15 10.1099/00222615-46-1-1 10.1111/j.1472-765X.2011.03145.x 10.1128/msystems.00157-18 10.1186/s40168-017-0309-z 10.1128/AAC.00766-07 10.1016/S1684-1182(10)60050-3 10.1016/j.ijantimicag.2010.10.005 10.3109/01480545.2013.834360 10.1016/0002-9610(94)90126-0 10.1021/jm900999h 10.1016/S1473-3099(18)30099-9 10.1128/JCM.01106-10 10.1128/AAC.00973-17 10.1177/030006057600400503 10.1128/AAC.05191-11 10.1128/AAC.36.4.717 10.1097/00000658-199507000-00010 10.1001/archneur.1971.00490020059006 10.1016/S0021-9673(00)88926-8 10.1074/jbc.M106961200 10.1002/cpt.981 10.1016/j.addr.2014.03.006 10.1038/s41598-019-44965-y 10.1111/j.1365-2958.1994.tb00329.x 10.1021/cb500080r 10.1001/archopht.1969.00990010006002 10.1093/emboj/19.8.1861 10.1185/03007995.2011.626557 10.1093/cid/ciaa121 10.1007/s00134-002-1238-1 10.3343/alm.2016.36.2.124 10.1111/j.1462-2920.2009.02138.x 10.1093/jac/dku536 10.1073/pnas.91.1.133 10.1179/146532809X440761 10.1016/j.ijantimicag.2016.08.010 10.1128/AAC.00741-13 10.1093/cid/cis588 10.1128/JCM.39.1.183-190.2001 10.1099/mic.0.28692-0 10.1128/AAC.01069-13 10.1007/BF00144743 10.1016/j.ijantimicag.2015.07.021 10.1056/NEJM196409172711225 10.1016/j.lfs.2016.02.006 10.1185/03007998809114240 10.1056/NEJMc071717 10.4103/ijccm.IJCCM_302_17 10.1086/517243 10.1007/BF01901128 10.1128/AAC.00925-12 10.1345/aph.1K346 10.1093/infdis/124.6.610 10.1586/14787210.5.5.811 10.1007/BF01694341 10.1016/S1473-3099(20)30696-4 10.1111/j.1749-6632.1949.tb27314.x 10.1179/joc.2011.23.1.13 10.1111/j.1464-410X.1988.tb04293.x 10.1007/BF01706355 10.1093/jac/dkm305 10.1179/1973947813Y.0000000143 10.1086/374337 10.1007/s00134-007-0675-2 10.1128/AAC.00070-14 10.1128/AAC.00485-09 10.1074/jbc.M500964200 10.1097/00003246-199011000-00011 10.1021/acschemneuro.8b00300 10.1016/j.jinf.2019.06.011 10.1177/106002809102501101 10.1007/s10096-014-2101-3 10.3390/jcm8091444 10.1128/JCM.03385-12 10.1016/j.chembiol.2011.09.017 10.1021/jp808379x 10.1128/AAC.00788-18 10.1016/S0939-6411(02)00044-9 10.1128/AAC.01624-13 10.1093/jac/dkv135 10.1016/j.ijantimicag.2016.07.018 10.1097/00007890-199306000-00018 10.5694/j.1326-5377.1970.tb63262.x 10.1111/j.1749-6632.1949.tb27313.x 10.1097/00003246-199311000-00018 10.1016/S0140-6736(03)14409-1 10.1074/jbc.M106960200 10.1093/cid/cis286 10.1016/j.diagmicrobio.2018.01.028 10.3389/fmicb.2014.00643 10.1016/j.ijantimicag.2012.10.005 10.1016/j.celrep.2020.108313 10.1001/jama.1969.03150240119022 10.1016/j.ijantimicag.2004.10.001 10.1128/AAC.00756-12 10.1185/03007990802583845 10.1016/j.ijantimicag.2014.09.010 10.1016/j.ijantimicag.2007.05.017 10.1093/jac/dkt039 10.1016/j.clinthera.2007.09.005 10.1128/AAC.00084-14 10.1001/jama.1991.03460200084041 10.1021/ja01191a068 10.1016/j.jinf.2008.04.002 10.1074/jbc.271.51.32599 10.1021/acsinfecdis.5b00085 10.1099/jmm.0.000879 10.1093/jac/dkr069 10.1128/AAC.02442-17 10.1128/AAC.00713-12 10.1128/AAC.00762-09 10.1093/jac/dkq040 10.1128/AAC.00881-09 10.1074/jbc.273.35.22395 10.1128/AAC.00857-17 10.1073/pnas.1201313109 10.1128/JCM.38.9.3523-3523.2000 10.1128/AAC.01461-12 10.3389/fcimb.2017.00246 10.3389/fphar.2019.01146 10.1016/j.jdermsci.2012.03.002 10.1128/AAC.01576-06 10.3349/ymj.2014.55.1.118 10.1136/adc.84.5.432 10.1128/JCM.02129-13 10.1128/AAC.02927-15 10.1016/j.ijantimicag.2013.02.010 10.1016/S1473-3099(12)70322-5 10.1128/AAC.01733-10 10.1128/JB.186.13.4124-4133.2004 10.1093/jac/dkn018 10.1097/IPC.0b013e31802df0d7 10.1378/chest.11-1483 10.1128/AAC.00356-17 10.1038/clpt.2011.48 10.1093/jac/dkr483 10.1164/rccm.201312-2208OC 10.1128/AAC.00965-19 10.1016/j.diagmicrobio.2010.01.004 10.1128/AAC.2.5.331 10.1016/j.cbi.2017.04.027 10.1128/AAC.00493-15 10.1186/s12866-019-1424-8 10.2807/1560-7917.ES.2017.22.31.30589 10.1128/AAC.02319-16 10.1128/AAC.05682-11 10.1128/AAC.01581-07 10.1177/0300060519879336 10.1128/AAC.4.5.521 10.1007/s00204-018-2192-1 10.1345/aph.1E485 10.1093/jac/dks437 10.1021/acs.jnatprod.6b01176 10.1128/AAC.00483-18 10.1038/163611a0 10.1016/j.diagmicrobio.2012.08.025 10.1016/j.ijid.2010.08.001 10.15252/emmm.201607336 10.1128/AAC.02690-16 10.1016/j.jcf.2008.02.003 10.1002/ags3.12015 10.1128/AAC.00013-14 10.1016/j.ijantimicag.2017.11.011 10.1128/IAI.72.12.7107-7114.2004 10.2217/fmb.13.39 10.1093/jac/dkv340 10.1128/AAC.02025-16 10.1378/chest.125.2.502 10.1080/22221751.2020.1732231 10.1128/mBio.00440-18 10.1093/jac/dkl330 10.1093/jac/dkw213 10.4155/fmc-2016-0091 10.1016/j.carres.2003.07.010 10.1128/JCM.43.2.903-905.2005 10.1111/j.1476-5381.1964.tb01610.x 10.1089/mdr.2005.11.287 10.1016/j.abb.2017.03.008 10.1111/j.1469-0691.2009.03019.x 10.1038/s41426-018-0124-z 10.1093/jac/dkl562 10.1128/AAC.48.3.753-757.2004 10.1016/j.diagmicrobio.2012.04.007 10.1002/bjs.1800670812 10.1136/jcp.42.6.645 10.1093/jac/dky111 10.1099/mic.0.2008/022301-0 10.1111/j.1749-6632.1949.tb27315.x 10.1093/jac/dkq285 10.1093/jac/dkg468 10.1016/0005-2736(68)90020-5 10.1128/AAC.00765-13 10.1186/cc5088 10.1038/164622a0 10.1128/AAC.01530-12 10.1093/jac/dkq390 10.1093/toxsci/kft247 10.1086/318850 10.1146/annurev.bi.46.070177.003451 10.1016/j.arth.2006.05.006 10.3389/fmicb.2019.01689 10.1016/j.jpeds.2012.09.013 10.1128/AAC.13.1.78 10.1016/j.addr.2014.10.022 10.1111/tid.13312 10.1128/AAC.01064-12 10.1517/17425247.2012.660480 10.1128/AAC.7.5.596 10.1016/0006-2952(93)90346-X 10.3389/fmicb.2018.02776 10.1093/cid/cis909 10.1007/s15010-012-0349-z 10.1093/jac/dkx186 10.1093/jac/dkq360 10.1183/09031936.00156906 10.1093/jac/dkx286 10.1128/AAC.05298-11 10.1016/j.jmii.2014.08.009 10.1152/physiolgenomics.00076.2013 10.1093/jac/dku065 10.1155/2017/5437139 10.1371/journal.pone.0096288 10.1111/j.1749-6632.1949.tb27318.x 10.1016/j.ijantimicag.2008.05.016 10.7164/antibiotics.33.1551 10.1111/jcpt.12138 10.3390/antibiotics8010031 10.1093/jac/dkw115 10.1128/AAC.05028-11 10.1128/AAC.01361-08 10.1093/jac/dkt022 10.1097/00005373-198704000-00003 10.1128/AAC.01414-15 10.1016/j.jmii.2016.12.008 10.7164/antibiotics.54.595 10.1128/AAC.00035-06 10.1155/2015/679109 10.1093/jac/dkq072 10.1093/jb/mvp096 10.1016/j.peptides.2010.09.010 10.1093/jac/dks438 10.1002/psc.367 10.1128/AAC.01732-10 10.1007/s00134-015-3751-z 10.1021/ja01648a039 10.1203/00006450-197901000-00011 10.1016/S1473-3099(15)00424-7 10.1093/jac/dkh167 10.1128/AAC.04037-14 10.1111/j.1744-9987.1998.tb00066.x 10.1128/AAC.00834-10 10.1128/AAC.01587-19 10.1111/j.1365-2958.2006.05544.x 10.1093/jac/dku441 10.1248/cpb.57.332 10.1016/0019-2791(76)90181-6 10.7326/0003-4819-74-1-144 10.1136/bmj.4.5734.525 10.1038/ja.2015.27 10.1086/520658 10.1128/AAC.50.5.1715-1720.2006 10.1021/acsinfecdis.5b00097 10.1183/09031936.00090314 10.1097/MJT.0b013e3182a32df3 10.1089/mdr.2014.0006 10.1128/AAC.06268-11 10.1016/j.ijantimicag.2015.07.019 10.1016/S0305-4179(00)00147-9 10.1128/AAC.00179-13 10.1128/AAC.03110-14 10.1016/j.idc.2016.02.005 10.1016/j.ijantimicag.2012.06.003 10.1111/j.1365-2958.2008.06152.x 10.1007/s12098-015-1798-z 10.7326/0003-4819-117-7-545 10.1128/AAC.49.9.3624-3630.2005 10.1128/AAC.00328-11 10.1378/chest.127.2.522 10.1128/AAC.00387-11 10.1016/j.jiac.2013.08.004 10.1179/joc.2004.16.3.282 10.7164/antibiotics.30.1042 10.1111/j.1469-0691.2011.03514.x 10.1016/S0021-9673(02)00375-8 10.1136/thx.52.7.656 10.1074/jbc.M701454200 10.1128/AAC.01475-17 10.1093/jac/dkx538 10.1016/j.ijantimicag.2013.08.008 10.1186/s40360-018-0226-1 10.1128/AAC.9.3.493 10.1111/mmi.13018 10.1128/AAC.00343-13 10.1016/j.ijantimicag.2009.11.005 10.1016/j.ijantimicag.2020.106061 10.1159/000309190 10.1128/AAC.01337-16 10.1093/jac/dkn530 10.1093/jac/dku323 10.1128/AAC.00231-12 10.1093/jac/dkr007 10.1371/journal.pone.0161057 10.1093/emboj/19.19.5071 10.1074/jbc.M706172200 10.1093/jac/dkt503 10.1016/S0732-8893(02)00373-5 10.1093/infdis/121.5.555 10.1093/jac/dki153 10.1016/j.ijantimicag.2012.09.016 10.1128/JCM.00268-17 10.1038/212311a0 10.1016/S1473-3099(11)70035-4 10.1021/ac504516k 10.1128/AAC.02609-12 10.1128/AAC.00903-09 10.1186/1471-2180-13-137 10.1186/s13756-018-0313-5 10.1128/AAC.02391-16 10.1007/s00134-011-2307-0 10.1016/j.ijantimicag.2006.09.009 10.1248/cpb.59.597 10.1093/cid/cir137 10.1128/AAC.01271-08 10.1155/2014/249856 10.4103/0255-0857.93020 10.1186/cc3995 10.1007/BF01969025 10.1016/j.addr.2014.11.004 10.1056/NEJM196204122661505 10.1164/ajrccm.158.3.9712079 10.1128/AAC.9.1.11 10.1111/j.1469-0691.2011.03572.x 10.1074/jbc.M505020200 10.1128/AAC.02353-12 10.1007/s00134-010-1826-4 10.1164/ajrccm.164.3.2005003 10.1086/599225 10.1074/jbc.M304043200 10.1016/j.diagmicrobio.2007.01.008 10.1128/AAC.00510-13 10.1042/bj1810623 10.7326/0003-4819-72-6-857 10.1016/j.ijantimicag.2010.10.031 10.1155/2015/568079 10.1002/phar.1493 10.1128/AAC.00126-11 10.1128/AAC.00702-16 10.1128/msystems.00149-18 10.1097/00000372-199012000-00011 10.1086/380461 10.1016/j.ijantimicag.2010.06.004 10.3390/ijms17040565 10.1038/ja.2016.146 10.1128/JB.187.15.5387-5396.2005 10.1007/978-3-030-16373-0_15 10.1093/ofid/ofz360.775 10.1128/IAI.71.9.5225-5230.2003 10.1038/ja.2009.99 10.1093/cid/ciw839 10.1016/j.bjid.2013.07.002 10.1128/AAC.00030-09 10.1016/S0091-6749(03)01881-5 10.1016/j.cmi.2017.11.020 10.1007/BF02124474 10.1128/AAC.00554-15 10.1093/jac/49.2.403 10.1038/srep45527 10.1093/jac/dku567 10.1093/ofid/ofz360.758 10.1038/ja.2013.111 10.1016/j.jgar.2013.03.012 10.1021/bi702457c 10.1371/journal.pone.0018485 10.1002/bjs.7703 10.1016/0014-5793(81)80777-6 10.1128/AAC.03733-14 10.1016/j.jinf.2004.05.008 10.1073/pnas.0903229106 10.1016/j.ijantimicag.2013.10.015 10.1016/j.peptides.2012.03.033 10.1093/jac/dkh369 10.1093/chromsci/35.12.557 10.1093/jac/dkm511 10.1021/bc500094d 10.1128/AAC.02101-17 10.1001/jama.2009.856 10.1093/jac/39.2.255 10.1128/AAC.01216-15 10.1186/cc9655 10.1016/j.ijantimicag.2016.06.023 10.1111/j.1469-0691.2011.03682.x 10.1128/AAC.00405-08 10.1111/jcpt.12543 10.1093/infdis/156.5.706 10.1164/rccm.200505-820OC 10.1093/jac/dkx002 10.1021/bi9512408 10.3389/fmicb.2014.00551 10.1179/1973947813Y.0000000136 10.1128/AAC.02587-12 10.1111/j.1469-0691.2009.02921.x 10.1128/AAC.00756-06 10.1128/AAC.45.3.781-785.2001 10.1016/j.jcf.2003.12.005 10.1093/jac/dkh289 10.1074/jbc.M501534200 10.1093/ajhp/62.1.39 10.1128/JB.186.2.575-579.2004 10.1093/cid/cit680 10.1128/AAC.00254-13 10.1021/jp064757+ 10.1039/D0MO00015A 10.1186/1423-0127-17-60 10.1093/jac/dkp331 10.1128/AAC.00515-15 10.1093/cid/civ048 10.1128/AAC.01333-12 10.1128/AAC.00985-17 10.1128/AAC.01495-19 10.1016/j.diagmicrobio.2012.04.002 10.1023/A:1007487330893 10.1128/AAC.00103-06 10.1128/MMBR.67.4.593-656.2003 10.1074/jbc.M109377200 10.1128/AAC.06486-11 10.1046/j.1365-2958.1999.01600.x 10.1371/journal.pone.0207588 10.1128/AAC.00556-19 10.7164/antibiotics.30.767 10.1016/j.ijid.2005.03.005 10.1128/AAC.01705-13 10.1136/thx.52.11.987 10.1021/acsinfecdis.0c00190 10.1128/AAC.01433-06 10.1093/jac/dkh470 10.3109/15376516.2012.754533 10.1345/aph.18426 10.1080/23744235.2017.1296183 10.1016/j.jinf.2005.11.019 10.1183/09031936.98.12030592 10.1093/jac/dkn425 10.1093/jac/dks257 10.1111/j.1476-5381.1967.tb01946.x 10.1128/IAI.68.11.6139-6146.2000 10.1016/j.ijantimicag.2017.05.016 10.3390/antibiotics8010027 10.1128/AAC.00786-09 10.1080/10790268.2006.11753877 10.1186/cc5780 10.1186/1752-1947-6-426 10.1128/AAC.01018-18 10.1074/jbc.M414265200 10.1093/jac/dkr239 10.1093/jac/dkaa376 10.1016/j.bpj.2016.09.001 10.3389/fpubh.2019.00151 10.1111/j.1365-2958.2010.07150.x 10.1128/JCM.00427-13 10.1179/joc.2006.18.5.554 10.1128/AAC.01329-12 10.1093/jac/dkx327 10.1128/AAC.02121-16 10.1128/AAC.02176-18 10.1016/j.ijid.2009.09.001 10.1016/j.diagmicrobio.2012.07.010 |
| ContentType | Journal Article |
| Copyright | 2021 American Society for Pharmacology and Experimental Therapeutics Copyright © 2021 by The Author(s). Copyright © 2021 by The Author(s) 2021 |
| Copyright_xml | – notice: 2021 American Society for Pharmacology and Experimental Therapeutics – notice: Copyright © 2021 by The Author(s). – notice: Copyright © 2021 by The Author(s) 2021 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
| DOI | 10.1124/pharmrev.120.000020 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Pharmacy, Therapeutics, & Pharmacology |
| DocumentTitleAlternate | Pharmacology of Polymyxins |
| EISSN | 1521-0081 |
| EndPage | 728 |
| ExternalDocumentID | PMC7911091 33627412 10_1124_pharmrev_120_000020 S0031699724006604 |
| Genre | Review Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NIAID NIH HHS grantid: R01 AI132681 – fundername: NIAID NIH HHS grantid: R01 AI132154 – fundername: NIAID NIH HHS grantid: R01 AI146160 |
| GroupedDBID | --- -~X .55 .GJ 0R~ 123 18M 1KJ 2WC 3O- 4.4 53G 5RE 5VS AAJMC AALRI AAXUO AAYOK ABCQX ABJNI ABOCM ABSQV ACGFO ACGFS ADBBV ADCOW AENEX AERNN AFHIN AFOSN AGFXO ALMA_UNASSIGNED_HOLDINGS BAWUL BTFSW CS3 DIK DU5 E3Z EBS EJD F5P F9R FDB GX1 H13 HZ~ INIJC KQ8 L7B LSO MVM N4W N9A O9- OK1 P2P RHF RHI RPT SJN TR2 W8F WOQ X7M YBU YHG YNH ZGI ZKB ZXP AAYXX AETEA CITATION M41 ROL CGR CUY CVF ECM EIF NPM 7X8 5PM |
| ID | FETCH-LOGICAL-c459t-f847aecd94169397c78c2c481f7befe499f60ae0cfd56a58a1cc5f785c08115d3 |
| ISSN | 0031-6997 1521-0081 |
| IngestDate | Thu Aug 21 13:31:19 EDT 2025 Fri Jul 11 05:27:11 EDT 2025 Mon Jul 21 06:00:24 EDT 2025 Thu Apr 24 23:05:52 EDT 2025 Tue Jul 01 05:21:21 EDT 2025 Sat Jan 25 15:58:37 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | IVM FDA CBA HFIM VAP TCS fAUC CNS UTI ATCC LPS AUC KIM-1 SDD NDM Kdo ESBL fCmax MDR FADD NDH-2 pEtN PEPT2 XFM CLSI Css,avg Css Dab EUCAST L-Ara4N MIC CAMHB XDR CMS SOD IU TD cfu CAS PD PAE ROS MIU ICU PK DPI ELF KPC |
| Language | English |
| License | Copyright © 2021 by The Author(s). This is an open access article distributed under the CC BY-NC Attribution 4.0 International license. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c459t-f847aecd94169397c78c2c481f7befe499f60ae0cfd56a58a1cc5f785c08115d3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC7911091 |
| PMID | 33627412 |
| PQID | 2493456714 |
| PQPubID | 23479 |
| PageCount | 50 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_7911091 proquest_miscellaneous_2493456714 pubmed_primary_33627412 crossref_primary_10_1124_pharmrev_120_000020 crossref_citationtrail_10_1124_pharmrev_120_000020 elsevier_sciencedirect_doi_10_1124_pharmrev_120_000020 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 20210401 |
| PublicationDateYYYYMMDD | 2021-04-01 |
| PublicationDate_xml | – month: 4 year: 2021 text: 20210401 day: 1 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: Bethesda, MD |
| PublicationTitle | Pharmacological reviews |
| PublicationTitleAlternate | Pharmacol Rev |
| PublicationYear | 2021 |
| Publisher | Elsevier Inc The American Society for Pharmacology and Experimental Therapeutics |
| Publisher_xml | – name: Elsevier Inc – name: The American Society for Pharmacology and Experimental Therapeutics |
| References | de Smet, Hopmans, Minderhoud, Blok, Gossink-Franssen, Bernards, Bonten (bib166) 2009; 35 Manchandani, Thamlikitkul, Dubrovskaya, Babic, Lye, Lee, Tam (bib392) 2018; 104 Li, Milikowski, Selvaggi, Abbo, Skiada, Galimberti (bib358) 2020; 22 Tan, Ng (bib560) 2006; 58 Decker, Fincham (bib157) 1971; 25 Govaerts, Orwa, Van Schepdael, Roets, Hoogmartens (bib228) 2002; 976 Deris, Akter, Sivanesan, Roberts, Thompson, Nation, Li, Velkov (bib163) 2014; 67 Moskowitz, Ernst, Miller (bib427) 2004; 186 Dai, Tang, Velkov, Xiao (bib146) 2016; 53 Ochoa-Ardila, García-Cañas, Gómez-Mediavilla, González-Torralba, Alía, García-Hierro, Taylor, van Saene, de la Cal (bib454) 2011; 37 Al Shirawi, Memish, Cherfan, Al Shimemeri (bib18) 2006; 18 Madrid, Spain. Zalts, Neuberger, Hussein, Raz-Pasteur, Geffen, Mashiach, Finkelstein (bib648) 2016; 23 Li, Nation, Turnidge (bib352) 2006; 50 Glupczynski, Delmee, Bruck, Labbe, Avesani, Burette (bib220) 1988; 4 Burt, Crowell, Ackley, Magee, Aubrecht (bib93) 2014; 37 Justo, Bosso (bib290) 2015; 35 Zhou, Leung, Tang, Parumasivam, Loh, Chan (bib661) 2015; 85 Salazar, Alarcón, Huerta, Navarro, Aguayo (bib514) 2017; 620 Kim, Patel, Park, Slusky, Klauda, Widmalm, Im (bib308) 2016; 111 Plachouras, Giamarellos-Bourboulis, Kentepozidis, Baziaka, Karagianni, Giamarellou (bib480) 2007; 57 Sampson, Liu, Schroeder, Kraft, Burd, Weiss (bib515) 2012; 56 (bib131) 2018 Diep, Jacobs, Sharma, Covelli, Bowers, Russo, Rao (bib173) 2017; 61 Sandri, Landersdorfer, Jacob, Boniatti, Dalarosa, Falci, Behle, Saitovitch, Wang, Forrest (bib519) 2013; 68 Behera, Mathur, Das, Kapil, Gupta, Bhoi, Farooque, Sharma, Misra (bib48) 2010; 14 de Jonge, Schultz, Spanjaard, Bossuyt, Vroom, Dankert, Kesecioglu (bib159) 2003; 362 Clausell, Garcia-Subirats, Pujol, Busquets, Rabanal, Cajal (bib126) 2007; 111 Zaidi, Al Omran, Al Aithan, Al Sultan (bib647) 2014; 39 Mathur, Waldor (bib402) 2004; 72 Viena, Austria. Parker, Rathnum, Dean, Nimeck, Brown, Meyers (bib471) 1977; 30 Tietgen, Semmler, Riedel-Christ, Kempf, Molinaro, Ewers, Göttig (bib573) 2018; 51 Lenhard, Smith, Bulman, Tao, Thamlikitkul, Shin, Nation, Li, Bulitta, Tsuji (bib341) 2017; 61 Sánchez García, Cambronero Galache, López Diaz, Cerdá Cerdá, Rubio Blasco, Gómez Aguinaga, Núnez Reiz, Rogero Marín, Onoro Canaveral, Sacristán del Castillo (bib516) 1998; 158 Macedo, Gonçalves, Bispo, Almeida, Brito (bib385) 2011; 15 Zavascki, Schuster, Duquia (bib653) 2016; 48 Ng, Teng, Lye, Apisarnthanarak (bib444) 2014; 35 Cheong, Kim, Wi, Peck, Ko (bib119) 2019; 8 Mingeot-Leclercq, Tulkens, Denamur, Vaara, Vaara (bib416) 2012; 35 Deris, Swarbrick, Roberts, Azad, Akter, Horne, Nation, Rogers, Thompson, Velkov (bib164) 2014; 25 Liu, Wang, Walsh, Yi, Zhang, Spencer, Doi, Tian, Dong, Huang (bib372) 2016; 16 Sandri, Landersdorfer, Jacob, Boniatti, Dalarosa, Falci, Behle, Bordinhão, Wang, Forrest (bib518) 2013; 57 Walkty, DeCorby, Nichol, Karlowsky, Hoban, Zhanel (bib614) 2009; 53 Henry, Crane, Powell, Deveson Lucas, Li, Aranda, Harrison, Nation, Adler, Harper (bib257) 2015; 70 Gordeev MF, Liu J, Wang Z, and Yuan Z (2016) inventors, Micurx Pharmaceuticals Inc, assignee. Antimicrobial polymyxins for treatment of bacterial infections. Patent WO2016100578. 2016 Jun 23. Zhanel, Adam, Baxter, Fuller, Nichol, Denisuik, Lagacé-Wiens, Walkty, Karlowsky, Schweizer (bib655) 2013; 68 Ma, Wang, Nation, Li, Turnidge, Coulthard, Milne (bib383) 2009; 53 Cassir, Rolain, Brouqui (bib104) 2014; 5 Okuda, Saito, Urakami, Takano, Inui (bib455) 1996; 224 Oostdijk, de Smet, Kesecioglu, Bonten (bib458) 2011; 39 Abdul Rahim, Cheah, Johnson, Zhu, Yu, Sidjabat, Butler, Cooper, Fu, Paterson (bib5) 2020; 56 Percin, Akyol, Kalin (bib476) 2014; 9 Nastro, Rodríguez, Monge, Zintgraff, Neira, Rebollo, Vay, Famiglietti (bib437) 2014; 26 (bib109) 2019 Fernandez-Viladrich, Corbella, Corral, Tubau, Mateu (bib201) 1999; 28 Lin, Zhou, Hu, Onufrak, Sun, Wang, Forrest, Chan, Li (bib370) 2017; 61 Jiang, Yang, Yuan, Han, Zhu, Roberts, Patil, Li, Gong, Hancock (bib279) 2020; 75 Bengoechea, Skurnik (bib52) 2000; 37 Maalej, Meziou, Rhimi, Hammami (bib384) 2011; 53 Kaye, Pogue, Tran, Nation, Li (bib300) 2016; 30 Pugin, Auckenthaler, Lew, Suter (bib489) 1991; 265 Li, Milne, Nation, Turnidge, Smeaton, Coulthard (bib348) 2003; 47 Sorlí, Luque, Li, Campillo, Danés, Montero, Segura, Grau, Horcajada (bib543) 2019; 79 Jin, Nation, Li, Nicolazzo (bib284) 2013; 57 Li, Rayner, Nation, Deans, Boots, Widdecombe, Douglas, Lipman (bib354) 2005; 49 Albur, Noel, Bowker, MacGowan (bib14) 2015; 46 Reynolds, Kalb, Cotter, Raetz (bib497) 2005; 280 Yagmur, Esen (bib634) 2006; 10 Boisson, Jacobs, Grégoire, Gobin, Marchand, Couet, Mimoz (bib71) 2014; 58 Dance, Wuthiekanun, Naigowit, White (bib153) 1989; 42 Meletis, Tzampaz, Sianou, Tzavaras, Sofianou (bib409) 2011; 66 Nang, Li, Velkov (bib436) 2019; 45 Leite, Oliveira, Perdigão-Neto, Rocha, Guimarães, Rizek, Levin, Costa (bib340) 2016; 11 Cheng, Chen, Peng (bib117) 2010; 17 Cockerill, Muller, Anhalt, Marsh, Farnell, Mucha, Gillespie, Ilstrup, Larson-Keller, Thompson (bib133) 1992; 117 Sivanesan S, Wang J, Cheah SE, Schittenhelm R, Purcell AW, Velkov T, and Li J (2017c) EP0951: Identification of potential early urinary biomarkers for polymyxin-induced nephrotoxicity using proteomics, in Srinivasan, Singh, Priyadarshi, Chauhan, Rajamohan (bib546) 2014; 9 Shimizu, Miyake, Tani (bib532) 2017; 1 Aydin, Atabay, Akan (bib30) 2001; 90 Shoji, Kato, Hinoo (bib536) 1977; 30 Vaara, Fox, Loidl, Siikanen, Apajalahti, Hansen, Frimodt-Møller, Nagai, Takano, Vaara (bib586) 2008; 52 Lee, Bergen, Bulitta, Tsuji, Forrest, Nation, Li (bib337) 2013; 57 Jeannot, Bolard, Plésiat (bib277) 2017; 49 Qureshi, Hittle, O’Hara, Rivera, Syed, Shields, Pasculle, Ernst, Doi (bib492) 2015; 60 Sun, Shields, Cacciarelli, Muder, Singh (bib553) 2010; 12 Park, Choi, Jang, Jeong, Kim, Choi, Kang, Park, Moon (bib469) 2016; 36 Azad, Finnin, Poudyal, Davis, Li, Hill, Nation, Velkov, Li (bib33) 2013; 57 Lahiry, Choudhury, Mukherjee, Bhunya, Bala (bib328) 2017; 11 Piparsania, Rajput, Bhatambare (bib479) 2012; 54 Garnacho-Montero, Ortiz-Leyba, Jiménez-Jiménez, Barrero-Almodóvar, García-Garmendia, Bernabeu-WittelI, Gallego-Lara, Madrazo-Osuna (bib211) 2003; 36 Elemam, Rahimian, Doymaz (bib185) 2010; 48 Pastewski, Caruso, Parris, Dizon, Kopec, Sharma, Mayer, Ghitan, Chapnick (bib472) 2008; 42 Cernohorská, Sláviková (bib110) 2009; 58 Hsieh, Chen, Ou, Jean, Lee (bib265) 2016; 49 Shimomura, Matsuura, Saito, Hirai, Isshiki, Kawahara (bib533) 2003; 71 Velkov, Roberts, Nation, Wang, Thompson, Li (bib602) 2014; 9 Malinverni, Silhavy (bib390) 2009; 106 Nation, Forrest (bib438) 2019; 1145 Chen, Kuo (bib115) 2016; 17 Fernández, Gooderham, Bains, McPhee, Wiegand, Hancock (bib199) 2010; 54 Dai, Ciccotosto, Cappai, Tang, Li, Xie, Xiao, Velkov (bib143) 2018; 55 Bergen, Landersdorfer, Zhang, Zhao, Lee, Nation, Li (bib57) 2012; 74 Qureshi, Paterson, Potoski, Kilayko, Sandovsky, Sordillo, Polsky, Adams-Haduch, Doi (bib493) 2012; 56 Tang, Ku, Lee, Chuang, Yu (bib563) 2015; 2015 Decolin, Leroy, Nicolas, Archimbault (bib158) 1997; 35 Yu, Qin, Lin, Fang, Qiu (bib642) 2015; 2015 Jin, Li, Nation, Nicolazzo (bib281) 2009; 53 Makris, Petinaki, Tsolaki, Manoulakas, Mantzarlis, Apostolopoulou, Sfyras, Zakynthinos (bib389) 2018; 22 Aoki, Tateda, Kikuchi, Kimura, Miyazaki, Ishii, Tanabe, Gejyo, Yamaguchi (bib24) 2009; 63 Shields, Nguyen, Hao, Kline, Clancy (bib531) 2018; 62 Bishop, Gibbons, Guina, Trent, Miller, Raetz (bib68) 2000; 19 Pankuch, Seifert, Appelbaum (bib466) 2010; 67 Chin, Gregg, Napier, Ernst, Weiss (bib121) 2015; 59 (bib189) 2010 Ku, Chen, Lee, Chuang, Tang, Yu (bib319) 2017; 50 Zavascki, Nation (bib652) 2017; 61 Sader, Rhomberg, Flamm, Jones (bib513) 2012; 74 Lu, Chan, Xu, Zhu, Zhou, Roberts, Chan, Li, Zhou (bib377) 2016; 71 Li, Nation, Owen, Wong, Spelman, Franklin (bib351) 2007; 45 Mutlu Yilmaz, Sunbul, Aksoy, Yilmaz, Guney, Guvenc (bib433) 2012; 40 Vaara, Vaara, Jensen, Helander, Nurminen, Rietschel, Mäkelä (bib592) 1981; 129 Di, Wang, Liu, Zhang, Ni, Wang, Liang, Cai, Liu (bib172) 2015; 68 Vardakas, Voulgaris, Samonis, Falagas (bib594) 2018; 51 Gkoufa A, Karaiskos I, Routsi C, Friberg L, Sou T, Lin YW, Li J, and Giamarellou H (2019) P-3296: Pulmonary and systemic pharmacokinetics of colistin methanesulfonate (CMS) and formed colistin following nebulization of CMS after a single inhalation dose of 3 MIU and 5 MIU in ICU patients with ventilator-associated pneumonia, in Dai, Li, Tang, Li, Xiao (bib145) 2014; 58 Hanasawa, Tani, Oka, Yoshioka, Aoki, Endo, Kodama (bib241) 1988; 264 (bib192) 2020 (bib581) 2018 Trent, Ribeiro, Lin, Cotter, Raetz (bib576) 2001; 276 Finland, Garner, Wilcox, Sabath (bib202) 1976; 9 Pamp, Gjermansen, Johansen, Tolker-Nielsen (bib465) 2008; 68 Nummila, Kilpeläinen, Zähringer, Vaara, Helander (bib452) 1995; 16 Shaheen, Li, Ross, Vederas, Jensen (bib527) 2011; 18 Lesmana, Subekti, Tjaniadi, Simanjuntak, Punjabi, Campbell, Oyofo (bib345) 2002; 43 Kvitko, Rigatto, Moro, Zavascki (bib323) 2011; 66 Wang, Feng, Liu, Wei, Kang, Zong (bib616) 2020; 9 (bib269) 2004 Barret, Jeschke, Herndon (bib47) 2001; 27 He, Ledesma, Lam, Figueroa, Lim, Chow, Tam (bib251) 2010; 35 Pogue, Jones, Bradley, Andes, Bhavnani, Drusano, Dudley, Flamm, Rodvold, Ambrose (bib483) 2020; 64 Dai, Xiao, Li, Ciccotosto, Cappai, Tang, Schneider-Futschik, Hoyer, Velkov, Shen (bib147) 2019; 10 Suh, Son, Chung, Peck, Ko, Song (bib552) 2010; 54 Hankins, Madsen, Giles, Brodbelt, Trent (bib243) 2012; 109 Tiddens, Bos, Mouton, Devadason, Janssens (bib572) 2014; 44 Azad MAK, Li M, Zhu Y, Chapman R, Gould J, Hertzog P, Thompson PE, Roberts KD, Velkov T, and Li J (2018) Understanding the structure-nephrotoxicity relationship of polymyxins: a transcriptomic approach, in Kox, Wösten, Groisman (bib316) 2000; 19 Fechner, Jacobs, Parsons (bib198) 1993; 46 Wright, Welch (bib632) 1959–1960; 7 Dubrovskaya, Chen, Scipione, Esaian, Phillips, Papadopoulos, Mehta (bib179) 2013; 57 Suzuki, Yamaguchi, Ogura, Kobayashi, Yamada, Iseki (bib556) 2013; 57 Motaouakkil, Charra, Hachimi, Nejmi, Benslama, Elmdaghri, Belabbes, Benbachir (bib431) 2006; 53 Payen, Guilhot, Launey, Plachouras (10.1124/pharmrev.120.000020_bib480) 2007; 57 Maichuk (10.1124/pharmrev.120.000020_bib387) 1991; 68 Carattoli (10.1124/pharmrev.120.000020_bib102) 2017; 22 Velkov (10.1124/pharmrev.120.000020_bib597) 2015; 85 Lin (10.1124/pharmrev.120.000020_bib363) 2019; 63 Berlana (10.1124/pharmrev.120.000020_bib62) 2005; 62 Gutu (10.1124/pharmrev.120.000020_bib234) 2013; 57 Garonzik (10.1124/pharmrev.120.000020_bib212) 2011; 55 Tzeng (10.1124/pharmrev.120.000020_bib580) 2005; 187 Nikaido (10.1124/pharmrev.120.000020_bib446) 2003; 67 Williams (10.1124/pharmrev.120.000020_bib627) 2005; 280 Nakamura (10.1124/pharmrev.120.000020_bib435) 2014; 20 Wareham (10.1124/pharmrev.120.000020_bib619) 2011; 66 Herrera (10.1124/pharmrev.120.000020_bib259) 2010; 76 Makris (10.1124/pharmrev.120.000020_bib389) 2018; 22 Mattos (10.1124/pharmrev.120.000020_bib404) 2016; 29 Dai (10.1124/pharmrev.120.000020_bib144) 2018; 9 Lee (10.1124/pharmrev.120.000020_bib336) 2004; 186 Imberti (10.1124/pharmrev.120.000020_bib268) 2012; 56 Burt (10.1124/pharmrev.120.000020_bib93) 2014; 37 Chen (10.1124/pharmrev.120.000020_bib115) 2016; 17 Genée (10.1124/pharmrev.120.000020_bib213) 1982; 184 Conway (10.1124/pharmrev.120.000020_bib135) 1997; 52 Yapa (10.1124/pharmrev.120.000020_bib637) 2014; 58 (10.1124/pharmrev.120.000020_bib189) 2010 Lee (10.1124/pharmrev.120.000020_bib338) 2013; 51 Poudyal (10.1124/pharmrev.120.000020_bib486) 2008; 62 Ahmed (10.1124/pharmrev.120.000020_bib9) 2017; 61 Velkov (10.1124/pharmrev.120.000020_bib605) 2016; 2 Azad (10.1124/pharmrev.120.000020_bib35) 2015; 87 Moskowitz (10.1124/pharmrev.120.000020_bib428) 2010; 65 Babic (10.1124/pharmrev.120.000020_bib40) 2017; 61 Waterman (10.1124/pharmrev.120.000020_bib620) 2012; 41 Dezoti Fonseca (10.1124/pharmrev.120.000020_bib171) 2012; 56 Abdul Rahim (10.1124/pharmrev.120.000020_bib5) 2020; 56 Khawcharoenporn (10.1124/pharmrev.120.000020_bib304) 2010; 16 Leite (10.1124/pharmrev.120.000020_bib340) 2016; 11 Gaibani (10.1124/pharmrev.120.000020_bib205) 2014; 69 Mutlu Yilmaz (10.1124/pharmrev.120.000020_bib433) 2012; 40 Drehobl (10.1124/pharmrev.120.000020_bib177) 2008; 24 Arroyo (10.1124/pharmrev.120.000020_bib27) 2011; 55 Landman (10.1124/pharmrev.120.000020_bib331) 2005; 55 Yu (10.1124/pharmrev.120.000020_bib641) 2017; 7 Albur (10.1124/pharmrev.120.000020_bib12) 2012; 56 Azad (10.1124/pharmrev.120.000020_bib31) 2015; 59 Bukhary (10.1124/pharmrev.120.000020_bib91) 2005; 26 Cheng (10.1124/pharmrev.120.000020_bib117) 2010; 17 Lin (10.1124/pharmrev.120.000020_bib365) 2019; 63 10.1124/pharmrev.120.000020_bib540 Fernández (10.1124/pharmrev.120.000020_bib200) 2012; 56 (10.1124/pharmrev.120.000020_bib581) 2018 Kosakai (10.1124/pharmrev.120.000020_bib315) 1976; 29 Lin (10.1124/pharmrev.120.000020_bib369) 2018; 62 Baiocchi (10.1124/pharmrev.120.000020_bib41) 2010; 18 Decolin (10.1124/pharmrev.120.000020_bib158) 1997; 35 Azad (10.1124/pharmrev.120.000020_bib37) 2014; 58 (10.1124/pharmrev.120.000020_bib109) 2019 10.1124/pharmrev.120.000020_bib302 Flynn (10.1124/pharmrev.120.000020_bib203) 1987; 156 Kieffer (10.1124/pharmrev.120.000020_bib306) 2019; 63 Tascini (10.1124/pharmrev.120.000020_bib567) 2004; 16 (10.1124/pharmrev.120.000020_bib441) 1976 Buyck (10.1124/pharmrev.120.000020_bib95) 2013; 57 Kohanski (10.1124/pharmrev.120.000020_bib314) 2007; 130 Pamp (10.1124/pharmrev.120.000020_bib465) 2008; 68 Falagas (10.1124/pharmrev.120.000020_bib194) 2007; 29 Yun (10.1124/pharmrev.120.000020_bib646) 2018; 92 Justo (10.1124/pharmrev.120.000020_bib290) 2015; 35 Queenan (10.1124/pharmrev.120.000020_bib490) 2012; 73 Peterson (10.1124/pharmrev.120.000020_bib478) 1996 Al-Sweih (10.1124/pharmrev.120.000020_bib17) 2011; 23 Vattimo (10.1124/pharmrev.120.000020_bib596) 2016; 11 Kasiakou (10.1124/pharmrev.120.000020_bib297) 2005; 11 Rios (10.1124/pharmrev.120.000020_bib500) 2007; 30 Urban (10.1124/pharmrev.120.000020_bib582) 2010; 54 Cheah (10.1124/pharmrev.120.000020_bib112) 2016; 60 Hsieh (10.1124/pharmrev.120.000020_bib265) 2016; 49 Parker (10.1124/pharmrev.120.000020_bib471) 1977; 30 Borowiak (10.1124/pharmrev.120.000020_bib72) 2017; 72 Barret (10.1124/pharmrev.120.000020_bib47) 2001; 27 (10.1124/pharmrev.120.000020_bib78) 2018 Llobet (10.1124/pharmrev.120.000020_bib373) 2008; 154 Han (10.1124/pharmrev.120.000020_bib238) 2018; 9 Guo (10.1124/pharmrev.120.000020_bib233) 2018; 7 Papagelopoulos (10.1124/pharmrev.120.000020_bib468) 2007; 22 Morrison (10.1124/pharmrev.120.000020_bib426) 1976; 13 Buelow (10.1124/pharmrev.120.000020_bib90) 2017; 5 Barnett (10.1124/pharmrev.120.000020_bib45) 1964; 23 Maalej (10.1124/pharmrev.120.000020_bib384) 2011; 53 Tsuji (10.1124/pharmrev.120.000020_bib577) 2019; 39 D’Souza (10.1124/pharmrev.120.000020_bib178) 2014; 20 Yun (10.1124/pharmrev.120.000020_bib645) 2015; 59 Reychler (10.1124/pharmrev.120.000020_bib496) 2004; 125 Yoon (10.1124/pharmrev.120.000020_bib638) 2004; 48 Dortet (10.1124/pharmrev.120.000020_bib176) 2014; 2014 Li (10.1124/pharmrev.120.000020_bib348) 2003; 47 White (10.1124/pharmrev.120.000020_bib623) 1949; 51 Jacquemin (10.1124/pharmrev.120.000020_bib272) 1994; 91 Dai (10.1124/pharmrev.120.000020_bib146) 2016; 53 Jayol (10.1124/pharmrev.120.000020_bib275) 2018; 24 Jin (10.1124/pharmrev.120.000020_bib284) 2013; 57 Morrissey (10.1124/pharmrev.120.000020_bib425) 2020; 64 Charretier (10.1124/pharmrev.120.000020_bib111) 2018; 62 Hausmann (10.1124/pharmrev.120.000020_bib245) 1954; 76 Mingeot-Leclercq (10.1124/pharmrev.120.000020_bib416) 2012; 35 Sabet (10.1124/pharmrev.120.000020_bib511) 2019; 6 Hartzell (10.1124/pharmrev.120.000020_bib244) 2009; 48 Dai (10.1124/pharmrev.120.000020_bib148) 2013; 23 Kox (10.1124/pharmrev.120.000020_bib316) 2000; 19 Miglis (10.1124/pharmrev.120.000020_bib414) 2018; 62 Valour (10.1124/pharmrev.120.000020_bib593) 2013; 41 Betts (10.1124/pharmrev.120.000020_bib65) 2014; 33 Zavascki (10.1124/pharmrev.120.000020_bib651) 2015; 49 Beveridge (10.1124/pharmrev.120.000020_bib66) 1967; 29 Leong (10.1124/pharmrev.120.000020_bib343) 2010; 14 Bergen (10.1124/pharmrev.120.000020_bib57) 2012; 74 (10.1124/pharmrev.120.000020_bib131) 2018 Furtado (10.1124/pharmrev.120.000020_bib204) 2007; 30 Jayol (10.1124/pharmrev.120.000020_bib274) 2015; 59 Rodríguez Guardado (10.1124/pharmrev.120.000020_bib505) 2008; 61 Sirijatuphat (10.1124/pharmrev.120.000020_bib537) 2015; 59 Nilsson (10.1124/pharmrev.120.000020_bib448) 2015; 28 Duperthuy (10.1124/pharmrev.120.000020_bib182) 2010; 12 Jiang (10.1124/pharmrev.120.000020_bib279) 2020; 75 Landersdorfer (10.1124/pharmrev.120.000020_bib330) 2018; 73 Miori (10.1124/pharmrev.120.000020_bib417) 1990; 12 Jin (10.1124/pharmrev.120.000020_bib281) 2009; 53 Kwa (10.1124/pharmrev.120.000020_bib324) 2007; 5 Vaara (10.1124/pharmrev.120.000020_bib585) 2019; 10 Okuda (10.1124/pharmrev.120.000020_bib455) 1996; 224 Murray (10.1124/pharmrev.120.000020_bib432) 1984 Wertheim (10.1124/pharmrev.120.000020_bib621) 2013; 1 Lee (10.1124/pharmrev.120.000020_bib335) 2013; 5 Couet (10.1124/pharmrev.120.000020_bib139) 2011; 89 Souli (10.1124/pharmrev.120.000020_bib544) 2009; 53 Zarkotou (10.1124/pharmrev.120.000020_bib649) 2011; 17 Lin (10.1124/pharmrev.120.000020_bib364) 2014; 58 Vaara (10.1124/pharmrev.120.000020_bib583) 2013; 68 Velkov (10.1124/pharmrev.120.000020_bib602) 2014; 9 Choi (10.1124/pharmrev.120.000020_bib123) 2014; 55 Newton (10.1124/pharmrev.120.000020_bib443) 1954; 10 Wilkinson (10.1124/pharmrev.120.000020_bib624) 1949; 164 10.1124/pharmrev.120.000020_bib32 10.1124/pharmrev.120.000020_bib34 Shimomura (10.1124/pharmrev.120.000020_bib533) 2003; 71 Abele-Horn (10.1124/pharmrev.120.000020_bib7) 1997; 23 Sato (10.1124/pharmrev.120.000020_bib522) 2011; 59 10.1124/pharmrev.120.000020_bib38 Kerver (10.1124/pharmrev.120.000020_bib303) 1988; 16 Barcelos (10.1124/pharmrev.120.000020_bib42) 2016; 148 Di (10.1124/pharmrev.120.000020_bib172) 2015; 68 Sader (10.1124/pharmrev.120.000020_bib512) 2011; 37 Anderson (10.1124/pharmrev.120.000020_bib19) 2006; 50 Bengoechea (10.1124/pharmrev.120.000020_bib52) 2000; 37 Kimura (10.1124/pharmrev.120.000020_bib310) 1981; 206 Maifiah (10.1124/pharmrev.120.000020_bib388) 2017; 7 Thamlikitkul (10.1124/pharmrev.120.000020_bib570) 2016; 61 Srinivasan (10.1124/pharmrev.120.000020_bib546) 2014; 9 Dautrevaux (10.1124/pharmrev.120.000020_bib155) 1961; 43 Ruza (10.1124/pharmrev.120.000020_bib508) 1998; 14 Alothman (10.1124/pharmrev.120.000020_bib16) 2005; 127 (10.1124/pharmrev.120.000020_bib630) 2017 Benedict (10.1124/pharmrev.120.000020_bib51) 1947; 54 10.1124/pharmrev.120.000020_bib39 Holmes (10.1124/pharmrev.120.000020_bib263) 1964; 271 Ito-Kagawa (10.1124/pharmrev.120.000020_bib271) 1980; 33 Stoutenbeek (10.1124/pharmrev.120.000020_bib551) 1987; 27 Kiehlbauch (10.1124/pharmrev.120.000020_bib307) 1992; 36 Niu (10.1124/pharmrev.120.000020_bib449) 2013; 13 Jayol (10.1124/pharmrev.120.000020_bib276) 2014; 58 Aydin (10.1124/pharmrev.120.000020_bib30) 2001; 90 Reynolds (10.1124/pharmrev.120.000020_bib497) 2005; 280 Olaitan (10.1124/pharmrev.120.000020_bib456) 2014; 5 Pankuch (10.1124/pharmrev.120.000020_bib466) 2010; 67 Waites (10.1124/pharmrev.120.000020_bib613) 2006; 29 Abe (10.1124/pharmrev.120.000020_bib6) 1998; 273 10.1124/pharmrev.120.000020_bib510 Melsen (10.1124/pharmrev.120.000020_bib410) 2012; 99 Abdallah (10.1124/pharmrev.120.000020_bib1) 2015; 59 Gales (10.1124/pharmrev.120.000020_bib207) 2006; 12 Lagerbäck (10.1124/pharmrev.120.000020_bib327) 2016; 71 Falagas (10.1124/pharmrev.120.000020_bib197) 2008; 32 Sivanesan (10.1124/pharmrev.120.000020_bib539) 2017; 80 He (10.1124/pharmrev.120.000020_bib250) 2013; 68 AbuOun (10.1124/pharmrev.120.000020_bib8) 2017; 72 Fernández (10.1124/pharmrev.120.000020_bib199) 2010; 54 Eadon (10.1124/pharmrev.120.000020_bib183) 2013; 45 Price (10.1124/pharmrev.120.000020_bib488) 1970; 4 Wunsch (10.1124/pharmrev.120.000020_bib633) 2012; 141 Falagas (10.1124/pharmrev.120.000020_bib195) 2005; 40 Karaiskos (10.1124/pharmrev.120.000020_bib295) 2019; 7 Cheng (10.1124/pharmrev.120.000020_bib118) 2016; 60 Deris (10.1124/pharmrev.120.000020_bib163) 2014; 67 Bergen (10.1124/pharmrev.120.000020_bib59) 2006; 50 Govaerts (10.1124/pharmrev.120.000020_bib227) 2002; 8 Li (10.1124/pharmrev. |
| References_xml | – volume: 70 start-page: 3771 year: 1948 end-page: 3774 ident: bib530 article-title: Chemical studies on polymyxin; isolation and preliminary purification publication-title: J Am Chem Soc – volume: 64 start-page: e01699-19 year: 2020 ident: bib425 article-title: In vitro activity of eravacycline against Gram-negative bacilli isolated in clinical laboratories worldwide from 2013 to 2017 publication-title: Antimicrob Agents Chemother – volume: 19 start-page: 5071 year: 2000 end-page: 5080 ident: bib68 article-title: Transfer of palmitate from phospholipids to lipid A in outer membranes of Gram-negative bacteria publication-title: EMBO J – volume: 65 start-page: 2645 year: 2010 end-page: 2649 ident: bib495 article-title: Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria publication-title: J Antimicrob Chemother – volume: 30 start-page: 767 year: 1977 end-page: 769 ident: bib471 article-title: Polymyxin E, a new peptide antibiotic publication-title: J Antibiot (Tokyo) – volume: 85 start-page: 83 year: 2015 end-page: 99 ident: bib661 article-title: Inhaled formulations and pulmonary drug delivery systems for respiratory infections publication-title: Adv Drug Deliv Rev – volume: 9 year: 2014 ident: bib546 article-title: Role of novel multidrug efflux pump involved in drug resistance in publication-title: PLoS One – volume: 30 start-page: 1042 year: 1977 end-page: 1048 ident: bib535 article-title: The structure of polymyxin T1. (Studies on antibiotics from the genus Bacillus. XXII) publication-title: J Antibiot (Tokyo) – volume: 35 start-page: 28 year: 2015 end-page: 33 ident: bib290 article-title: Adverse reactions associated with systemic polymyxin therapy publication-title: Pharmacotherapy – volume: 56 start-page: 5724 year: 2012 end-page: 5727 ident: bib3 article-title: Pharmacokinetics and renal disposition of polymyxin B in an animal model publication-title: Antimicrob Agents Chemother – volume: 55 start-page: 502 year: 2011 end-page: 507 ident: bib282 article-title: Impact of p-glycoprotein inhibition and lipopolysaccharide administration on blood-brain barrier transport of colistin in mice publication-title: Antimicrob Agents Chemother – volume: 43 start-page: 874 year: 2008 end-page: 881 ident: bib429 article-title: Shifting patterns of inhaled antibiotic use in cystic fibrosis publication-title: Pediatr Pulmonol – volume: 54 start-page: 3372 year: 2010 end-page: 3382 ident: bib199 article-title: Adaptive resistance to the “last hope” antibiotics polymyxin B and colistin in publication-title: Antimicrob Agents Chemother – volume: 61 start-page: e01337-16 year: 2016 ident: bib570 article-title: Dosing and pharmacokinetics of polymyxin B in patients with renal insufficiency publication-title: Antimicrob Agents Chemother – volume: 12 start-page: 592 year: 1998 end-page: 594 ident: bib334 article-title: Four years’ experience of intravenous colomycin in an adult cystic fibrosis unit publication-title: Eur Respir J – volume: 56 start-page: 398 year: 2013 end-page: 404 ident: bib606 article-title: Association between colistin dose and microbiologic outcomes in patients with multidrug-resistant Gram-negative bacteremia publication-title: Clin Infect Dis – volume: 24 start-page: 249 year: 2019 ident: bib584 article-title: Polymyxin derivatives that sensitize Gram-negative bacteria to other antibiotics publication-title: Molecules – volume: 35 start-page: 49 year: 2014 end-page: 55 ident: bib444 article-title: A multicenter case-case control study for risk factors and outcomes of extensively drug-resistant publication-title: Infect Control Hosp Epidemiol – volume: 70 start-page: 3357 year: 2015 end-page: 3365 ident: bib498 article-title: Osteoarticular infection caused by MDR publication-title: J Antimicrob Chemother – volume: 53 start-page: 2133 year: 2009 end-page: 2135 ident: bib544 article-title: Does the activity of the combination of imipenem and colistin in vitro exceed the problem of resistance in metallo-beta-lactamase-producing publication-title: Antimicrob Agents Chemother – year: 2021 ident: bib191 article-title: Breakpoint tables for interpretation of MICs and zone diameters. Version 11.0 – volume: 282 start-page: 15569 year: 2007 end-page: 15577 ident: bib127 article-title: Secondary acylation of publication-title: J Biol Chem – volume: 87 start-page: 1590 year: 2015 end-page: 1595 ident: bib35 article-title: Significant accumulation of polymyxin in single renal tubular cells: a medicinal chemistry and triple correlative microscopy approach publication-title: Anal Chem – volume: 49 start-page: 526 year: 2017 end-page: 535 ident: bib277 article-title: Resistance to polymyxins in Gram-negative organisms publication-title: Int J Antimicrob Agents – volume: 29 start-page: 125 year: 1967 end-page: 135 ident: bib66 article-title: Sodium sulphomethyl derivatives of polymyxins publication-title: Br J Pharmacol Chemother – volume: 57 start-page: 5258 year: 2013 end-page: 5265 ident: bib125 article-title: Mutations of the publication-title: Antimicrob Agents Chemother – volume: 79 start-page: 253 year: 2019 end-page: 261 ident: bib543 article-title: Colistin for the treatment of urinary tract infections caused by extremely drug-resistant publication-title: J Infect – volume: 58 start-page: 2570 year: 2014 end-page: 2579 ident: bib637 article-title: Pulmonary and systemic pharmacokinetics of inhaled and intravenous colistin methanesulfonate in cystic fibrosis patients: targeting advantage of inhalational administration publication-title: Antimicrob Agents Chemother – volume: 59 start-page: 2780 year: 2015 end-page: 2784 ident: bib274 article-title: Heteroresistance to colistin in publication-title: Antimicrob Agents Chemother – volume: 1 start-page: 512 year: 2015 end-page: 522 ident: bib654 article-title: Permeability barrier of Gram-negative cell envelopes and approaches to bypass it publication-title: ACS Infect Dis – volume: 23 start-page: e78 year: 2016 end-page: e85 ident: bib648 article-title: Treatment of carbapenem-resistant publication-title: Am J Ther – volume: 360 start-page: 20 year: 2009 end-page: 31 ident: bib168 article-title: Decontamination of the digestive tract and oropharynx in ICU patients publication-title: N Engl J Med – volume: 57 start-page: 222 year: 2013 end-page: 223 ident: bib376 article-title: Efficacy of high-dose nebulized colistin in ventilator-associated pneumonia caused by multidrug-resistant publication-title: Anesthesiology – volume: 57 start-page: 6319 year: 2013 end-page: 6324 ident: bib556 article-title: Megalin contributes to kidney accumulation and nephrotoxicity of colistin publication-title: Antimicrob Agents Chemother – volume: 104 start-page: 534 year: 2018 end-page: 538 ident: bib392 article-title: Population pharmacokinetics of polymyxin B publication-title: Clin Pharmacol Ther – volume: 9 start-page: e00440-18 year: 2018 ident: bib161 article-title: Genomic analysis of a pan-resistant isolate of publication-title: MBio – volume: 54 start-page: 2732 year: 2010 end-page: 2734 ident: bib582 article-title: In vitro double and triple bactericidal activities of doripenem, polymyxin B, and rifampin against multidrug-resistant publication-title: Antimicrob Agents Chemother – volume: 73 start-page: 462 year: 2018 end-page: 468 ident: bib330 article-title: Pharmacokinetics/pharmacodynamics of systemically administered polymyxin B against publication-title: J Antimicrob Chemother – volume: 2 start-page: 341 year: 2016 end-page: 351 ident: bib605 article-title: A novel chemical biology approach for mapping of polymyxin lipopeptide antibody binding epitopes publication-title: ACS Infect Dis – volume: 47 start-page: 621 year: 2006 end-page: 624 ident: bib561 article-title: The in-vitro activity of colistin in Gram-negative bacteria publication-title: Singapore Med J – volume: 10 start-page: 491 year: 1954 end-page: 499 ident: bib443 article-title: Site of action of polymyxin on publication-title: J Gen Microbiol – volume: 4 start-page: e00157-18 year: 2019 ident: bib665 article-title: Metabolic responses to polymyxin treatment in publication-title: mSystems – volume: 29 start-page: 217 year: 2006 end-page: 226 ident: bib613 article-title: Evaluation of 3 methods of bladder irrigation to treat bacteriuria in persons with neurogenic bladder publication-title: J Spinal Cord Med – volume: 62 start-page: e01790-17 year: 2018 ident: bib369 article-title: Elucidating the pharmacokinetics/pharmacodynamics of aerosolized colistin against multidrug-resistant publication-title: Antimicrob Agents Chemother – start-page: 89 year: 1984 end-page: 95 ident: bib432 article-title: Use of antibiotic-containing bone cement publication-title: Clin Orthop Relat Res – volume: 69 start-page: 1432 year: 2014 end-page: 1434 ident: bib13 article-title: Colistin susceptibility testing: time for a review publication-title: J Antimicrob Chemother – volume: 75 start-page: 3534 year: 2020 end-page: 3543 ident: bib279 article-title: Molecular dynamics simulations informed by membrane lipidomics reveal the structure-interaction relationship of polymyxins with the lipid A-based outer membrane of publication-title: J Antimicrob Chemother – volume: 66 start-page: 207 year: 2012 end-page: 215 ident: bib122 article-title: Kojic acid-induced IL-6 production in human keratinocytes plays a role in its anti-melanogenic activity in skin publication-title: J Dermatol Sci – volume: 74 start-page: 48 year: 2019 end-page: 57 ident: bib10 article-title: Intracellular localization of polymyxins in human alveolar epithelial cells publication-title: J Antimicrob Chemother – volume: 10 start-page: 428 year: 2006 ident: bib634 article-title: Intrathecal colistin for treatment of publication-title: Crit Care – volume: 5 start-page: 643 year: 2014 ident: bib456 article-title: Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria publication-title: Front Microbiol – volume: 16 start-page: R148 year: 2012 ident: bib266 article-title: Endotoxemia and mortality prediction in ICU and other settings: underlying risk and co-detection of gram negative bacteremia are confounders publication-title: Crit Care – volume: 189 start-page: 975 year: 2014 end-page: 982 ident: bib247 article-title: Inhaled colistin in patients with bronchiectasis and chronic publication-title: Am J Respir Crit Care Med – volume: 53 start-page: 4247 year: 2009 end-page: 4251 ident: bib281 article-title: Brain penetration of colistin in mice assessed by a novel high-performance liquid chromatographic technique publication-title: Antimicrob Agents Chemother – volume: 362 start-page: 1011 year: 2003 end-page: 1016 ident: bib159 article-title: Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial publication-title: Lancet – year: 2017 ident: bib630 article-title: Global Priority List of Antibiotic-Resistant Bacteria Guide to Guide Research, Discovery, and Development of New Antibiotics – volume: 50 start-page: 2946 year: 2006 end-page: 2950 ident: bib355 article-title: Heteroresistance to colistin in multidrug-resistant publication-title: Antimicrob Agents Chemother – volume: 39 start-page: 272 year: 2014 end-page: 276 ident: bib647 article-title: Efficacy and safety of low-dose colistin in the treatment for infections caused by multidrug-resistant Gram-negative bacteria publication-title: J Clin Pharm Ther – volume: 29 start-page: 159 year: 1976 end-page: 166 ident: bib315 article-title: [Distribution and changes of antibiotic susceptibility of genus publication-title: Jpn J Antibiot – volume: 53 start-page: 3430 year: 2009 end-page: 3436 ident: bib481 article-title: Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by Gram-negative bacteria publication-title: Antimicrob Agents Chemother – reference: , CA. – volume: 62 start-page: e02442-17 year: 2018 ident: bib169 article-title: Emergence of high-level colistin resistance in an publication-title: Antimicrob Agents Chemother – volume: 55 start-page: 3284 year: 2011 end-page: 3294 ident: bib212 article-title: Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients publication-title: Antimicrob Agents Chemother – volume: 8 start-page: 711 year: 2013 end-page: 724 ident: bib601 article-title: Pharmacology of polymyxins: new insights into an ‘old’ class of antibiotics publication-title: Future Microbiol – volume: 43 start-page: 140 year: 2014 end-page: 147 ident: bib79 article-title: Bactericidal effect of colistin on planktonic publication-title: Int J Antimicrob Agents – volume: 12 start-page: 315 year: 2006 end-page: 321 ident: bib207 article-title: Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004) publication-title: Clin Microbiol Infect – volume: 50 start-page: 4231 year: 2006 end-page: 4232 ident: bib352 article-title: Defining the dosage units for colistin methanesulfonate: urgent need for international harmonization publication-title: Antimicrob Agents Chemother – volume: 25 start-page: 750 year: 2014 end-page: 760 ident: bib164 article-title: Probing the penetration of antimicrobial polymyxin lipopeptides into Gram-negative bacteria publication-title: Bioconjug Chem – volume: 48 start-page: 3558 year: 2010 end-page: 3562 ident: bib185 article-title: In vitro evaluation of antibiotic synergy for polymyxin B-resistant carbapenemase-producing publication-title: J Clin Microbiol – volume: 55 start-page: 5134 year: 2011 end-page: 5142 ident: bib56 article-title: Clinically relevant plasma concentrations of colistin in combination with imipenem enhance pharmacodynamic activity against multidrug-resistant publication-title: Antimicrob Agents Chemother – volume: 57 start-page: 3738 year: 2013 end-page: 3745 ident: bib337 article-title: Synergistic activity of colistin and rifampin combination against multidrug-resistant publication-title: Antimicrob Agents Chemother – volume: 58 start-page: 154 year: 2009 end-page: 157 ident: bib110 article-title: [Antibiotic resistance and biofilm formation in publication-title: Epidemiol Mikrobiol Imunol – volume: 55 start-page: 421 year: 2018 end-page: 434 ident: bib143 article-title: Curcumin attenuates colistin-induced neurotoxicity in N2a cells via anti-inflammatory activity, suppression of oxidative stress, and apoptosis publication-title: Mol Neurobiol – volume: 72 start-page: 3577 year: 2004 end-page: 3583 ident: bib402 article-title: The publication-title: Infect Immun – volume: 276 start-page: 43111 year: 2001 end-page: 43121 ident: bib663 article-title: Lipid A modifications in polymyxin-resistant publication-title: J Biol Chem – volume: 51 start-page: 875 year: 1949 end-page: 878 ident: bib85 article-title: Antibiotics derived from publication-title: Ann N Y Acad Sci – volume: 6 start-page: 2110 year: 2020 end-page: 2119 ident: bib280 article-title: Structure-interaction relationship of polymyxins with the membrane of human kidney proximal tubular cells publication-title: ACS Infect Dis – volume: 54 start-page: 4971 year: 2010 end-page: 4977 ident: bib421 article-title: Colistin resistance in publication-title: Antimicrob Agents Chemother – volume: 129 start-page: 145 year: 1981 end-page: 149 ident: bib592 article-title: Characterization of the lipopolysaccharide from the polymyxin-resistant publication-title: FEBS Lett – volume: 28 start-page: 916 year: 1999 end-page: 917 ident: bib201 article-title: Successful treatment of ventriculitis due to carbapenem-resistant publication-title: Clin Infect Dis – volume: 47 start-page: 1766 year: 2003 end-page: 1770 ident: bib348 article-title: Use of high-performance liquid chromatography to study the pharmacokinetics of colistin sulfate in rats following intravenous administration publication-title: Antimicrob Agents Chemother – volume: 146 start-page: 491 year: 2009 end-page: 499 ident: bib422 article-title: Polymyxin B identified as an inhibitor of alternative NADH dehydrogenase and malate: quinone oxidoreductase from the Gram-positive bacterium publication-title: J Biochem – volume: 55 start-page: 3022 year: 2011 end-page: 3024 ident: bib420 article-title: Insertion sequence IS publication-title: Antimicrob Agents Chemother – volume: 57 start-page: 4329 year: 2013 end-page: 4335 ident: bib33 article-title: Polymyxin B induces apoptosis in kidney proximal tubular cells publication-title: Antimicrob Agents Chemother – volume: 54 start-page: 25 year: 2002 end-page: 32 ident: bib333 article-title: Dry powder inhalation of antibiotics in cystic fibrosis therapy: part 2. Inhalation of a novel colistin dry powder formulation: a feasibility study in healthy volunteers and patients publication-title: Eur J Pharm Biopharm – volume: 76 start-page: 1444 year: 2010 end-page: 1460 ident: bib259 article-title: Activation of PmrA inhibits LpxT-dependent phosphorylation of lipid A promoting resistance to antimicrobial peptides publication-title: Mol Microbiol – volume: 71 start-page: 403 year: 2016 end-page: 412 ident: bib377 article-title: Human oligopeptide transporter 2 (PEPT2) mediates cellular uptake of polymyxins publication-title: J Antimicrob Chemother – volume: 27 start-page: 357 year: 1987 end-page: 364 ident: bib551 article-title: The effect of oropharyngeal decontamination using topical nonabsorbable antibiotics on the incidence of nosocomial respiratory tract infections in multiple trauma patients publication-title: J Trauma – volume: 41 start-page: 975 year: 2015 end-page: 984 ident: bib474 article-title: Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial publication-title: Intensive Care Med – volume: 6 start-page: 26 year: 2016 ident: bib2 article-title: Efficacy and toxicity of aerosolised colistin in ventilator-associated pneumonia: a prospective, randomised trial publication-title: Ann Intensive Care – volume: 59 start-page: 7911 year: 2015 end-page: 7914 ident: bib121 article-title: A PmrB-regulated deacetylase required for lipid A modification and polymyxin resistance in publication-title: Antimicrob Agents Chemother – volume: 65 start-page: 981 year: 2010 end-page: 985 ident: bib608 article-title: Novel polymyxin derivatives are effective in treating experimental publication-title: J Antimicrob Chemother – volume: 9 start-page: 508 year: 2020 end-page: 516 ident: bib616 article-title: Identification of novel mobile colistin resistance gene publication-title: Emerg Microbes Infect – volume: 17 start-page: 1798 year: 2011 end-page: 1803 ident: bib649 article-title: Predictors of mortality in patients with bloodstream infections caused by KPC-producing publication-title: Clin Microbiol Infect – volume: 51 start-page: 952 year: 1949 end-page: 967 ident: bib88 article-title: The pharmacology of polymyxin A, B, and D publication-title: Ann N Y Acad Sci – volume: 1 start-page: 127 year: 1948 end-page: 132 ident: bib86 article-title: Chemotherapy and pharmacology of aerosporin; a selective Gram-negative antibiotic publication-title: Lancet – year: 2018 ident: bib78 article-title: British Pharmacopoeia – volume: 18 start-page: 1239 year: 1990 end-page: 1242 ident: bib504 article-title: Prevention of nosocomial lung infection in ventilated patients: use of an antimicrobial pharyngeal nonabsorbable paste publication-title: Crit Care Med – volume: 54 start-page: 1720 year: 2012 end-page: 1726 ident: bib149 article-title: High-dose, extended-interval colistin administration in critically ill patients: is this the right dosing strategy? A preliminary study publication-title: Clin Infect Dis – volume: 49 start-page: 3624 year: 2005 end-page: 3630 ident: bib558 article-title: Pharmacodynamics of polymyxin B against publication-title: Antimicrob Agents Chemother – volume: 56 start-page: 5642 year: 2012 end-page: 5649 ident: bib515 article-title: Rapid killing of publication-title: Antimicrob Agents Chemother – volume: 24 start-page: 175 year: 2018 end-page: 179 ident: bib275 article-title: Comparison of methods for detection of plasmid-mediated and chromosomally encoded colistin resistance in Enterobacteriaceae publication-title: Clin Microbiol Infect – volume: 9 start-page: Doc14 year: 2014 ident: bib476 article-title: In vitro synergism of combinations of colistin with selected antibiotics against colistin-resistant publication-title: GMS Hyg Infect Control – volume: 60 start-page: 1029 year: 2015 end-page: 1034 ident: bib394 article-title: Characterization of polymyxin B biodistribution and disposition in an animal model publication-title: Antimicrob Agents Chemother – volume: 48 start-page: 579 year: 2016 end-page: 580 ident: bib653 article-title: Histopathological findings of pigmented lesion and recovery of natural skin colour in a patient with polymyxin B-associated diffuse hyperpigmentation publication-title: Int J Antimicrob Agents – volume: 7 start-page: 170 year: 1952 end-page: 188 ident: bib89 article-title: The chemotherapy and pharmacology of the polymyxins publication-title: Br J Pharmacol Chemother – year: 2013 ident: bib108 article-title: Antibiotic Resistance Threats in the United States – volume: 4 start-page: 521 year: 1973 end-page: 524 ident: bib434 article-title: Natural colistin resistance in publication-title: Antimicrob Agents Chemother – year: 2010 ident: bib189 article-title: Breakpoint tables for interpretation of MICs and zone diameters. Version 1.0 – volume: 67 start-page: 593 year: 2003 end-page: 656 ident: bib446 article-title: Molecular basis of bacterial outer membrane permeability revisited publication-title: Microbiol Mol Biol Rev – volume: 51 start-page: 2005 year: 2007 end-page: 2010 ident: bib124 article-title: Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant publication-title: Antimicrob Agents Chemother – volume: 30 start-page: 391 year: 2016 end-page: 414 ident: bib300 article-title: Agents of last resort: polymyxin resistance publication-title: Infect Dis Clin North Am – volume: 4 start-page: 296 year: 1976 end-page: 304 ident: bib506 article-title: Polyacrylic bone cement containing erythromycin and colistin. I. In vitro bacteriological activity and diffusion properties of erythromycin, colistin and erythromycin/colistin comibination publication-title: J Int Med Res – volume: 60 start-page: 3709 year: 2016 end-page: 3716 ident: bib118 article-title: Amino acid substitutions of CrrB responsible for resistance to colistin through CrrC in publication-title: Antimicrob Agents Chemother – volume: 63 start-page: e00556-19 year: 2019 ident: bib363 article-title: Resistance and heteroresistance to colistin in publication-title: Antimicrob Agents Chemother – volume: 30 start-page: 34 year: 2012 end-page: 38 ident: bib74 article-title: In vitro pharmacodynamic properties of colistin methanesulfonate and amikacin against publication-title: Indian J Med Microbiol – volume: 111 start-page: 1750 year: 2016 end-page: 1760 ident: bib308 article-title: Bilayer properties of lipid A from various Gram-negative bacteria publication-title: Biophys J – year: 2018 ident: bib581 article-title: United States pharmacopeia 40: National Formulary 31 – volume: 11 start-page: 372 year: 2011 end-page: 380 ident: bib167 article-title: Selective digestive tract decontamination and selective oropharyngeal decontamination and antibiotic resistance in patients in intensive-care units: an open-label, clustered group-randomised, crossover study publication-title: Lancet Infect Dis – volume: 37 start-page: 314 year: 2014 end-page: 320 ident: bib116 article-title: Influencing factors of successful eradication of multidrug-resistant publication-title: Biomed J – volume: 57 start-page: 3224 year: 2013 end-page: 3229 ident: bib237 article-title: Emergence of colistin resistance in Enterobacteriaceae after the introduction of selective digestive tract decontamination in an intensive care unit publication-title: Antimicrob Agents Chemother – volume: 7 start-page: 22 year: 2018 ident: bib233 article-title: Successful treatment of extensively drug-resistant publication-title: Antimicrob Resist Infect Control – volume: 71 start-page: 2218 year: 2016 end-page: 2229 ident: bib615 article-title: Clinically relevant concentrations of fosfomycin combined with polymyxin B, tobramycin or ciprofloxacin enhance bacterial killing of publication-title: J Antimicrob Chemother – volume: 12 start-page: 951 year: 2010 end-page: 963 ident: bib182 article-title: The major outer membrane protein OmpU of publication-title: Environ Microbiol – volume: 16 start-page: 161 year: 2016 end-page: 168 ident: bib372 article-title: Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study publication-title: Lancet Infect Dis – volume: 280 start-page: 23000 year: 2005 end-page: 23008 ident: bib627 article-title: Structure and function of both domains of ArnA, a dual function decarboxylase and a formyltransferase, involved in 4-amino-4-deoxy-L-arabinose biosynthesis publication-title: J Biol Chem – volume: 66 start-page: 946 year: 2011 end-page: 947 ident: bib409 article-title: Colistin heteroresistance in carbapenemase-producing publication-title: J Antimicrob Chemother – volume: 109 start-page: 8722 year: 2012 end-page: 8727 ident: bib243 article-title: Amino acid addition to publication-title: Proc Natl Acad Sci USA – volume: 74 start-page: 412 year: 2012 end-page: 414 ident: bib513 article-title: Use of a surfactant (polysorbate 80) to improve MIC susceptibility testing results for polymyxin B and colistin publication-title: Diagn Microbiol Infect Dis – volume: 18 start-page: 554 year: 2006 end-page: 558 ident: bib18 article-title: Post-neurosurgical meningitis due to multidrug-resistant publication-title: J Chemother – volume: 58 start-page: 1195 year: 2014 end-page: 1199 ident: bib457 article-title: In vitro responses of publication-title: Antimicrob Agents Chemother – volume: 50 start-page: 1953 year: 2006 end-page: 1958 ident: bib59 article-title: Colistin methanesulfonate is an inactive prodrug of colistin against publication-title: Antimicrob Agents Chemother – volume: 74 start-page: 144 year: 1971 end-page: 145 ident: bib399 article-title: Polymyxin inhalation therapeutic hazard publication-title: Ann Intern Med – volume: 37 start-page: 67 year: 2000 end-page: 80 ident: bib52 article-title: Temperature-regulated efflux pump/potassium antiporter system mediates resistance to cationic antimicrobial peptides in publication-title: Mol Microbiol – volume: 42 start-page: 645 year: 1989 end-page: 648 ident: bib153 article-title: Identification of publication-title: J Clin Pathol – volume: 70 start-page: 827 year: 2015 end-page: 829 ident: bib644 article-title: Imaging the distribution of polymyxins in the kidney publication-title: J Antimicrob Chemother – volume: 63 start-page: 534 year: 2009 end-page: 542 ident: bib24 article-title: Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant publication-title: J Antimicrob Chemother – volume: 32 start-page: 1569 year: 2006 end-page: 1576 ident: bib253 article-title: Effects of long-term routine use of selective digestive decontamination on antimicrobial resistance publication-title: Intensive Care Med – start-page: 343 year: 2019 end-page: 362 ident: bib600 article-title: Discovery of novel polymyxin-like antibiotics publication-title: Polymyxin Antibiotics: From Laboratory Bench to Bedside – volume: 9 year: 2014 ident: bib252 article-title: Impact of publication-title: PLoS One – volume: 68 start-page: 674 year: 2013 end-page: 677 ident: bib519 article-title: Pharmacokinetics of polymyxin B in patients on continuous venovenous haemodialysis publication-title: J Antimicrob Chemother – volume: 61 start-page: 636 year: 2008 end-page: 642 ident: bib58 article-title: Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: studies with publication-title: J Antimicrob Chemother – volume: 31 start-page: 168 year: 1979 end-page: 170 ident: bib81 article-title: Additivity of action between polysorbate 80 and polymyxin B towards spheroplasts of publication-title: J Pharm Pharmacol – volume: 2 start-page: 3 year: 1998 end-page: 12 ident: bib534 article-title: Extracorporeal endotoxin removal by polymyxin B immobilized fiber cartridge: designing and antiendotoxin efficacy in the clinical application publication-title: Ther Apher – year: 2018 ident: bib131 article-title: Performance Standards for Antimicrobial Susceptibility Testing – reference: , Madrid, Spain. – year: 1976 ident: bib441 article-title: Performance Standards for Antimicrobial Disk Susceptibility Tests – volume: 57 start-page: 3990 year: 2013 end-page: 3993 ident: bib568 article-title: Synergistic activity of colistin plus rifampin against colistin-resistant KPC-producing publication-title: Antimicrob Agents Chemother – volume: 8 start-page: 27 year: 2019 ident: bib67 article-title: A breath of fresh air in the fog of antimicrobial resistance: inhaled polymyxins for Gram-negative pneumonia publication-title: Antibiotics (Basel) – volume: 68 start-page: 83 year: 1991 end-page: 93 ident: bib387 article-title: Dexamethasone in the complex treatment of Chlamydial conjunctivitis publication-title: Rev Int Trach Pathol Ocul Trop Subtrop Sante Publique – volume: 51 start-page: 917 year: 1949 end-page: 923 ident: bib106 article-title: The chemistry of polymyxin A publication-title: Ann N Y Acad Sci – volume: 4 start-page: e00149-18 year: 2019 ident: bib239 article-title: Comparative metabolomics and transcriptomics reveal multiple pathways associated with polymyxin killing in publication-title: mSystems – volume: 56 start-page: 5240 year: 2012 end-page: 5246 ident: bib283 article-title: Effect of systemic infection induced by publication-title: Antimicrob Agents Chemother – volume: 2015 start-page: 568079 year: 2015 ident: bib563 article-title: In vitro activity of imipenem and colistin against a carbapenem-resistant publication-title: BioMed Res Int – volume: 1145 start-page: 89 year: 2019 end-page: 103 ident: bib395 article-title: Pharmacokinetics of polymyxins in animals publication-title: Adv Exp Med Biol – volume: 65 start-page: 942 year: 2010 end-page: 945 ident: bib589 article-title: Susceptibility of carbapenemase-producing strains of publication-title: J Antimicrob Chemother – volume: 35 start-page: 299 year: 1996 end-page: 308 ident: bib98 article-title: Intermembrane molecular contacts by polymyxin B mediate exchange of phospholipids publication-title: Biochemistry – volume: 207 start-page: 2099 year: 1969 end-page: 2101 ident: bib509 article-title: Colistimethate toxicity. Report of a fatal case in a previously healthy child publication-title: JAMA – volume: 181 start-page: 623 year: 1979 end-page: 632 ident: bib273 article-title: Further studies on the structural requirements for polypeptide-mediated histamine release from rat mast cells publication-title: Biochem J – volume: 21 start-page: 1692 year: 1993 end-page: 1698 ident: bib569 article-title: Decreased mortality rate and length of hospital stay in surgical intensive care unit patients with successful selective decontamination of the gut publication-title: Crit Care Med – volume: 16 start-page: 327 year: 2020 end-page: 338 ident: bib357 article-title: Pan-transcriptomic analysis identified common differentially expressed genes of publication-title: Mol Omics – volume: 276 start-page: 43122 year: 2001 end-page: 43131 ident: bib576 article-title: An inner membrane enzyme in publication-title: J Biol Chem – volume: 58 start-page: 864 year: 2006 end-page: 867 ident: bib560 article-title: Comparison of three standardized disc susceptibility testing methods for colistin publication-title: J Antimicrob Chemother – volume: 53 start-page: 4685 year: 2016 end-page: 4700 ident: bib146 article-title: Colistin-induced apoptosis of neuroblastoma-2a cells involves the generation of reactive oxygen species, mitochondrial dysfunction, and autophagy publication-title: Mol Neurobiol – volume: 35 start-page: 248 year: 2012 end-page: 252 ident: bib416 article-title: Novel polymyxin derivatives are less cytotoxic than polymyxin B to renal proximal tubular cells publication-title: Peptides – volume: 22 start-page: 457 year: 2007 end-page: 463 ident: bib468 article-title: Management of a multidrug-resistant publication-title: J Arthroplasty – reference: , Vienna, Austria. – volume: 31 start-page: 2318 year: 2010 end-page: 2321 ident: bib590 article-title: Structure-activity studies on novel polymyxin derivatives that carry only three positive charges publication-title: Peptides – volume: 48 start-page: 85 year: 1973 end-page: 90 ident: bib359 article-title: The second international standard for polymyxin B publication-title: Bull World Health Organ – volume: 61 start-page: e00356-17 year: 2017 ident: bib43 article-title: Deciphering heteroresistance to colistin in a publication-title: Antimicrob Agents Chemother – volume: 58 start-page: 5181 year: 2014 end-page: 5190 ident: bib364 article-title: , a PhoP-regulated locus necessary for polymyxin B resistance publication-title: Antimicrob Agents Chemother – volume: 22 start-page: 30589 year: 2017 ident: bib102 article-title: Novel plasmid-mediated colistin resistance publication-title: Euro Surveill – volume: 11 start-page: R47 year: 2007 ident: bib141 article-title: Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review publication-title: Crit Care – volume: 27 start-page: 439 year: 2001 end-page: 445 ident: bib47 article-title: Selective decontamination of the digestive tract in severely burned pediatric patients publication-title: Burns – volume: 62 start-page: 675 year: 2009 end-page: 679 ident: bib360 article-title: In vitro activity of various combinations of antimicrobials against carbapenem-resistant publication-title: J Antibiot (Tokyo) – volume: 29 start-page: 1950 year: 2007 end-page: 1956 ident: bib494 article-title: Pooled analysis of two clinical trials comparing the clinical outcomes of topical ciprofloxacin/dexamethasone otic suspension and polymyxin B/neomycin/hydrocortisone otic suspension for the treatment of acute otitis externa in adults and children publication-title: Clin Ther – volume: 73 start-page: 1791 year: 2018 end-page: 1795 ident: bib636 article-title: Novel plasmid-mediated colistin resistance gene publication-title: J Antimicrob Chemother – volume: 71 start-page: 2321 year: 2016 end-page: 2325 ident: bib327 article-title: Evaluation of antibacterial activities of colistin, rifampicin and meropenem combinations against NDM-1-producing publication-title: J Antimicrob Chemother – volume: 58 start-page: 6337 year: 2014 end-page: 6338 ident: bib37 article-title: Measuring polymyxin uptake by renal tubular cells: is BODIPY-polymyxin B an appropriate probe? publication-title: Antimicrob Agents Chemother – reference: Azad MAK, Zhu Y, Han ML, Wang J, Creek DJ, Velkov T, and Li J (2017b) P-217: Effect of poly-L-aspartic acid on polymyxin-induced nephrotoxicity: a system pharmacology approach, in – volume: 39 start-page: 183 year: 2001 end-page: 190 ident: bib209 article-title: Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines publication-title: J Clin Microbiol – volume: 31 start-page: 404 year: 2015 end-page: 412 ident: bib128 article-title: Effect of divalent cation removal on the structure of Gram-negative bacterial outer membrane models publication-title: Langmuir – volume: 75 start-page: 3 year: 2014 end-page: 17 ident: bib662 article-title: Emerging inhalation aerosol devices and strategies: where are we headed? publication-title: Adv Drug Deliv Rev – volume: 58 start-page: 1757 year: 2014 end-page: 1762 ident: bib564 article-title: Evaluation of double- and triple-antibiotic combinations for VIM- and NDM-producing publication-title: Antimicrob Agents Chemother – volume: 43 start-page: 903 year: 2005 end-page: 905 ident: bib26 article-title: Reliability of the E-test method for detection of colistin resistance in clinical isolates of publication-title: J Clin Microbiol – volume: 81 start-page: 4 year: 1969 end-page: 10 ident: bib381 article-title: Colistin sulfate ophthalmic in the treatment of ocular infections publication-title: Arch Ophthalmol – volume: 50 start-page: 1715 year: 2006 end-page: 1720 ident: bib19 article-title: Predictors of mortality in patients with bloodstream infection due to ceftazidime-resistant publication-title: Antimicrob Agents Chemother – volume: 72 start-page: 3317 year: 2017 end-page: 3324 ident: bib72 article-title: Identification of a novel transposon-associated phosphoethanolamine transferase gene, publication-title: J Antimicrob Chemother – volume: 72 start-page: 2528 year: 2017 end-page: 2530 ident: bib612 article-title: Evaluation of two automated systems for colistin susceptibility testing of carbapenem-resistant publication-title: J Antimicrob Chemother – volume: 22 year: 2020 ident: bib358 article-title: Polymyxin B-induced skin hyperpigmentation publication-title: Transpl Infect Dis – volume: 39 start-page: 10 year: 2019 end-page: 39 ident: bib577 article-title: International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP) publication-title: Pharmacotherapy – volume: 50 start-page: 348 year: 2005 end-page: 352 ident: bib298 article-title: Cure of post-traumatic recurrent multiresistant Gram-negative rod meningitis with intraventricular colistin publication-title: J Infect – start-page: 321 year: 2019 end-page: 341 ident: bib566 article-title: Anti-endotoxin properties of polymyxin B-immobilized fibers publication-title: Polymyxin Antibiotics: From Laboratory Bench to Bedside – reference: Azad MAK, Cheah SE, Yun B, Maifiah MHM, Johnson MD, Wang J, Boughton BA, Chapman R, Gould J, Hertzog P, et al. (2015b) P-A942: Understanding polymyxin-induced nephrotoxicity: combination of transcriptomics, metabolomics and mass spectrometry imaging, in – volume: 65 start-page: 2231 year: 2010 end-page: 2237 ident: bib186 article-title: The impact of polymyxin B dosage on in-hospital mortality of patients treated with this antibiotic publication-title: J Antimicrob Chemother – volume: 22 start-page: 354 year: 1966 end-page: 355 ident: bib249 article-title: Chemical structure of polymyxin D1 publication-title: Experientia – volume: 61 start-page: e00973-17 year: 2017 ident: bib370 article-title: Pulmonary pharmacokinetics of colistin following administration of dry powder aerosols in rats publication-title: Antimicrob Agents Chemother – volume: 68 start-page: 223 year: 2008 end-page: 240 ident: bib465 article-title: Tolerance to the antimicrobial peptide colistin in publication-title: Mol Microbiol – volume: 68 start-page: 551 year: 2015 end-page: 555 ident: bib172 article-title: In vitro activity of fosfomycin in combination with colistin against clinical isolates of carbapenem-resistant Pseudomas aeruginosa publication-title: J Antibiot (Tokyo) – volume: 141 start-page: 515 year: 2012 end-page: 517 ident: bib633 article-title: Polymyxin use associated with respiratory arrest publication-title: Chest – volume: 51 start-page: 1924 year: 2013 end-page: 1926 ident: bib338 article-title: Comparison of the Vitek 2, MicroScan, and Etest methods with the agar dilution method in assessing colistin susceptibility of bloodstream isolates of publication-title: J Clin Microbiol – volume: 59 start-page: 7489 year: 2015 end-page: 7496 ident: bib645 article-title: Cellular uptake and localization of polymyxins in renal tubular cells using rationally designed fluorescent probes publication-title: Antimicrob Agents Chemother – volume: 59 start-page: 1802 year: 2015 end-page: 1805 ident: bib1 article-title: Activity of eravacycline against Enterobacteriaceae and publication-title: Antimicrob Agents Chemother – volume: 132 start-page: 277 year: 1986 end-page: 287 ident: bib574 article-title: Decreased particulate NADH oxidase activity in publication-title: J Gen Microbiol – volume: 55 start-page: 5893 year: 2011 end-page: 5899 ident: bib520 article-title: Comparative effectiveness of aminoglycosides, polymyxin B, and tigecycline for clearance of carbapenem-resistant publication-title: Antimicrob Agents Chemother – volume: 5 start-page: 811 year: 2007 end-page: 821 ident: bib324 article-title: Polymyxin B: similarities to and differences from colistin (polymyxin E) publication-title: Expert Rev Anti Infect Ther – volume: 61 start-page: e02391-16 year: 2017 ident: bib393 article-title: Role of renal drug exposure in polymyxin B-induced nephrotoxicity publication-title: Antimicrob Agents Chemother – volume: 270 start-page: 1030 year: 1964 end-page: 1035 ident: bib450 article-title: Polymyxin B and colistin. A critical comparison publication-title: N Engl J Med – volume: 49 start-page: 609 year: 2017 end-page: 616 ident: bib96 article-title: Pharmacodynamics of tigecycline alone and in combination with colistin against clinical isolates of multidrug-resistant publication-title: Int J Antimicrob Agents – volume: 11 year: 2016 ident: bib596 article-title: Polymyxin B nephrotoxicity: from organ to cell damage publication-title: PLoS One – volume: 65 start-page: 1416 year: 2010 end-page: 1423 ident: bib428 article-title: Colistin susceptibility testing: evaluation of reliability for cystic fibrosis isolates of publication-title: J Antimicrob Chemother – reference: ; 12–15 September 2010; Boston, MA. – volume: 83 start-page: 179 year: 2016 end-page: 180 ident: bib225 article-title: Polymyxin B induced generalized hyperpigmentation in neonates publication-title: Indian J Pediatr – volume: 1145 start-page: 219 year: 2019 end-page: 249 ident: bib438 article-title: Clinical pharmacokinetics, pharmacodynamics and toxicodynamics of polymyxins: implications for therapeutic use publication-title: Adv Exp Med Biol – volume: 54 start-page: 3341 year: 2010 end-page: 3346 ident: bib588 article-title: A novel polymyxin derivative that lacks the fatty acid tail and carries only three positive charges has strong synergism with agents excluded by the intact outer membrane publication-title: Antimicrob Agents Chemother – volume: 47 start-page: 5977 year: 2019 end-page: 5985 ident: bib470 article-title: Survival of carbapenem-resistant publication-title: J Int Med Res – volume: 6 start-page: S319 year: 2019 ident: bib511 article-title: 707. QPX9003: Pharmacology of a novel polymyxin in mice and rats publication-title: Open Forum Infect Dis – volume: 42 start-page: 199 year: 2014 end-page: 202 ident: bib218 article-title: Colistin bladder instillation, an alternative way of treating multi-resistant publication-title: Infection – volume: 23 start-page: 552 year: 1964 end-page: 574 ident: bib45 article-title: Sodium sulphomethyl derivatives of polymyxins publication-title: Br J Pharmacol Chemother – volume: 38 start-page: e7 year: 2004 end-page: e9 ident: bib292 article-title: Colistin for publication-title: Clin Infect Dis – volume: 30 start-page: 153 year: 1990 end-page: 156 ident: bib609 article-title: Relationship between structure and histamine releasing action of polymyxin B and its analogues publication-title: Agents Actions – volume: 11 start-page: 193 year: 1980 end-page: 195 ident: bib175 article-title: ( publication-title: J Clin Microbiol – volume: 26 start-page: 276 year: 2014 end-page: 281 ident: bib162 article-title: Carbapenem-resistant publication-title: J Chemother – volume: 30 start-page: 143 year: 2008 end-page: 151 ident: bib397 article-title: Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, Gram-negative bacilli infections: a prospective, open-label, uncontrolled study publication-title: Clin Ther – reference: Sivanesan S, Wang J, Cheah SE, Schittenhelm R, Purcell AW, Velkov T, and Li J (2017c) EP0951: Identification of potential early urinary biomarkers for polymyxin-induced nephrotoxicity using proteomics, in – volume: 58 start-page: 3541 year: 2014 end-page: 3546 ident: bib64 article-title: In vitro and in vivo activities of tigecycline-colistin combination therapies against carbapenem-resistant Enterobacteriaceae publication-title: Antimicrob Agents Chemother – volume: 91 start-page: 133 year: 1994 end-page: 137 ident: bib272 article-title: Expression cloning of a rat liver Na(+)-independent organic anion transporter publication-title: Proc Natl Acad Sci USA – volume: 9 start-page: 430 year: 2017 end-page: 447 ident: bib305 article-title: A publication-title: EMBO Mol Med – volume: 271 start-page: 633 year: 1964 end-page: 634 ident: bib263 article-title: Toxicity of colistin and polymixin B publication-title: N Engl J Med – volume: 57 start-page: 4336 year: 2013 end-page: 4342 ident: bib284 article-title: Species-dependent blood-brain barrier disruption of lipopolysaccharide: amelioration by colistin in vitro and in vivo publication-title: Antimicrob Agents Chemother – volume: 76 start-page: 4892 year: 1954 end-page: 4896 ident: bib245 article-title: Polymyxin-B1 - fractionation, molecular weight determination, amino acid and fatty acid composition publication-title: J Am Chem Soc – volume: 54 start-page: 1057 year: 2004 end-page: 1061 ident: bib262 article-title: Pitfalls of polymyxin antimicrobial susceptibility testing of publication-title: J Antimicrob Chemother – volume: 41 start-page: 292 year: 2013 end-page: 293 ident: bib591 article-title: The novel polymyxin derivative NAB739 is remarkably less cytotoxic than polymyxin B and colistin to human kidney proximal tubular cells publication-title: Int J Antimicrob Agents – reference: Azad MAK, Li M, Zhu Y, Chapman R, Gould J, Hertzog P, Thompson PE, Roberts KD, Velkov T, and Li J (2018) Understanding the structure-nephrotoxicity relationship of polymyxins: a transcriptomic approach, in – volume: 45 start-page: 199 year: 2015 end-page: 200 ident: bib400 article-title: Inhaled colistimethate sodium in ventilator-associated tracheobronchitis due to multidrug-resistant Gram-negative bacteria publication-title: Int J Antimicrob Agents – volume: 69 start-page: 2434 year: 2014 end-page: 2442 ident: bib374 article-title: Activity of colistin combined with doripenem at clinically relevant concentrations against multidrug-resistant publication-title: J Antimicrob Chemother – volume: 912 start-page: 369 year: 2001 end-page: 373 ident: bib460 article-title: Isolation and structural characterization of polymyxin B components publication-title: J Chromatogr A – volume: 61 start-page: e00857-17 year: 2017 ident: bib296 article-title: Colistin is extensively lost during standard in vitro experimental conditions publication-title: Antimicrob Agents Chemother – volume: 281 start-page: 61 year: 1999 end-page: 66 ident: bib25 article-title: Trends in infectious disease mortality in the United States during the 20th century publication-title: JAMA – volume: 3 start-page: 23 year: 2004 end-page: 28 ident: bib622 article-title: Effect of nebulized colistin sulphate and colistin sulphomethate on lung function in patients with cystic fibrosis: a pilot study publication-title: J Cyst Fibros – volume: 61 start-page: e00211 year: 2017 end-page: e00217 ident: bib367 article-title: Aerosolized polymyxin B for treatment of respiratory tract infections: determination of pharmacokinetic-pharmacodynamic indices for aerosolized polymyxin B against publication-title: Antimicrob Agents Chemother – volume: 60 start-page: 3921 year: 2016 end-page: 3933 ident: bib112 article-title: Colistin and polymyxin B dosage regimens against publication-title: Antimicrob Agents Chemother – volume: 54 start-page: 548 year: 2012 end-page: 554 ident: bib479 article-title: Intraventricular polymyxin B for the treatment of neonatal meningo-ventriculitis caused by multi-resistant publication-title: Turk J Pediatr – volume: 41 start-page: 754 year: 2005 end-page: 757 ident: bib326 article-title: Nebulized colistin in the treatment of pneumonia due to multidrug-resistant publication-title: Clin Infect Dis – volume: 55 start-page: 32 year: 2016 end-page: 37 ident: bib617 article-title: Effects of colistin on amino acid neurotransmitters and blood-brain barrier in the mouse brain publication-title: Neurotoxicol Teratol – volume: 98 year: 2019 ident: bib660 article-title: Risk factors for acquisition and mortality of multidrug-resistant publication-title: Medicine (Baltimore) – volume: 81 start-page: 43 year: 1947 end-page: 54 ident: bib549 article-title: Polymyxin: a new chemotherapeutic agent publication-title: Bull Johns Hopkins Hosp – volume: 6 start-page: 589 year: 2006 end-page: 601 ident: bib353 article-title: Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections publication-title: Lancet Infect Dis – volume: 74 start-page: 377 year: 2014 end-page: 387 ident: bib134 article-title: Colistimethate sodium dry powder for inhalation: a review of its use in the treatment of chronic publication-title: Drugs – volume: 264 start-page: 337 year: 1988 end-page: 341 ident: bib241 article-title: Selective removal of endotoxin from the blood by extracorporeal hemoperfusion with polymyxin B immobilized fiber publication-title: Prog Clin Biol Res – volume: 43 start-page: xxvi year: 1948 ident: bib287 article-title: The chemical basis for the classification of the polymyxins publication-title: Biochem J – volume: 48 start-page: 583 year: 2016 end-page: 591 ident: bib46 article-title: Molecular mechanisms of polymyxin resistance: knowns and unknowns publication-title: Int J Antimicrob Agents – volume: 51 start-page: 3431 year: 2007 end-page: 3433 ident: bib317 article-title: Colistin methanesulfonate against multidrug-resistant publication-title: Antimicrob Agents Chemother – volume: 8 start-page: 1444 year: 2019 ident: bib119 article-title: Colistin heteroresistance in publication-title: J Clin Med – volume: 53 start-page: 4924 year: 2009 end-page: 4926 ident: bib614 article-title: In vitro activity of colistin (polymyxin E) against 3,480 isolates of Gram-negative bacilli obtained from patients in Canadian hospitals in the CANWARD study, 2007-2008 publication-title: Antimicrob Agents Chemother – volume: 55 start-page: 4469 year: 2011 end-page: 4474 ident: bib255 article-title: Pharmacokinetics/pharmacodynamics of colistin and imipenem on mucoid and nonmucoid publication-title: Antimicrob Agents Chemother – volume: 54 start-page: 24 year: 1947 end-page: 25 ident: bib51 article-title: Antibiotic activity of publication-title: J Bacteriol – volume: 57 start-page: 5394 year: 2013 end-page: 5397 ident: bib179 article-title: Risk factors for treatment failure of polymyxin B monotherapy for carbapenem-resistant publication-title: Antimicrob Agents Chemother – reference: Keith DD, Borders D, Curran W, Leese R, Mahamoon A, Jarolmen H, Francis N, Zhang Y, Arya A, Cotroneo N, et al. (2010) F1-1619: Synthesis and activity of CB-182,804, a novel polymyxin analog active against clinically relevant Gram-negative bacteria, in – volume: 51 start-page: 1 year: 2018 end-page: 9 ident: bib594 article-title: Inhaled colistin monotherapy for respiratory tract infections in adults without cystic fibrosis: a systematic review and meta-analysis publication-title: Int J Antimicrob Agents – volume: 338 start-page: 2431 year: 2003 end-page: 2447 ident: bib103 article-title: Structure of bacterial lipopolysaccharides publication-title: Carbohydr Res – volume: 23 start-page: 187 year: 1997 end-page: 195 ident: bib7 article-title: Decrease in nosocomial pneumonia in ventilated patients by selective oropharyngeal decontamination (SOD) publication-title: Intensive Care Med – volume: 37 start-page: 1458 year: 2011 end-page: 1465 ident: bib454 article-title: Long-term use of selective decontamination of the digestive tract does not increase antibiotic resistance: a 5-year prospective cohort study publication-title: Intensive Care Med – volume: 72 start-page: 2745 year: 2017 end-page: 2749 ident: bib8 article-title: and publication-title: J Antimicrob Chemother – volume: 61 start-page: e02690-16 year: 2017 ident: bib9 article-title: Potential toxicity of polymyxins in human lung epithelial cells publication-title: Antimicrob Agents Chemother – volume: 168 start-page: 323 year: 1989 end-page: 331 ident: bib240 article-title: New approach to endotoxic and septic shock by means of polymyxin B immobilized fiber publication-title: Surg Gynecol Obstet – volume: 10 start-page: 1689 year: 2019 ident: bib585 article-title: Polymyxins and their potential next generation as therapeutic antibiotics publication-title: Front Microbiol – volume: 167 start-page: 412 year: 1994 end-page: 417 ident: bib23 article-title: Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B-immobilized fiber publication-title: Am J Surg – volume: 62 start-page: e01475-17 year: 2018 ident: bib414 article-title: Population pharmacokinetics of polymyxin B in acutely ill adult patients publication-title: Antimicrob Agents Chemother – volume: 67 start-page: 565 year: 1980 end-page: 567 ident: bib270 article-title: The value of polymixin B in endotoxaemia due to experimental obstructive jaundice and mesenteric ischaemia publication-title: Br J Surg – volume: 58 start-page: 139 year: 2014 end-page: 141 ident: bib440 article-title: Consistent global approach on reporting of colistin doses to promote safe and effective use publication-title: Clin Infect Dis – volume: 2015 start-page: 679109 year: 2015 ident: bib642 article-title: Antibacterial mechanisms of polymyxin and bacterial resistance publication-title: BioMed Res Int – volume: 58 start-page: 4075 year: 2014 end-page: 4085 ident: bib145 article-title: Colistin-induced nephrotoxicity in mice involves the mitochondrial, death receptor, and endoplasmic reticulum pathways publication-title: Antimicrob Agents Chemother – volume: 64 start-page: e01587-19 year: 2019 ident: bib267 article-title: Metabolomics study of the synergistic killing of polymyxin B in combination with amikacin against polymyxin-susceptible and -resistant publication-title: Antimicrob Agents Chemother – volume: 29 start-page: 9 year: 2007 end-page: 25 ident: bib194 article-title: Intraventricular or intrathecal use of polymyxins in patients with Gram-negative meningitis: a systematic review of the available evidence publication-title: Int J Antimicrob Agents – volume: 49 start-page: 403 year: 2002 end-page: 406 ident: bib524 article-title: In vitro activity of the aerosolized agents colistin and tobramycin and five intravenous agents against publication-title: J Antimicrob Chemother – volume: 56 start-page: 59 year: 2012 end-page: 69 ident: bib258 article-title: Colistin-resistant, lipopolysaccharide-deficient publication-title: Antimicrob Agents Chemother – volume: 10 start-page: 124 year: 2004 end-page: 129 ident: bib447 article-title: [Multiresistant nosocomial bacterial strains and their “in vitro” susceptibility to chloramphenicol and colistin] publication-title: Klin Mikrobiol Infekc Lek – volume: 11 start-page: 481 year: 1994 end-page: 487 ident: bib254 article-title: Increased substitution of phosphate groups in lipopolysaccharides and lipid A of the polymyxin-resistant publication-title: Mol Microbiol – volume: 186 start-page: 575 year: 2004 end-page: 579 ident: bib427 article-title: PmrAB, a two-component regulatory system of publication-title: J Bacteriol – volume: 2017 start-page: 5437139 year: 2017 ident: bib643 article-title: Oxidative stress induced by polymyxin E is involved in rapid killing of publication-title: BioMed Res Int – volume: 35 start-page: 1609 year: 2009 end-page: 1613 ident: bib166 article-title: Decontamination of the digestive tract and oropharynx: hospital acquired infections after discharge from the intensive care unit publication-title: Intensive Care Med – volume: 32 start-page: 450 year: 2008 end-page: 454 ident: bib197 article-title: Pandrug-resistant publication-title: Int J Antimicrob Agents – volume: 50 start-page: 931 year: 2017 end-page: 939 ident: bib319 article-title: Comparison of synergism between colistin, fosfomycin and tigecycline against extended-spectrum β-lactamase-producing publication-title: J Microbiol Immunol Infect – volume: 52 start-page: 656 year: 1997 end-page: 658 ident: bib174 article-title: Effect of tonicity of nebulised colistin on chest tightness and pulmonary function in adults with cystic fibrosis publication-title: Thorax – volume: 49 start-page: 521 year: 2017 end-page: 527 ident: bib565 article-title: Assessment of early combination effects of colistin and meropenem against publication-title: Infect Dis (Lond) – volume: 26 start-page: 211 year: 2014 end-page: 216 ident: bib437 article-title: Activity of the colistin-rifampicin combination against colistin-resistant, carbapenemase-producing Gram-negative bacteria publication-title: J Chemother – volume: 73 start-page: 267 year: 2012 end-page: 270 ident: bib490 article-title: Multidrug resistance among publication-title: Diagn Microbiol Infect Dis – volume: 80 start-page: 225 year: 2017 end-page: 229 ident: bib539 article-title: Pharmacokinetics of the individual major components of polymyxin B and colistin in rats publication-title: J Nat Prod – volume: 67 start-page: 147 year: 2014 end-page: 151 ident: bib163 article-title: A secondary mode of action of polymyxins against Gram-negative bacteria involves the inhibition of NADH-quinone oxidoreductase activity publication-title: J Antibiot (Tokyo) – volume: 55 start-page: 954 year: 2005 end-page: 957 ident: bib331 article-title: Citywide emergence of publication-title: J Antimicrob Chemother – volume: 55 start-page: 5685 year: 2011 end-page: 5695 ident: bib60 article-title: Synergistic killing of multidrug-resistant publication-title: Antimicrob Agents Chemother – volume: 61 start-page: e01735-17 year: 2017 ident: bib40 article-title: Evaluation of urinary KIM-1 for prediction of polymyxin B-induced nephrotoxicity publication-title: Antimicrob Agents Chemother – year: 2020 ident: bib132 article-title: Performance Standards for Antimicrobial Susceptibility Testing – volume: 1 start-page: e00119 year: 2016 end-page: 16 ident: bib657 article-title: Transcriptomic analysis of the activity of a novel polymyxin against publication-title: mSphere – volume: 71 start-page: e523 year: 2020 end-page: e529 ident: bib521 article-title: Clinical and Laboratory Standards Institute and European Committee on Antimicrobial Susceptibility Testing position statements on polymyxin B and colistin clinical breakpoints publication-title: Clin Infect Dis – volume: 40 start-page: 332 year: 2012 end-page: 336 ident: bib433 article-title: Efficacy of tigecycline/colistin combination in a pneumonia model caused by extensively drug-resistant publication-title: Int J Antimicrob Agents – volume: 61 start-page: e02319-16 year: 2017 ident: bib652 article-title: Nephrotoxicity of polymyxins: is there any difference between colistimethate and polymyxin B? publication-title: Antimicrob Agents Chemother – volume: 280 start-page: 14154 year: 2005 end-page: 14167 ident: bib75 article-title: A formyltransferase required for polymyxin resistance in publication-title: J Biol Chem – volume: 70 start-page: 3291 year: 2015 end-page: 3297 ident: bib113 article-title: New pharmacokinetic/pharmacodynamic studies of systemically administered colistin against publication-title: J Antimicrob Chemother – volume: 70 start-page: 386 year: 2017 end-page: 394 ident: bib84 article-title: Development of new polymyxin derivatives for multi-drug resistant Gram-negative infections publication-title: J Antibiot (Tokyo) – volume: 62 start-page: e01018-18 year: 2018 ident: bib531 article-title: Colistin does not potentiate ceftazidime-avibactam killing of carbapenem-resistant Enterobacteriaceae in vitro or suppress emergence of ceftazidime-avibactam resistance publication-title: Antimicrob Agents Chemother – volume: 59 start-page: 7240 year: 2015 end-page: 7248 ident: bib293 article-title: Colistin population pharmacokinetics after application of a loading dose of 9 MU colistin methanesulfonate in critically ill patients publication-title: Antimicrob Agents Chemother – volume: 280 start-page: 28186 year: 2005 end-page: 28194 ident: bib575 article-title: Resistance to the antimicrobial peptide polymyxin requires myristoylation of publication-title: J Biol Chem – volume: 18 start-page: 1640 year: 2011 end-page: 1648 ident: bib527 article-title: PKB1 produces variants of polymyxin B-type antibiotics publication-title: Chem Biol – volume: 164 start-page: 622 year: 1949 ident: bib624 article-title: Crystalline derivatives of the polymyxins and the identification of the fatty acid component publication-title: Nature – volume: 16 start-page: 307 year: 1990 end-page: 311 ident: bib221 article-title: Intestinal decontamination in a polyvalent ICU. A double-blind study publication-title: Intensive Care Med – volume: 271 start-page: 67 year: 2017 end-page: 78 ident: bib378 article-title: Salidroside attenuates colistin-induced neurotoxicity in RSC96 Schwann cells through PI3K/Akt pathway publication-title: Chem Biol Interact – volume: 25 start-page: 1168 year: 1991 end-page: 1170 ident: bib73 article-title: Toxicity of colistin in cystic fibrosis patients publication-title: DICP – volume: 58 start-page: 235 year: 2007 end-page: 240 ident: bib477 article-title: Salvage treatment of pneumonia and initial treatment of tracheobronchitis caused by multidrug-resistant Gram-negative bacilli with inhaled polymyxin B publication-title: Diagn Microbiol Infect Dis – volume: 157 start-page: 142 year: 1972 end-page: 148 ident: bib611 article-title: Antimicrobial resistance of the genera publication-title: Med Microbiol Immunol (Berl) – volume: 69 start-page: 1856 year: 2014 end-page: 1865 ident: bib205 article-title: In vitro activity and post-antibiotic effects of colistin in combination with other antimicrobials against colistin-resistant KPC-producing publication-title: J Antimicrob Chemother – volume: 16 start-page: 271 year: 1995 end-page: 278 ident: bib452 article-title: Lipopolysaccharides of polymyxin B-resistant mutants of publication-title: Mol Microbiol – volume: 54 start-page: 3783 year: 2010 end-page: 3789 ident: bib55 article-title: Pharmacokinetic/pharmacodynamic investigation of colistin against publication-title: Antimicrob Agents Chemother – volume: 46 start-page: 47 year: 1993 end-page: 54 ident: bib198 article-title: Inhibition of melanogenesis in human melanoma cells by novel analogues of the partial histamine (H2) agonist nordimaprit publication-title: Biochem Pharmacol – volume: 56 start-page: 5103 year: 2012 end-page: 5112 ident: bib165 article-title: The combination of colistin and doripenem is synergistic against publication-title: Antimicrob Agents Chemother – volume: 164 start-page: 382 year: 2001 end-page: 388 ident: bib61 article-title: Prevention of ventilator-associated pneumonia by oral decontamination: a prospective, randomized, double-blind, placebo-controlled study publication-title: Am J Respir Crit Care Med – volume: 45 start-page: 877 year: 2013 end-page: 888 ident: bib183 article-title: Cell cycle arrest in a model of colistin nephrotoxicity publication-title: Physiol Genomics – volume: 46 start-page: 560 year: 2015 end-page: 567 ident: bib14 article-title: The combination of colistin and fosfomycin is synergistic against NDM-1-producing Enterobacteriaceae in in vitro pharmacokinetic/pharmacodynamic model experiments publication-title: Int J Antimicrob Agents – volume: 70 start-page: 1303 year: 2015 end-page: 1313 ident: bib257 article-title: The transcriptomic response of publication-title: J Antimicrob Chemother – volume: 73 start-page: 354 year: 2012 end-page: 360 ident: bib206 article-title: Antimicrobial resistance among Gram-negative bacilli isolated from Latin America: results from SENTRY Antimicrobial Surveillance Program (Latin America, 2008-2010) publication-title: Diagn Microbiol Infect Dis – volume: 112 start-page: S83 year: 2003 end-page: S88 ident: bib398 article-title: The histamine-cytokine network in allergic inflammation publication-title: J Allergy Clin Immunol – volume: 276 start-page: F658 year: 1999 end-page: F665 ident: bib528 article-title: Localization of PEPT1 and PEPT2 proton-coupled oligopeptide transporter mRNA and protein in rat kidney publication-title: Am J Physiol – volume: 51 start-page: 554 year: 2018 end-page: 561 ident: bib573 article-title: Impact of the colistin resistance gene publication-title: Int J Antimicrob Agents – volume: 33 start-page: 960 year: 1999 end-page: 967 ident: bib193 article-title: Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant Gram-negative bacteria publication-title: Ann Pharmacother – volume: 35 start-page: 308 year: 2010 end-page: 310 ident: bib251 article-title: Variability of polymyxin B major components in commercial formulations publication-title: Int J Antimicrob Agents – volume: 22 start-page: 67 year: 2018 end-page: 77 ident: bib389 article-title: Colistin versus colistin combined with ampicillin-sulbactam for multiresistant publication-title: Indian J Crit Care Med – volume: 19 start-page: 60 year: 2019 ident: bib44 article-title: Comparative evaluation of the UMIC Colistine kit to assess MIC of colistin of Gram-negative rods publication-title: BMC Microbiol – volume: 52 start-page: 987 year: 2003 end-page: 992 ident: bib346 article-title: Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis publication-title: J Antimicrob Chemother – volume: 33 start-page: 307 year: 2005 end-page: 314 ident: bib100 article-title: Prevention of acquired infections in intubated patients with the combination of two decontamination regimens publication-title: Crit Care Med – volume: 7 start-page: 2000704 year: 2020 ident: bib664 article-title: Polymyxins bind to the cell surface of unculturable publication-title: Adv Sci (Weinh) – volume: 70 start-page: 2589 year: 2015 end-page: 2597 ident: bib4 article-title: Synergistic killing of NDM-producing MDR publication-title: J Antimicrob Chemother – volume: 56 start-page: 5082 year: 2012 end-page: 5087 ident: bib171 article-title: Role of heme oxygenase-1 in polymyxin B-induced nephrotoxicity in rats publication-title: Antimicrob Agents Chemother – volume: 68 start-page: 344 year: 2013 end-page: 350 ident: bib525 article-title: Safety, efficacy and convenience of colistimethate sodium dry powder for inhalation (Colobreathe DPI) in patients with cystic fibrosis: a randomised study publication-title: Thorax – volume: 42 start-page: 565 year: 2013 end-page: 570 ident: bib379 article-title: Rapid emergence of secondary resistance to gentamicin and colistin following selective digestive decontamination in patients with KPC-2-producing publication-title: Int J Antimicrob Agents – volume: 152 start-page: 657 year: 2006 end-page: 666 ident: bib309 article-title: Phosphoethanolamine substitution in the lipid A of publication-title: Microbiology (Reading) – volume: 224 start-page: 500 year: 1996 end-page: 507 ident: bib455 article-title: cDNA cloning and functional expression of a novel rat kidney organic cation transporter, OCT2 publication-title: Biochem Biophys Res Commun – reference: Azad MAK, Zhu Y, Yu HH, Velkov T, and Li J (2019) P-8: Transcriptomic analysis reveals perturbations of cellular signalling networks in human lung epithelial cells due to polymyxin treatment, in – volume: 111 start-page: 551 year: 2007 end-page: 563 ident: bib126 article-title: Gram-negative outer and inner membrane models: insertion of cyclic cationic lipopeptides publication-title: J Phys Chem B – volume: 61 start-page: 908 year: 2008 end-page: 913 ident: bib505 article-title: Multidrug-resistant publication-title: J Antimicrob Chemother – volume: 158 start-page: 908 year: 1998 end-page: 916 ident: bib516 article-title: Effectiveness and cost of selective decontamination of the digestive tract in critically ill intubated patients. A randomized, double-blind, placebo-controlled, multicenter trial publication-title: Am J Respir Crit Care Med – volume: 56 start-page: 4416 year: 2012 end-page: 4421 ident: bib268 article-title: Pharmacokinetics of colistin in cerebrospinal fluid after intraventricular administration of colistin methanesulfonate publication-title: Antimicrob Agents Chemother – volume: 15 start-page: 235 year: 2011 ident: bib385 article-title: Intrathecal (intraventricular) polymyxin B in the treatment of patients with meningoencephalitis by publication-title: Crit Care – volume: 55 start-page: 4044 year: 2011 end-page: 4049 ident: bib639 article-title: Melatonin attenuates colistin-induced nephrotoxicity in rats publication-title: Antimicrob Agents Chemother – volume: 271 start-page: 32599 year: 1996 end-page: 32604 ident: bib94 article-title: Electrogenic properties and substrate specificity of the polyspecific rat cation transporter rOCT1 publication-title: J Biol Chem – volume: 5 start-page: 1645 year: 2019 end-page: 1656 ident: bib83 article-title: Design of next generation polymyxins with lower toxicity: the discovery of SPR206 publication-title: ACS Infect Dis – volume: 173 start-page: 1348 year: 2006 end-page: 1355 ident: bib313 article-title: Oral decontamination with chlorhexidine reduces the incidence of ventilator-associated pneumonia publication-title: Am J Respir Crit Care Med – volume: 16 start-page: 485 year: 2018 end-page: 499 ident: bib69 article-title: Can octapeptin antibiotics combat extensively drug-resistant (XDR) bacteria? publication-title: Expert Rev Anti Infect Ther – volume: 25 start-page: 380 year: 2018 end-page: 391.e5 ident: bib599 article-title: Structure, function, and biosynthetic origin of octapeptin antibiotics active against extensively drug-resistant Gram-negative bacteria publication-title: Cell Chem Biol – volume: 6 start-page: S313 year: 2019 ident: bib105 article-title: 690. Activity of a novel polymyxin analog, QPX9003, tested against resistant Gram-negative pathogens, including carbapenem-resistant publication-title: Open Forum Infect Dis – volume: 30 start-page: 307 year: 2007 end-page: 313 ident: bib500 article-title: Ventilator-associated pneumonia due to colistin susceptible-only microorganisms publication-title: Eur Respir J – volume: 53 start-page: 2857 year: 2009 end-page: 2864 ident: bib383 article-title: Renal disposition of colistin in the isolated perfused rat kidney publication-title: Antimicrob Agents Chemother – volume: 50 start-page: Suppl:ix year: 1968 ident: bib82 article-title: Synergistic action of polysorbate 80 and polymyxin B sulphate on publication-title: J Gen Microbiol – volume: 1 start-page: 105 year: 2017 end-page: 113 ident: bib532 article-title: History and current status of polymyxin B-immobilized fiber column for treatment of severe sepsis and septic shock publication-title: Ann Gastroenterol Surg – volume: 17 start-page: 1444 year: 2011 end-page: 1447 ident: bib412 article-title: Outbreak of KPC-3-producing, and colistin-resistant, publication-title: Clin Microbiol Infect – volume: 47 start-page: 905 year: 2003 end-page: 909 ident: bib231 article-title: Synergistic activity of colistin and ceftazidime against multiantibiotic-resistant publication-title: Antimicrob Agents Chemother – volume: 59 start-page: 597 year: 2011 end-page: 602 ident: bib522 article-title: Novel des-fatty acyl-polymyxin B derivatives with publication-title: Chem Pharm Bull (Tokyo) – volume: 65 start-page: 80 year: 2012 end-page: 87 ident: bib320 article-title: Incidence and predictors of acute kidney injury associated with intravenous polymyxin B therapy publication-title: J Infect – volume: 357 start-page: 2310 year: 2007 end-page: 2311 ident: bib408 article-title: Compounded colistimethate as possible cause of fatal acute respiratory distress syndrome publication-title: N Engl J Med – volume: 45 start-page: 131 year: 2019 end-page: 161 ident: bib436 article-title: The rise and spread of publication-title: Crit Rev Microbiol – volume: 67 start-page: 191 year: 2010 end-page: 197 ident: bib466 article-title: Activity of doripenem with and without levofloxacin, amikacin, and colistin against publication-title: Diagn Microbiol Infect Dis – volume: 66 start-page: 2070 year: 2011 end-page: 2074 ident: bib208 article-title: Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006-09) publication-title: J Antimicrob Chemother – volume: 60 start-page: 1295 year: 2015 end-page: 1303 ident: bib492 article-title: Colistin-resistant publication-title: Clin Infect Dis – volume: 74 start-page: 213 year: 2012 end-page: 223 ident: bib57 article-title: Pharmacokinetics and pharmacodynamics of ‘old’ polymyxins: what is new? publication-title: Diagn Microbiol Infect Dis – volume: 34 start-page: 305 year: 1999 end-page: 316 ident: bib386 article-title: PhoP-PhoQ homologues in publication-title: Mol Microbiol – volume: 18 start-page: 398 year: 1992 end-page: 404 ident: bib502 article-title: Prevention of nosocomial infection in critically ill patients by selective decontamination of the digestive tract. A randomized, double blind, placebo-controlled study publication-title: Intensive Care Med – year: 2013 ident: bib129 article-title: Performance Standards for Antimicrobial Susceptibility Testing, 23rd information supplement – volume: 35 start-page: 557 year: 1997 end-page: 564 ident: bib158 article-title: Hyphenated liquid chromatographic method for the determination of colistin residues in bovine tissues publication-title: J Chromatogr Sci – volume: 13 start-page: 541 year: 2007 end-page: 544 ident: bib562 article-title: Comparison of Etest, Vitek and agar dilution for susceptibility testing of colistin publication-title: Clin Microbiol Infect – volume: 51 start-page: 897 year: 1949 end-page: 908 ident: bib50 article-title: Chemical studies on polymyxin; comparison with aerosporin publication-title: Ann N Y Acad Sci – volume: 39 start-page: 255 year: 1997 end-page: 260 ident: bib107 article-title: A reassessment of the in-vitro activity of colistin sulphomethate sodium publication-title: J Antimicrob Chemother – volume: 117 start-page: 545 year: 1992 end-page: 553 ident: bib133 article-title: Prevention of infection in critically ill patients by selective decontamination of the digestive tract publication-title: Ann Intern Med – volume: 48 start-page: 559 year: 2016 end-page: 563 ident: bib371 article-title: Synergistic killing by meropenem and colistin combination of carbapenem-resistant publication-title: Int J Antimicrob Agents – volume: 37 start-page: 141 year: 2011 end-page: 146 ident: bib464 article-title: Could nephrotoxicity due to colistin be ameliorated with the use of N-acetylcysteine? publication-title: Intensive Care Med – volume: 6 start-page: 426 year: 2012 ident: bib610 article-title: Intravesical colistin irrigation to treat multidrug-resistant publication-title: J Med Case Reports – volume: 41 start-page: 197 year: 2013 end-page: 199 ident: bib593 article-title: Difficult-to-treat Gram-negative bone and joint infections: efficacy and safety of prolonged intravenous colistin publication-title: Int J Antimicrob Agents – volume: 58 start-page: 5696 year: 2014 end-page: 5703 ident: bib101 article-title: MgrB inactivation is a common mechanism of colistin resistance in KPC-producing publication-title: Antimicrob Agents Chemother – volume: 48 start-page: 753 year: 2004 end-page: 757 ident: bib638 article-title: In vitro double and triple synergistic activities of polymyxin B, imipenem, and rifampin against multidrug-resistant publication-title: Antimicrob Agents Chemother – volume: 61 start-page: e00985-17 year: 2017 ident: bib538 article-title: Gelofusine ameliorates colistin-induced nephrotoxicity publication-title: Antimicrob Agents Chemother – volume: 29 start-page: 388 year: 2016 end-page: 390 ident: bib404 article-title: Acquired skin hyperpigmentation following intravenous polymyxin B treatment: a cohort study publication-title: Pigment Cell Melanoma Res – volume: 57 start-page: 1442 year: 2013 end-page: 1446 ident: bib430 article-title: Nephrotoxicity and efficacy assessment of polymyxin use in 92 transplant patients publication-title: Antimicrob Agents Chemother – volume: 56 start-page: 4241 year: 2012 end-page: 4249 ident: bib423 article-title: Application of a loading dose of colistin methanesulfonate in critically ill patients: population pharmacokinetics, protein binding, and prediction of bacterial kill publication-title: Antimicrob Agents Chemother – volume: 47 start-page: 1298 year: 2008 end-page: 1304 ident: bib650 article-title: Pharmacokinetics of intravenous polymyxin B in critically ill patients publication-title: Clin Infect Dis – volume: 27 start-page: 2261 year: 2011 end-page: 2270 ident: bib419 article-title: Safety and pharmacokinetic evaluation of intravenous colistin methanesulfonate sodium in Japanese healthy male subjects publication-title: Curr Med Res Opin – volume: 61 start-page: e02025-16 year: 2017 ident: bib368 article-title: Pharmacokinetics/Pharmacodynamics of pulmonary delivery of colistin against publication-title: Antimicrob Agents Chemother – volume: 7 start-page: 122 year: 2018 ident: bib618 article-title: Emergence of a novel mobile colistin resistance gene, publication-title: Emerg Microbes Infect – volume: 266 start-page: 759 year: 1962 end-page: 762 ident: bib629 article-title: Neurotoxic and nephrotoxic effects of colistin in patients with renal disease publication-title: N Engl J Med – volume: 68 start-page: 1213 year: 2013 end-page: 1219 ident: bib583 article-title: Novel derivatives of polymyxins publication-title: J Antimicrob Chemother – volume: 51 start-page: 891 year: 1949 end-page: 896 ident: bib87 article-title: Comparative biological studies of polymyxin A and polymyxin D publication-title: Ann N Y Acad Sci – reference: , Viena, Austria. – volume: 58 start-page: 874 year: 2014 end-page: 879 ident: bib236 article-title: In vitro pharmacodynamics of polymyxin B and tigecycline alone and in combination against carbapenem-resistant publication-title: Antimicrob Agents Chemother – volume: 25 start-page: 141 year: 1971 end-page: 144 ident: bib157 article-title: Respiratory arrest in myasthenia gravis with colistimethate therapy publication-title: Arch Neurol – volume: 35 start-page: 593 year: 1989 end-page: 596 ident: bib557 article-title: [Clinical effects of intravesical instillation of polymyxin B in patients with acute cystitis] publication-title: Hinyokika Kiyo – volume: 59 start-page: 473 year: 2007 end-page: 477 ident: bib461 article-title: In vitro pharmacodynamics of colistin against publication-title: J Antimicrob Chemother – volume: 41 start-page: 256 year: 2012 end-page: 259 ident: bib620 article-title: The elution of colistimethate sodium from polymethylmethacrylate and calcium phosphate cement beads publication-title: Am J Orthop – volume: 68 start-page: 2311 year: 2013 end-page: 2317 ident: bib250 article-title: Pharmacokinetics of four different brands of colistimethate and formed colistin in rats publication-title: J Antimicrob Chemother – volume: 4 start-page: 154 year: 1988 end-page: 157 ident: bib220 article-title: Susceptibility of clinical isolates of publication-title: Eur J Epidemiol – volume: 57 start-page: 2204 year: 2013 end-page: 2215 ident: bib234 article-title: Polymyxin resistance of publication-title: Antimicrob Agents Chemother – volume: 66 start-page: 1047 year: 2011 end-page: 1051 ident: bib619 article-title: In vitro activity of teicoplanin combined with colistin versus multidrug-resistant strains of publication-title: J Antimicrob Chemother – volume: 57 start-page: 2310 year: 2013 end-page: 2318 ident: bib95 article-title: Pharmacodynamic evaluation of the intracellular activity of antibiotics towards publication-title: Antimicrob Agents Chemother – volume: 1145 start-page: 289 year: 2019 end-page: 304 ident: bib484 article-title: Toxicity in patients publication-title: Adv Exp Med Biol – volume: 54 start-page: 560 year: 2010 end-page: 562 ident: bib552 article-title: Nonclonal emergence of colistin-resistant publication-title: Antimicrob Agents Chemother – volume: 52 start-page: 351 year: 2008 end-page: 352 ident: bib246 article-title: Colistin heteroresistance in publication-title: Antimicrob Agents Chemother – volume: 19 start-page: 41 year: 2018 ident: bib659 article-title: Polymyxin B-induced skin hyperpigmentation: a rare case report and literature review publication-title: BMC Pharmacol Toxicol – volume: 59 start-page: 2051 year: 2015 end-page: 2061 ident: bib507 article-title: PmrD is required for modifications to publication-title: Antimicrob Agents Chemother – volume: 70 start-page: 380 year: 2011 end-page: 386 ident: bib529 article-title: Comparative in vitro antimicrobial susceptibilities and synergistic activities of antimicrobial combinations against carbapenem-resistant publication-title: Diagn Microbiol Infect Dis – volume: 23 start-page: 13 year: 2011 end-page: 16 ident: bib17 article-title: Emergence of tigecycline and colistin resistance in publication-title: J Chemother – volume: 9 start-page: 11 year: 1976 end-page: 19 ident: bib202 article-title: Susceptibility of beta-hemolytic streptococci to 65 antibacterial agents publication-title: Antimicrob Agents Chemother – volume: 61 start-page: e01268-16 year: 2017 ident: bib341 article-title: High-dose ampicillin-sulbactam combinations combat polymyxin-resistant publication-title: Antimicrob Agents Chemother – volume: 64 start-page: e01495-19 year: 2020 ident: bib483 article-title: Polymyxin susceptibility testing and interpretive breakpoints: recommendations from the United States Committee on Antimicrobial Susceptibility Testing (USCAST) publication-title: Antimicrob Agents Chemother – volume: 45 start-page: 781 year: 2001 end-page: 785 ident: bib356 article-title: In vitro pharmacodynamic properties of colistin and colistin methanesulfonate against publication-title: Antimicrob Agents Chemother – volume: 38 start-page: 241 year: 2010 end-page: 244 ident: bib462 article-title: Successful treatment of three children with post-neurosurgical multidrug-resistant publication-title: Infection – volume: 17 start-page: 565 year: 2016 ident: bib115 article-title: The role of galectin-3 in the kidneys publication-title: Int J Mol Sci – volume: 2 start-page: 923 year: 1970 end-page: 924 ident: bib80 article-title: Acute renal failure due to overdosage of colistin publication-title: Med J Aust – volume: 59 start-page: 7316 year: 2015 end-page: 7319 ident: bib136 article-title: In vitro activities of novel antimicrobial combinations against extensively drug-resistant publication-title: Antimicrob Agents Chemother – volume: 49 start-page: 4814 year: 2005 end-page: 4815 ident: bib354 article-title: Pharmacokinetics of colistin methanesulfonate and colistin in a critically ill patient receiving continuous venovenous hemodiafiltration publication-title: Antimicrob Agents Chemother – volume: 186 start-page: 4124 year: 2004 end-page: 4133 ident: bib336 article-title: The PmrA-regulated publication-title: J Bacteriol – volume: 57 start-page: 3463 year: 2013 end-page: 3469 ident: bib463 article-title: How does colistin-induced nephropathy develop and can it be treated? publication-title: Antimicrob Agents Chemother – volume: 10 start-page: 1146 year: 2019 ident: bib366 article-title: Synergistic combination of polymyxin B and enrofloxacin induced metabolic perturbations in extensive drug-resistant publication-title: Front Pharmacol – volume: 63 start-page: e02176-18 year: 2019 ident: bib365 article-title: Novel polymyxin combination with the antiretroviral zidovudine exerts synergistic killing against NDM-producing multidrug-resistant publication-title: Antimicrob Agents Chemother – volume: 222 start-page: 57 year: 1995 end-page: 65 ident: bib380 article-title: Controlled clinical trial of selective decontamination for the treatment of severe acute pancreatitis publication-title: Ann Surg – volume: 24 start-page: 113 year: 2013 end-page: 124 ident: bib554 article-title: p53 is renoprotective after ischemic kidney injury by reducing inflammation publication-title: J Am Soc Nephrol – volume: 1 start-page: 922 year: 1963 end-page: 923 ident: bib625 article-title: Identity of colistin and polymyxin E publication-title: Lancet – volume: 55 start-page: 3743 year: 2011 end-page: 3751 ident: bib27 article-title: The publication-title: Antimicrob Agents Chemother – volume: 56 start-page: 3441 year: 2012 end-page: 3443 ident: bib12 article-title: Bactericidal activity of multiple combinations of tigecycline and colistin against NDM-1-producing Enterobacteriaceae publication-title: Antimicrob Agents Chemother – volume: 90 start-page: 637 year: 2001 end-page: 642 ident: bib30 article-title: The isolation and characterization of publication-title: J Appl Microbiol – volume: 9 start-page: 1172 year: 2014 end-page: 1177 ident: bib602 article-title: Teaching ‘old’ polymyxins new tricks: new-generation lipopeptides targeting Gram-negative ‘superbugs’ publication-title: ACS Chem Biol – volume: 61 start-page: 1771 year: 2015 end-page: 1777 ident: bib150 article-title: Colistin-associated acute kidney injury in severely ill patients: a step toward a better renal care? A prospective cohort study publication-title: Clin Infect Dis – volume: 210 start-page: 746 year: 1995 end-page: 752 ident: bib97 article-title: Direct vesicle-vesicle exchange of phospholipids mediated by polymyxin B publication-title: Biochem Biophys Res Commun – volume: 70 start-page: 1434 year: 2015 end-page: 1442 ident: bib382 article-title: Colistin and doripenem combinations against publication-title: J Antimicrob Chemother – volume: 13 start-page: 328 year: 2013 end-page: 341 ident: bib154 article-title: Effect of selective decontamination on antimicrobial resistance in intensive care units: a systematic review and meta-analysis publication-title: Lancet Infect Dis – volume: 2014 start-page: 249856 year: 2014 ident: bib176 article-title: Worldwide dissemination of the NDM-type carbapenemases in Gram-negative bacteria publication-title: BioMed Res Int – volume: 278 start-page: 24731 year: 2003 end-page: 24739 ident: bib77 article-title: Origin of lipid A species modified with 4-amino-4-deoxy-L-arabinose in polymyxin-resistant mutants of publication-title: J Biol Chem – volume: 37 start-page: 174 year: 2011 end-page: 175 ident: bib512 article-title: Susceptibility of publication-title: Int J Antimicrob Agents – volume: 41 start-page: 321 year: 2013 end-page: 328 ident: bib499 article-title: Comparison of polymyxin B with other antimicrobials in the treatment of ventilator-associated pneumonia and tracheobronchitis caused by publication-title: Infection – volume: 277 start-page: 2886 year: 2002 end-page: 2896 ident: bib76 article-title: Oxidative decarboxylation of UDP-glucuronic acid in extracts of polymyxin-resistant publication-title: J Biol Chem – volume: 49 start-page: 523 year: 2016 end-page: 530 ident: bib265 article-title: Role of aerosolized colistin methanesulfonate therapy for extensively-drug-resistant publication-title: J Microbiol Immunol Infect – volume: 57 start-page: 332 year: 2009 end-page: 336 ident: bib299 article-title: Development of des-fatty acyl-polymyxin B decapeptide analogs with publication-title: Chem Pharm Bull (Tokyo) – volume: 47 start-page: 2814 year: 2008 end-page: 2825 ident: bib214 article-title: An inner membrane dioxygenase that generates the 2-hydroxymyristate moiety of publication-title: Biochemistry – volume: 9 start-page: 493 year: 1976 end-page: 497 ident: bib321 article-title: In vitro and in vivo activities of minocycline and other antibiotics against publication-title: Antimicrob Agents Chemother – volume: 29 start-page: 51 year: 2007 end-page: 55 ident: bib467 article-title: Colistin offers prolonged survival in experimental infection by multidrug-resistant publication-title: Int J Antimicrob Agents – volume: 7 start-page: 45527 year: 2017 ident: bib388 article-title: Untargeted metabolomics analysis reveals key pathways responsible for the synergistic killing of colistin and doripenem combination against publication-title: Sci Rep – reference: Saadi M, Duperchy E, Brown P, Dawson MJ, and Wadman SN (2013) inventors, Cantab Anti-Infectives, assignee. Polymyxin derivatives. WO2013072695. 2013 May 23. – volume: 56 start-page: 106061 year: 2020 ident: bib5 article-title: Transcriptomic responses of a New Delhi metallo-β-lactamase-producing publication-title: Int J Antimicrob Agents – volume: 48 start-page: 1724 year: 2009 end-page: 1728 ident: bib244 article-title: Nephrotoxicity associated with intravenous colistin (colistimethate sodium) treatment at a tertiary care medical center publication-title: Clin Infect Dis – volume: 301 start-page: 2445 year: 2009 end-page: 2452 ident: bib140 article-title: Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial publication-title: JAMA – volume: 976 start-page: 65 year: 2002 end-page: 78 ident: bib228 article-title: Liquid chromatography-ion trap tandem mass spectrometry for the characterization of polypeptide antibiotics of the colistin series in commercial samples publication-title: J Chromatogr A – volume: 9 start-page: 333 year: 2012 end-page: 342 ident: bib22 article-title: Inhaled colistin for lower respiratory tract infections publication-title: Expert Opin Drug Deliv – volume: 36 start-page: 1111 year: 2003 end-page: 1118 ident: bib211 article-title: Treatment of multidrug-resistant publication-title: Clin Infect Dis – volume: 40 start-page: 537 year: 2007 end-page: 540 ident: bib261 article-title: Successful treatment of meningitis caused by multidrug-resistant publication-title: J Microbiol Immunol Infect – volume: 36 start-page: 383 year: 2010 end-page: 384 ident: bib248 article-title: Susceptibility of publication-title: Int J Antimicrob Agents – volume: 85 start-page: 65 year: 2015 end-page: 82 ident: bib597 article-title: Inhaled anti-infective chemotherapy for respiratory tract infections: successes, challenges and the road ahead publication-title: Adv Drug Deliv Rev – volume: 33 start-page: 1565 year: 2014 end-page: 1572 ident: bib65 article-title: Activity of colistin in combination with tigecycline or rifampicin against multidrug-resistant publication-title: Eur J Clin Microbiol Infect Dis – volume: 7 start-page: 41 year: 1959–1960 end-page: 60 ident: bib526 article-title: Microbiological and pharmacological studies of colistin sulfate and sodium colistinmethanesulfonate publication-title: Antibiot Annu – volume: 55 start-page: 118 year: 2014 end-page: 125 ident: bib123 article-title: Inhaled colistin for treatment of pneumonia due to colistin-only-susceptible publication-title: Yonsei Med J – volume: 163 start-page: 611 year: 1949 ident: bib548 article-title: Nomenclature of polymyxin antibiotics publication-title: Nature – year: 2019 ident: bib109 article-title: Antibiotic Resistance Threats in the United States – reference: , Sandiego, CA. – volume: 30 start-page: 315 year: 2007 end-page: 319 ident: bib204 article-title: Intravenous polymyxin B for the treatment of nosocomial pneumonia caused by multidrug-resistant publication-title: Int J Antimicrob Agents – volume: 12 start-page: 555 year: 2010 end-page: 560 ident: bib553 article-title: A novel combination regimen for the treatment of refractory bacteremia due to multidrug-resistant publication-title: Transpl Infect Dis – volume: 17 start-page: 60 year: 2010 ident: bib117 article-title: Molecular characterization of the PhoPQ-PmrD-PmrAB mediated pathway regulating polymyxin B resistance in publication-title: J Biomed Sci – volume: 62 start-page: 221 year: 2010 end-page: 229 ident: bib70 article-title: [Occurrence and susceptibility to antibiotics of carbapenem-resistant publication-title: Med Dosw Mikrobiol – volume: 40 start-page: 1333 year: 2005 end-page: 1341 ident: bib195 article-title: Colistin: the revival of polymyxins for the management of multidrug-resistant Gram-negative bacterial infections [published correction appears in publication-title: Clin Infect Dis – volume: 14 start-page: e1018 year: 2010 end-page: e1019 ident: bib343 article-title: Hypersensitivity pneumonitis due to high-dose colistin aerosol therapy publication-title: Int J Infect Dis – volume: 56 start-page: 2683 year: 2012 end-page: 2690 ident: bib256 article-title: In vivo pharmacokinetics/pharmacodynamics of colistin and imipenem in publication-title: Antimicrob Agents Chemother – volume: 13 start-page: 48 year: 1979 end-page: 51 ident: bib137 article-title: Effect of polymyxin B sulfate on endotoxin activity in a Gram-negative septicemia model publication-title: Pediatr Res – volume: 62 start-page: e02101 year: 2018 end-page: 17 ident: bib216 article-title: Successive emergence of ceftazidime-avibactam resistance through distinct genomic adaptations in publication-title: Antimicrob Agents Chemother – volume: 137 start-page: 278 year: 2014 end-page: 291 ident: bib301 article-title: Early prediction of polymyxin-induced nephrotoxicity with next-generation urinary kidney injury biomarkers publication-title: Toxicol Sci – volume: 97 start-page: 166 year: 2015 end-page: 178 ident: bib451 article-title: Extracellular zinc induces phosphoethanolamine addition to publication-title: Mol Microbiol – volume: 84 start-page: 432 year: 2001 end-page: 433 ident: bib142 article-title: Bronchoconstriction following nebulised colistin in cystic fibrosis publication-title: Arch Dis Child – volume: 16 start-page: 1087 year: 1988 end-page: 1093 ident: bib303 article-title: Prevention of colonization and infection in critically ill patients: a prospective randomized study publication-title: Crit Care Med – volume: 9 start-page: 445 year: 1969 end-page: 453 ident: bib403 article-title: Evaluation of the Bauer-Kirby-Sherris-Turck single-disc diffusion method of antibiotic susceptibility testing publication-title: Antimicrob Agents Chemother – volume: 39 start-page: 961 year: 2011 end-page: 966 ident: bib458 article-title: The role of intestinal colonization with Gram-negative bacteria as a source for intensive care unit-acquired bacteremia publication-title: Crit Care Med – volume: 58 start-page: 7331 year: 2014 end-page: 7339 ident: bib71 article-title: Comparison of intrapulmonary and systemic pharmacokinetics of colistin methanesulfonate (CMS) and colistin after aerosol delivery and intravenous administration of CMS in critically ill patients publication-title: Antimicrob Agents Chemother – volume: 104 start-page: 623 year: 1984 end-page: 626 ident: bib217 article-title: Efficacy of topical antibiotic therapy in acute conjunctivitis in children publication-title: J Pediatr – volume: 66 start-page: 175 year: 2011 end-page: 179 ident: bib323 article-title: Polymyxin B versus other antimicrobials for the treatment of publication-title: J Antimicrob Chemother – volume: 42 start-page: 1177 year: 2008 end-page: 1187 ident: bib472 article-title: Parenteral polymyxin B use in patients with multidrug-resistant Gram-negative bacteremia and urinary tract infections: a retrospective case series publication-title: Ann Pharmacother – volume: 183 start-page: S1 year: 2001 end-page: S4 ident: bib547 article-title: Urinary tract infections: disease panorama and challenges publication-title: J Infect Dis – volume: 54 start-page: 2051 year: 2010 end-page: 2062 ident: bib92 article-title: Attenuation of colistin bactericidal activity by high inoculum of publication-title: Antimicrob Agents Chemother – volume: 8 start-page: 45 year: 2002 end-page: 55 ident: bib227 article-title: Characterization of polypeptide antibiotics of the polymyxin series by liquid chromatography electrospray ionization ion trap tandem mass spectrometry publication-title: J Pept Sci – volume: 12 start-page: 598 year: 1990 end-page: 602 ident: bib417 article-title: Flagellate dermatitis after bleomycin. A histological and immunohistochemical study publication-title: Am J Dermatopathol – volume: 125 start-page: 502 year: 2004 end-page: 508 ident: bib496 article-title: Comparison of lung deposition in two types of nebulization: intrapulmonary percussive ventilation vs jet nebulization publication-title: Chest – volume: 62 start-page: B5128 year: 2015 ident: bib445 article-title: The incidence and prognosis of patients with bacteremia publication-title: Dan Med J – year: 1996 ident: bib478 article-title: Bacterial pathogenesis publication-title: Medical Microbiology – volume: 18 start-page: 870 year: 2012 end-page: 876 ident: bib322 article-title: Eradication of multidrug-resistant publication-title: Clin Microbiol Infect – volume: 36 start-page: 1394 year: 2010 end-page: 1402 ident: bib54 article-title: Impact of digestive and oropharyngeal decontamination on the intestinal microbiota in ICU patients publication-title: Intensive Care Med – volume: 56 start-page: 432 year: 2008 end-page: 436 ident: bib63 article-title: Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant publication-title: J Infect – volume: 55 start-page: 943 year: 2012 end-page: 950 ident: bib579 article-title: Predictors of mortality in bloodstream infections caused by publication-title: Clin Infect Dis – volume: 19 start-page: 1861 year: 2000 end-page: 1872 ident: bib316 article-title: A small protein that mediates the activation of a two-component system by another two-component system publication-title: EMBO J – volume: 37 start-page: 204 year: 2014 end-page: 212 ident: bib93 article-title: Application of emerging biomarkers of acute kidney injury in development of kidney-sparing polypeptide-based antibiotics publication-title: Drug Chem Toxicol – volume: 8 start-page: 1017 year: 2016 end-page: 1025 ident: bib603 article-title: Polymyxins: a new hope in combating Gram-negative superbugs? publication-title: Future Med Chem – year: 2016 ident: bib453 article-title: Tackling drug-resistant infections globally: final report and recommendations – year: 1980 ident: bib442 article-title: Performance Standards for Antimicrobial Susceptibility Testing – volume: 148 start-page: 247 year: 2016 end-page: 253 ident: bib42 article-title: Diclofenac pretreatment effects on the toll-like receptor 4/nuclear factor kappa B-mediated inflammatory response to eccentric exercise in rat liver publication-title: Life Sci – volume: 72 start-page: 381 year: 2011 end-page: 393 ident: bib230 article-title: Neurotoxic effects associated with antibiotic use: management considerations publication-title: Br J Clin Pharmacol – volume: 62 start-page: 1311 year: 2008 end-page: 1318 ident: bib486 article-title: In vitro pharmacodynamics of colistin against multidrug-resistant publication-title: J Antimicrob Chemother – volume: 53 start-page: 837 year: 2004 end-page: 840 ident: bib349 article-title: Pharmacokinetics of colistin methanesulphonate and colistin in rats following an intravenous dose of colistin methanesulphonate publication-title: J Antimicrob Chemother – volume: 5 start-page: 88 year: 2017 ident: bib90 article-title: Comparative gut microbiota and resistome profiling of intensive care patients receiving selective digestive tract decontamination and healthy subjects publication-title: Microbiome – volume: 73 start-page: 1217 year: 2018 end-page: 1221 ident: bib184 article-title: Identification of novel variants of the colistin resistance gene publication-title: J Antimicrob Chemother – volume: 33 start-page: 1551 year: 1980 end-page: 1555 ident: bib271 article-title: Selective cleavage of a peptide antibiotic, colistin by colistinase publication-title: J Antibiot (Tokyo) – volume: 5 start-page: 97 year: 2013 end-page: 100 ident: bib335 article-title: Polymyxins and doripenem combination against KPC-producing publication-title: J Clin Med Res – volume: 62 start-page: e01254-17 year: 2017 ident: bib36 article-title: Methionine ameliorates polymyxin-induced nephrotoxicity by attenuating cellular oxidative stress publication-title: Antimicrob Agents Chemother – volume: 10 start-page: 178 year: 2006 end-page: 179 ident: bib523 article-title: Successful treatment of multidrug-resistant publication-title: Int J Infect Dis – volume: 1 start-page: 131 year: 2013 end-page: 134 ident: bib621 article-title: Global survey of polymyxin use: a call for international guidelines publication-title: J Glob Antimicrob Resist – volume: 89 start-page: 875 year: 2011 end-page: 879 ident: bib139 article-title: Pharmacokinetics of colistin and colistimethate sodium after a single 80-mg intravenous dose of CMS in young healthy volunteers publication-title: Clin Pharmacol Ther – volume: 68 start-page: 6139 year: 2000 end-page: 6146 ident: bib232 article-title: Genetic and functional analysis of a PmrA-PmrB-regulated locus necessary for lipopolysaccharide modification, antimicrobial peptide resistance, and oral virulence of publication-title: Infect Immun – volume: 30 start-page: 427 year: 1977 end-page: 429 ident: bib536 article-title: The structures of two new polymyxin group antibiotics publication-title: J Antibiot (Tokyo) – volume: 13 start-page: 78 year: 1978 end-page: 80 ident: bib571 article-title: In vitro activity of antimicrobial agents on Legionnaires disease bacterium publication-title: Antimicrob Agents Chemother – volume: 52 start-page: 3229 year: 2008 end-page: 3236 ident: bib586 article-title: Novel polymyxin derivatives carrying only three positive charges are effective antibacterial agents publication-title: Antimicrob Agents Chemother – volume: 92 start-page: 2259 year: 2018 end-page: 2271 ident: bib646 article-title: Polymyxin B causes DNA damage in HK-2 cells and mice publication-title: Arch Toxicol – volume: 57 start-page: 226 year: 1965 end-page: 227 ident: bib555 article-title: The chemical structure of polymyxin E: the identities of polymyxin E1 with colistin A and of polymyxin E2 with colistin B publication-title: J Biochem – volume: 121 start-page: 555 year: 1970 end-page: 558 ident: bib229 article-title: The synergistic action of the sulfonamides and the polymyxins against publication-title: J Infect Dis – volume: 150 start-page: 159 year: 1968 end-page: 161 ident: bib418 article-title: Separation by density gradient centrifugation of two types of membranes from spheroplast membrane of publication-title: Biochim Biophys Acta – volume: 18 start-page: 391 year: 2018 end-page: 400 ident: bib473 article-title: Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial publication-title: Lancet Infect Dis – volume: 159 start-page: 263 year: 1947 ident: bib11 article-title: Aerosporin, an antibiotic produced by publication-title: Nature – volume: 7 start-page: 246 year: 2017 ident: bib641 article-title: In vitro pharmacokinetics/pharmacodynamics evaluation of fosfomycin combined with amikacin or colistin against KPC2-producing publication-title: Front Cell Infect Microbiol – volume: 11 start-page: FD01 year: 2017 end-page: FD02 ident: bib328 article-title: Polymyxin B-induced diffuse cutaneous hyperpigmentation publication-title: J Clin Diagn Res – volume: 15 start-page: 274 year: 2007 end-page: 277 ident: bib187 article-title: Treatment with intrathecal colistin of a resistant extended-spectrum β-lactamase-producing publication-title: Infect Dis Clin Pract – volume: 28 start-page: 432 year: 2002 end-page: 437 ident: bib482 article-title: Selective decontamination of subglottic area in mechanically ventilated patients with multiple trauma publication-title: Intensive Care Med – volume: 23 start-page: 281 year: 2013 end-page: 288 ident: bib148 article-title: Effect of colistin exposure on calcium homeostasis and mitochondria functions in chick cortex neurons publication-title: Toxicol Mech Methods – volume: 45 start-page: 594 year: 2007 end-page: 598 ident: bib351 article-title: Antibiograms of multidrug-resistant clinical publication-title: Clin Infect Dis – volume: 39 start-page: 949 year: 2005 end-page: 952 ident: bib491 article-title: Intrathecal colistin and sterilization of resistant publication-title: Ann Pharmacother – volume: 1 start-page: 568 year: 2015 end-page: 575 ident: bib501 article-title: Antimicrobial activity and toxicity of the major lipopeptide components of polymyxin B and colistin: last-line antibiotics against multidrug-resistant Gram-negative bacteria publication-title: ACS Infect Dis – volume: 212 start-page: 311 year: 1966 ident: bib626 article-title: Structures of the polymyxins A and the question of identity with the polymyxins M publication-title: Nature – year: 2004 ident: bib269 article-title: Bad Bugs, No Drugs – volume: 38 start-page: 3523 year: 2000 ident: bib595 article-title: Intrathecal use of colistin publication-title: J Clin Microbiol – volume: 17 start-page: 672 year: 2013 end-page: 681 ident: bib286 article-title: Susceptibility rates in Latin American nations: report from a regional resistance surveillance program (2011) publication-title: Braz J Infect Dis – volume: 70 start-page: 75 year: 2015 end-page: 80 ident: bib485 article-title: The publication-title: J Antimicrob Chemother – volume: 51 start-page: 3726 year: 2007 end-page: 3730 ident: bib375 article-title: Comparative evaluation of the VITEK 2, disk diffusion, etest, broth microdilution, and agar dilution susceptibility testing methods for colistin in clinical isolates, including heteroresistant publication-title: Antimicrob Agents Chemother – volume: 43 start-page: 91 year: 2002 end-page: 97 ident: bib345 article-title: Spectrum of publication-title: Diagn Microbiol Infect Dis – volume: 7 start-page: 151 year: 2019 ident: bib295 article-title: The “old” and the “new” antibiotics for MDR Gram-negative pathogens: from whom, when, and how publication-title: Front Public Health – volume: 127 start-page: 522 year: 2005 end-page: 529 ident: bib16 article-title: Bronchial constriction and inhaled colistin in cystic fibrosis publication-title: Chest – reference: , New Orleans. – reference: Leese RA (2010) inventors, BioSource Pharm Inc, assignee. Antibiotic composition for the treatment of Gram-negative infections. U.S. patent 2010/0160215 A1. 2010 Jun 24. – volume: 16 start-page: 184 year: 2010 end-page: 186 ident: bib413 article-title: Intravenous fosfomycin for the treatment of nosocomial infections caused by carbapenem-resistant publication-title: Clin Microbiol Infect – volume: 20 start-page: 48 year: 2014 end-page: 51 ident: bib435 article-title: Susceptibility of various oral antibacterial agents against extended spectrum β-lactamase producing publication-title: J Infect Chemother – volume: 16 start-page: 282 year: 2004 end-page: 287 ident: bib567 article-title: Microbiological activity and clinical efficacy of a colistin and rifampin combination in multidrug-resistant publication-title: J Chemother – volume: 49 start-page: 1171 year: 2015 end-page: 1172 ident: bib651 article-title: Head and neck hyperpigmentation probably associated with polymyxin B therapy publication-title: Ann Pharmacother – volume: 18 start-page: 182 year: 2010 end-page: 186 ident: bib41 article-title: Intrathecal colistin for treatment of multidrug resistant (MDR) publication-title: Infez Med – volume: 63 start-page: 848 year: 2007 end-page: 858 ident: bib401 article-title: Antimicrobial peptides activate the publication-title: Mol Microbiol – volume: 23 start-page: 400 year: 2005 end-page: 405 ident: bib607 article-title: A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection publication-title: Shock – volume: 9 start-page: 824 year: 2018 end-page: 837 ident: bib144 article-title: Rapamycin confers neuroprotection against colistin-induced oxidative stress, mitochondria dysfunction, and apoptosis through the activation of autophagy and mTOR/Akt/CREB signaling pathways publication-title: ACS Chem Neurosci – volume: 43 start-page: 323 year: 2010 end-page: 331 ident: bib362 article-title: Aerosolized colistin for the treatment of multidrug-resistant publication-title: J Microbiol Immunol Infect – volume: 41 start-page: 480 year: 2013 end-page: 483 ident: bib294 article-title: Successful treatment of extensively drug-resistant publication-title: Int J Antimicrob Agents – volume: 13 year: 2018 ident: bib415 article-title: Risk factors of colistin safety according to administration routes: intravenous and aerosolized colistin publication-title: PLoS One – volume: 54 start-page: 595 year: 2001 end-page: 599 ident: bib459 article-title: Isolation and structural characterization of colistin components publication-title: J Antibiot (Tokyo) – year: 2015 ident: bib130 article-title: Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically – volume: 13 start-page: 813 year: 1976 end-page: 818 ident: bib426 article-title: Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides publication-title: Immunochemistry – volume: 46 start-page: 723 year: 1977 end-page: 763 ident: bib550 article-title: Polymyxin and related peptide antibiotics publication-title: Annu Rev Biochem – volume: 72 start-page: 857 year: 1970 end-page: 868 ident: bib312 article-title: Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy publication-title: Ann Intern Med – volume: 113 start-page: 544 year: 2009 end-page: 551 ident: bib411 article-title: Comparison of the structure and dynamics of the antibiotic peptide polymyxin B and the inactive nonapeptide in aqueous trifluoroethanol by NMR spectroscopy publication-title: J Phys Chem B – volume: 37 start-page: 244 year: 2011 end-page: 247 ident: bib487 article-title: Activity of tigecycline alone and in combination with colistin and meropenem against publication-title: Int J Antimicrob Agents – volume: 156 start-page: 706 year: 1987 end-page: 712 ident: bib203 article-title: Polymyxin B moderates acidosis and hypotension in established, experimental Gram-negative septicemia publication-title: J Infect Dis – volume: 54 start-page: 566 year: 2004 end-page: 569 ident: bib542 article-title: Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infections publication-title: J Antimicrob Chemother – volume: 62 start-page: 140 year: 1988 end-page: 144 ident: bib475 article-title: Comparison of the efficacy of “Trisdine” and kanamycin-colistin bladder instillations in reducing bacteriuria during intermittent catheterisation of patients with acute spinal cord trauma publication-title: Br J Urol – volume: 10 start-page: 120 year: 2019 end-page: 131 ident: bib147 article-title: Molecular mechanisms of neurotoxicity induced by polymyxins and chemoprevention publication-title: ACS Chem Neurosci – volume: 16 start-page: 888 year: 2010 end-page: 894 ident: bib304 article-title: Intrathecal colistin for drug-resistant publication-title: Clin Microbiol Infect – volume: 53 start-page: 274 year: 2006 end-page: 278 ident: bib431 article-title: Colistin and rifampicin in the treatment of nosocomial infections from multiresistant publication-title: J Infect – volume: 5 start-page: 551 year: 2014 ident: bib104 article-title: A new strategy to fight antimicrobial resistance: the revival of old antibiotics publication-title: Front Microbiol – volume: 63 start-page: e00965-19 year: 2019 ident: bib306 article-title: , an inducible gene encoding an acquired phosphoethanolamine transferase in publication-title: Antimicrob Agents Chemother – volume: 20 start-page: 1125 year: 2020 end-page: 1126 ident: bib656 article-title: Use of polymyxins in Chinese hospitals publication-title: Lancet Infect Dis – volume: 184 start-page: 92 year: 1982 end-page: 96 ident: bib213 article-title: Trimethoprim-polymyxin eye drops versus neomycin-polymyxin-gramicidin eye drops in the treatment of presumptive bacterial conjunctivitis - a double-blind study publication-title: Ophthalmologica – reference: Gkoufa A, Karaiskos I, Routsi C, Friberg L, Sou T, Lin YW, Li J, and Giamarellou H (2019) P-3296: Pulmonary and systemic pharmacokinetics of colistin methanesulfonate (CMS) and formed colistin following nebulization of CMS after a single inhalation dose of 3 MIU and 5 MIU in ICU patients with ventilator-associated pneumonia, in – volume: 71 start-page: 5225 year: 2003 end-page: 5230 ident: bib533 article-title: Unusual interaction of a lipopolysaccharide isolated from publication-title: Infect Immun – volume: 62 start-page: e00788-18 year: 2018 ident: bib111 article-title: Colistin heteroresistance and involvement of the PmrAB regulatory system in publication-title: Antimicrob Agents Chemother – year: 2020 ident: bib192 article-title: European Pharmacopoeia – volume: 162 start-page: 857 year: 2013 end-page: 861 ident: bib628 article-title: A single-blinded randomized clinical trial comparing polymyxin B-trimethoprim and moxifloxacin for treatment of acute conjunctivitis in children publication-title: J Pediatr – volume: 68 start-page: i7 year: 2013 end-page: i22 ident: bib655 article-title: Antimicrobial susceptibility of 22746 pathogens from Canadian hospitals: results of the CANWARD 2007-11 study publication-title: J Antimicrob Chemother – volume: 61 start-page: e02121-16 year: 2017 ident: bib173 article-title: Polymyxin B in combination with rifampin and meropenem against polymyxin B-resistant KPC-producing publication-title: Antimicrob Agents Chemother – volume: 52 start-page: 1280 year: 2011 end-page: 1281 ident: bib325 article-title: Pharmacokinetics of polymyxin B in a patient with renal insufficiency: a case report publication-title: Clin Infect Dis – volume: 24 start-page: 865 year: 2018 end-page: 870 ident: bib406 article-title: Antimicrobial susceptibility testing of colistin - evaluation of seven commercial MIC products against standard broth microdilution for publication-title: Clin Microbiol Infect – volume: 282 start-page: 36077 year: 2007 end-page: 36089 ident: bib635 article-title: An undecaprenyl phosphate-aminoarabinose flippase required for polymyxin resistance in publication-title: J Biol Chem – volume: 57 start-page: 419 year: 2007 end-page: 422 ident: bib480 article-title: In vitro postantibiotic effect of colistin on multidrug-resistant publication-title: Diagn Microbiol Infect Dis – volume: 59 start-page: 786 year: 2007 end-page: 790 ident: bib21 article-title: Colistin-resistant isolates of publication-title: J Antimicrob Chemother – volume: 54 start-page: 290 year: 2004 end-page: 292 ident: bib53 article-title: Successful treatment of publication-title: J Antimicrob Chemother – volume: 1145 start-page: 133 year: 2019 end-page: 141 ident: bib347 article-title: Labelling conventions and product package insert of parenteral polymyxins: factors causing potential medication errors and impeding optimal clinical use publication-title: Adv Exp Med Biol – volume: 139 start-page: 1740 year: 2011 end-page: 1749 ident: bib578 article-title: Multidrug-resistant publication-title: Epidemiol Infect – volume: 54 start-page: 5316 year: 2010 end-page: 5322 ident: bib224 article-title: Potent synergy and sustained bactericidal activity of a vancomycin-colistin combination versus multidrug-resistant strains of publication-title: Antimicrob Agents Chemother – volume: 62 start-page: e00483-18 year: 2018 ident: bib329 article-title: Personalizing polymyxin B dosing using an adaptive feedback control algorithm publication-title: Antimicrob Agents Chemother – volume: 24 start-page: 3531 year: 2008 end-page: 3542 ident: bib177 article-title: Comparison of efficacy and safety of ciprofloxacin otic solution 0.2% versus polymyxin B-neomycin-hydrocortisone in the treatment of acute diffuse otitis externa publication-title: Curr Med Res Opin – volume: 58 start-page: 4762 year: 2014 end-page: 4766 ident: bib276 article-title: Resistance to colistin associated with a single amino acid change in protein PmrB among publication-title: Antimicrob Agents Chemother – volume: 11 year: 2016 ident: bib340 article-title: Antimicrobial combinations against pan-resistant publication-title: PLoS One – reference: Gordeev MF, Liu J, Wang Z, and Yuan Z (2016) inventors, Micurx Pharmaceuticals Inc, assignee. Antimicrobial polymyxins for treatment of bacterial infections. Patent WO2016100578. 2016 Jun 23. – volume: 28 start-page: 1823 year: 2015 end-page: 1830 ident: bib448 article-title: Investigating nephrotoxicity of polymyxin derivatives by mapping renal distribution using mass spectrometry imaging publication-title: Chem Res Toxicol – volume: 51 start-page: 1678 year: 2013 end-page: 1684 ident: bib260 article-title: Colistin MIC variability by method for contemporary clinical isolates of multidrug-resistant Gram-negative bacilli publication-title: J Clin Microbiol – volume: 36 start-page: 124 year: 2016 end-page: 130 ident: bib469 article-title: In vitro interactions of antibiotic combinations of colistin, tigecycline, and doripenem against extensively drug-resistant and multidrug-resistant publication-title: Ann Lab Med – volume: 55 start-page: 1306 year: 1993 end-page: 1309 ident: bib541 article-title: Selective decontamination in pediatric liver transplants. A randomized prospective study publication-title: Transplantation – volume: 57 start-page: 1938 year: 2013 end-page: 1940 ident: bib666 article-title: Combined intravenous and intraventricular administration of colistin methanesulfonate in critically ill patients with central nervous system infection publication-title: Antimicrob Agents Chemother – volume: 60 start-page: 1163 year: 2007 end-page: 1167 ident: bib311 article-title: High rates of resistance to colistin and polymyxin B in subgroups of publication-title: J Antimicrob Chemother – volume: 265 start-page: 2704 year: 1991 end-page: 2710 ident: bib489 article-title: Oropharyngeal decontamination decreases incidence of ventilator-associated pneumonia. A randomized, placebo-controlled, double-blind clinical trial publication-title: JAMA – volume: 620 start-page: 28 year: 2017 end-page: 34 ident: bib514 article-title: Phosphoethanolamine addition to the heptose I of the lipopolysaccharide modifies the inner core structure and has an impact on the binding of polymyxin B to the publication-title: Arch Biochem Biophys – volume: 187 start-page: 5387 year: 2005 end-page: 5396 ident: bib580 article-title: Cationic antimicrobial peptide resistance in publication-title: J Bacteriol – volume: 91 start-page: 194 year: 2018 end-page: 198 ident: bib545 article-title: Detection of colistin heteroresistance in publication-title: Diagn Microbiol Infect Dis – volume: 67 start-page: 2459 year: 2012 end-page: 2462 ident: bib396 article-title: Colistin pharmacokinetics in intensive care unit patients on continuous venovenous haemodiafiltration: an observational study publication-title: J Antimicrob Chemother – volume: 36 start-page: 717 year: 1992 end-page: 722 ident: bib307 article-title: In vitro susceptibilities of aerotolerant publication-title: Antimicrob Agents Chemother – volume: 72 start-page: 1415 year: 2017 end-page: 1420 ident: bib342 article-title: Polymyxin-resistant, carbapenem-resistant publication-title: J Antimicrob Chemother – volume: 14 start-page: e596 year: 2010 end-page: e601 ident: bib48 article-title: Evaluation of susceptibility testing methods for polymyxin publication-title: Int J Infect Dis – volume: 44 start-page: 1308 year: 2014 end-page: 1318 ident: bib572 article-title: Inhaled antibiotics: dry or wet? publication-title: Eur Respir J – volume: 25 start-page: 11 year: 2005 end-page: 25 ident: bib350 article-title: Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria publication-title: Int J Antimicrob Agents – volume: 43 start-page: 495 year: 1961 end-page: 504 ident: bib155 article-title: [Structure of colimycin] publication-title: Bull Soc Chim Biol (Paris) – volume: 4 start-page: 525 year: 1970 end-page: 527 ident: bib488 article-title: Effects of large doses of colistin sulphomethate sodium on renal function publication-title: BMJ – volume: 57 start-page: 524 year: 2013 end-page: 531 ident: bib518 article-title: Population pharmacokinetics of intravenous polymyxin B in critically ill patients: implications for selection of dosage regimens publication-title: Clin Infect Dis – volume: 59 start-page: 2136 year: 2015 end-page: 2143 ident: bib31 article-title: Major pathways of polymyxin-induced apoptosis in rat kidney proximal tubular cells publication-title: Antimicrob Agents Chemother – volume: 46 start-page: 1 year: 1997 end-page: 3 ident: bib242 article-title: Antibacterial peptides and the outer membranes of Gram-negative bacilli publication-title: J Med Microbiol – volume: 273 start-page: 22395 year: 1998 end-page: 22401 ident: bib6 article-title: Molecular characterization and tissue distribution of a new organic anion transporter subtype ( publication-title: J Biol Chem – volume: 130 start-page: 797 year: 2007 end-page: 810 ident: bib314 article-title: A common mechanism of cellular death induced by bactericidal antibiotics publication-title: Cell – volume: 7 year: 2019 ident: bib20 article-title: FDA approved antibacterial drugs: 2018-2019 publication-title: Discoveries (Craiova) – volume: 10 start-page: R27 year: 2006 ident: bib196 article-title: Toxicity of polymyxins: a systematic review of the evidence from old and recent studies publication-title: Crit Care – volume: 33 start-page: 108313 year: 2020 ident: bib407 article-title: CrrB positively regulates high-level polymyxin resistance and virulence in publication-title: Cell Rep – volume: 59 start-page: 536 year: 2015 end-page: 543 ident: bib631 article-title: Genomic and transcriptomic analyses of colistin-resistant clinical isolates of publication-title: Antimicrob Agents Chemother – volume: 51 start-page: 4106 year: 2013 end-page: 4111 ident: bib332 article-title: Irreproducible and uninterpretable polymyxin B MICs for publication-title: J Clin Microbiol – volume: 51 start-page: 909 year: 1949 end-page: 916 ident: bib288 article-title: Chemical evidence for the multiplicity of the antibiotics produced by publication-title: Ann N Y Acad Sci – volume: 56 start-page: 6212 year: 2012 end-page: 6222 ident: bib200 article-title: The two-component system CprRS senses cationic peptides and triggers adaptive resistance in publication-title: Antimicrob Agents Chemother – volume: 60 start-page: 6980 year: 2016 end-page: 6982 ident: bib391 article-title: Comparative pharmacokinetic profiling of different polymyxin B components publication-title: Antimicrob Agents Chemother – volume: 56 start-page: 2108 year: 2012 end-page: 2113 ident: bib493 article-title: Treatment outcome of bacteremia due to KPC-producing publication-title: Antimicrob Agents Chemother – volume: 67 start-page: 452 year: 2012 end-page: 459 ident: bib640 article-title: Ascorbic acid protects against the nephrotoxicity and apoptosis caused by colistin and affects its pharmacokinetics publication-title: J Antimicrob Chemother – volume: 6 year: 2011 ident: bib361 article-title: In-vitro activity of polymyxin B, rifampicin, tigecycline alone and in combination against carbapenem-resistant publication-title: PLoS One – volume: 57 start-page: 1421 year: 2013 end-page: 1427 ident: bib138 article-title: Activities of fosfomycin, tigecycline, colistin, and gentamicin against extended-spectrum-β-lactamase-producing publication-title: Antimicrob Agents Chemother – volume: 9 start-page: 8781 year: 2019 ident: bib289 article-title: Differences in colistin administration and bacterial and treatment outcomes in critically ill patients publication-title: Sci Rep – volume: 280 start-page: 21202 year: 2005 end-page: 21211 ident: bib497 article-title: A phosphoethanolamine transferase specific for the outer 3-deoxy-D-manno-octulosonic acid residue of publication-title: J Biol Chem – volume: 154 start-page: 3877 year: 2008 end-page: 3886 ident: bib373 article-title: Capsule polysaccharide is a bacterial decoy for antimicrobial peptides publication-title: Microbiology (Reading) – volume: 28 start-page: 1783 year: 2017 end-page: 1791 ident: bib264 article-title: Megalin blockade with cilastatin suppresses drug-induced nephrotoxicity publication-title: J Am Soc Nephrol – volume: 14 start-page: 719 year: 1998 end-page: 727 ident: bib508 article-title: Prevention of nosocomial infection in a pediatric intensive care unit (PICU) through the use of selective digestive decontamination publication-title: Eur J Epidemiol – volume: 13 start-page: 137 year: 2013 ident: bib449 article-title: Polymyxin P is the active principle in suppressing phytopathogenic publication-title: BMC Microbiol – year: 2019 ident: bib667 article-title: British Pharmacopoeia – volume: 29 start-page: 141 year: 2009 end-page: 147 ident: bib151 article-title: Successful treatment of multidrug-resistant publication-title: Ann Trop Paediatr – volume: 26 start-page: 656 year: 2005 end-page: 658 ident: bib91 article-title: Treatment of nosocomial meningitis due to a multidrug resistant publication-title: Saudi Med J – volume: 30 start-page: 179 year: 1977 end-page: 181 ident: bib170 article-title: Acute renal failure due to colistin intoxication publication-title: Acta Paediatr Belg – volume: 72 start-page: 7107 year: 2004 end-page: 7114 ident: bib99 article-title: Capsule polysaccharide mediates bacterial resistance to antimicrobial peptides publication-title: Infect Immun – volume: 19 start-page: 501 year: 2013 end-page: 509 ident: bib226 article-title: Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe publication-title: Clin Microbiol Infect – start-page: 171 year: 2016 end-page: 183 ident: bib517 article-title: Antibiotics and preservatives publication-title: Pharmaceutical Microbiology – volume: 59 start-page: 3224 year: 2015 end-page: 3232 ident: bib537 article-title: Preliminary clinical study of the effect of ascorbic acid on colistin-associated nephrotoxicity publication-title: Antimicrob Agents Chemother – volume: 51 start-page: 3413 year: 2007 end-page: 3415 ident: bib559 article-title: Activity of colistin against heteroresistant publication-title: Antimicrob Agents Chemother – volume: 53 start-page: 546 year: 2011 end-page: 551 ident: bib384 article-title: Comparison of disc diffusion, Etest and agar dilution for susceptibility testing of colistin against Enterobacteriaceae publication-title: Lett Appl Microbiol – volume: 62 start-page: 39 year: 2005 end-page: 47 ident: bib62 article-title: Use of colistin in the treatment of multiple-drug-resistant Gram-negative infections publication-title: Am J Health Syst Pharm – volume: 6 start-page: 2698 year: 2020 end-page: 2708 ident: bib278 article-title: Outer membranes of polymyxin-resistant publication-title: ACS Infect Dis – volume: 166 start-page: 1029 year: 2002 end-page: 1037 ident: bib318 article-title: Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical trial publication-title: Am J Respir Crit Care Med – volume: 33 start-page: 1162 year: 2007 end-page: 1167 ident: bib291 article-title: Safety and efficacy of colistin compared with imipenem in the treatment of ventilator-associated pneumonia: a matched case-control study publication-title: Intensive Care Med – volume: 151 start-page: e1 year: 2017 end-page: e3 ident: bib344 article-title: Pulmonary eosinophilia from inhaled colistin publication-title: Chest – volume: 99 start-page: 232 year: 2012 end-page: 237 ident: bib410 article-title: Selective decontamination of the oral and digestive tract in surgical versus non-surgical patients in intensive care in a cluster-randomized trial publication-title: Br J Surg – volume: 64 start-page: 565 year: 2017 end-page: 571 ident: bib439 article-title: Dosing guidance for intravenous colistin in critically-ill patients publication-title: Clin Infect Dis – volume: 60 start-page: 431 year: 2015 end-page: 436 ident: bib215 article-title: Influence of colistin dose on global cure in patients with bacteremia due to carbapenem-resistant Gram-negative bacilli publication-title: Antimicrob Agents Chemother – volume: 46 start-page: 616 year: 2015 end-page: 621 ident: bib503 article-title: In vitro activity of the next-generation aminoglycoside plazomicin alone and in combination with colistin, meropenem, fosfomycin or tigecycline against carbapenemase-producing Enterobacteriaceae strains publication-title: Int J Antimicrob Agents – volume: 181 start-page: 85 year: 2018 end-page: 90 ident: bib598 article-title: Polymyxins for CNS infections: pharmacology and neurotoxicity publication-title: Pharmacol Ther – volume: 79 start-page: 425 year: 2017 end-page: 448 ident: bib188 article-title: Receptor-mediated endocytosis in the proximal tubule publication-title: Annu Rev Physiol – volume: 7 start-page: 391 year: 2008 end-page: 397 ident: bib285 article-title: Spread of colistin resistant non-mucoid publication-title: J Cyst Fibros – volume: 51 start-page: 714 year: 2018 end-page: 720 ident: bib658 article-title: Pharmacokinetics of colistin methanesulfonate (CMS) in healthy Chinese subjects after single and multiple intravenous doses publication-title: Int J Antimicrob Agents – volume: 53 start-page: 1898 year: 2010 end-page: 1916 ident: bib604 article-title: Structure--activity relationships of polymyxin antibiotics publication-title: J Med Chem – reference: , Melbourne, Australia. – volume: 11 start-page: 287 year: 2005 end-page: 289 ident: bib297 article-title: Cure of multidrug-resistant publication-title: Microb Drug Resist – volume: 68 start-page: 636 year: 2013 end-page: 639 ident: bib587 article-title: Antimicrobial activity of the novel polymyxin derivative NAB739 tested against Gram-negative pathogens publication-title: J Antimicrob Chemother – volume: 2 start-page: 331 year: 1972 end-page: 335 ident: bib114 article-title: Locus of divalent cation inhibition of the bactericidal action of polymyxin B publication-title: Antimicrob Agents Chemother – reference: Gordeev MF (2018) Polymyxin soft drug MRX-8 with potential to address the class nephrotoxicity, in – volume: 68 start-page: 60 year: 2019 end-page: 66 ident: bib235 article-title: Comparison of susceptibility testing methods for determining the activity of colistin against Gram-negative bacilli of clinical origin publication-title: J Med Microbiol – volume: 7 start-page: 596 year: 1975 end-page: 600 ident: bib152 article-title: Effect of calcium and magnesium ions on the susceptibility of publication-title: Antimicrob Agents Chemother – volume: 206 start-page: 563 year: 1981 end-page: 572 ident: bib310 article-title: Analytical and preparative methods for polymyxin antibiotics using high-performance liquid-chromatography with a porous styrene-divinylbenzene co-polymer packing publication-title: J Chromatogr A – volume: 106 start-page: 8009 year: 2009 end-page: 8014 ident: bib390 article-title: An ABC transport system that maintains lipid asymmetry in the Gram-negative outer membrane publication-title: Proc Natl Acad Sci USA – volume: 320 start-page: 1455 year: 2018 end-page: 1463 ident: bib160 article-title: Effect of targeted polymyxin B hemoperfusion on 28-day mortality in patients with septic shock and elevated endotoxin level: the EUPHRATES randomized clinical trial publication-title: JAMA – volume: 9 start-page: 2776 year: 2018 ident: bib238 article-title: Metabolic analyses revealed time-dependent synergistic killing by colistin and aztreonam combination against multidrug-resistant publication-title: Front Microbiol – volume: 8 start-page: 31 year: 2019 ident: bib29 article-title: A review of the clinical pharmacokinetics of polymyxin B publication-title: Antibiotics (Basel) – volume: 52 start-page: 2940 year: 2008 end-page: 2942 ident: bib424 article-title: In vitro activity of tigecycline against multidrug-resistant publication-title: Antimicrob Agents Chemother – volume: 55 start-page: 2609 year: 2017 end-page: 2616 ident: bib120 article-title: Colistin and polymyxin B susceptibility testing for carbapenem-resistant and publication-title: J Clin Microbiol – volume: 11 start-page: 227 year: 1988 end-page: 231 ident: bib49 article-title: Trimethoprim-polymyxin B sulphate ophthalmic ointment in the treatment of bacterial conjunctivitis: a double-blind study versus chloramphenicol ophthalmic ointment publication-title: Curr Med Res Opin – volume: 7 start-page: 544 year: 1989 end-page: 546 ident: bib210 article-title: [In vitro activity of 16 antimicrobial agents against publication-title: Enferm Infecc Microbiol Clin – volume: 51 start-page: 879 year: 1949 end-page: 890 ident: bib623 article-title: Comparative biological studies of polymyxin and aerosporin publication-title: Ann N Y Acad Sci – volume: 52 start-page: 987 year: 1997 end-page: 993 ident: bib135 article-title: Intravenous colistin sulphomethate in acute respiratory exacerbations in adult patients with cystic fibrosis publication-title: Thorax – volume: 20 start-page: 550 year: 2014 end-page: 554 ident: bib178 article-title: In vitro synergistic activity of colistin and ceftazidime or ciprofloxacin against multidrug-resistant clinical strains of publication-title: Microb Drug Resist – volume: 124 start-page: 610 year: 1971 end-page: 612 ident: bib156 article-title: Activity of colistin against publication-title: J Infect Dis – volume: 42 start-page: 573 year: 2017 end-page: 578 ident: bib405 article-title: Skin hyperpigmentation following intravenous polymyxin B treatment associated with melanocyte activation and inflammatory process publication-title: J Clin Pharm Ther – volume: 64 start-page: 1067 year: 2009 end-page: 1070 ident: bib15 article-title: Pharmacokinetics of novel antimicrobial cationic peptides NAB 7061 and NAB 739 in rats following intravenous administration publication-title: J Antimicrob Chemother – volume: 7 start-page: 61 year: 1959–1960 end-page: 74 ident: bib632 article-title: Chemical, biological and clinical observations on colistin publication-title: Antibiot Annu – volume: 38 start-page: 1779 year: 2012 end-page: 1786 ident: bib28 article-title: Pharmacokinetics of inhaled colistimethate sodium (CMS) in mechanically ventilated critically ill patients publication-title: Intensive Care Med – volume: 47 start-page: 905 year: 2003 ident: 10.1124/pharmrev.120.000020_bib231 article-title: Synergistic activity of colistin and ceftazidime against multiantibiotic-resistant Pseudomonas aeruginosa in an in vitro pharmacodynamic model publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.47.3.905-909.2003 – volume: 11 year: 2016 ident: 10.1124/pharmrev.120.000020_bib340 article-title: Antimicrobial combinations against pan-resistant Acinetobacter baumannii isolates with different resistance mechanisms publication-title: PLoS One doi: 10.1371/journal.pone.0151270 – volume: 43 start-page: 495 year: 1961 ident: 10.1124/pharmrev.120.000020_bib155 article-title: [Structure of colimycin] publication-title: Bull Soc Chim Biol (Paris) – volume: 61 start-page: e00211 year: 2017 ident: 10.1124/pharmrev.120.000020_bib367 article-title: Aerosolized polymyxin B for treatment of respiratory tract infections: determination of pharmacokinetic-pharmacodynamic indices for aerosolized polymyxin B against Pseudomonas aeruginosa in a mouse lung infection model publication-title: Antimicrob Agents Chemother – ident: 10.1124/pharmrev.120.000020_bib223 – volume: 159 start-page: 263 year: 1947 ident: 10.1124/pharmrev.120.000020_bib11 article-title: Aerosporin, an antibiotic produced by Bacillus aerosporus Greer publication-title: Nature doi: 10.1038/160263a0 – volume: 37 start-page: 141 year: 2011 ident: 10.1124/pharmrev.120.000020_bib464 article-title: Could nephrotoxicity due to colistin be ameliorated with the use of N-acetylcysteine? publication-title: Intensive Care Med doi: 10.1007/s00134-010-2038-7 – volume: 11 start-page: FD01 year: 2017 ident: 10.1124/pharmrev.120.000020_bib328 article-title: Polymyxin B-induced diffuse cutaneous hyperpigmentation publication-title: J Clin Diagn Res – volume: 28 start-page: 1823 year: 2015 ident: 10.1124/pharmrev.120.000020_bib448 article-title: Investigating nephrotoxicity of polymyxin derivatives by mapping renal distribution using mass spectrometry imaging publication-title: Chem Res Toxicol doi: 10.1021/acs.chemrestox.5b00262 – volume: 151 start-page: e1 year: 2017 ident: 10.1124/pharmrev.120.000020_bib344 article-title: Pulmonary eosinophilia from inhaled colistin publication-title: Chest doi: 10.1016/j.chest.2016.07.001 – volume: 224 start-page: 500 year: 1996 ident: 10.1124/pharmrev.120.000020_bib455 article-title: cDNA cloning and functional expression of a novel rat kidney organic cation transporter, OCT2 publication-title: Biochem Biophys Res Commun doi: 10.1006/bbrc.1996.1056 – volume: 50 start-page: Suppl:ix year: 1968 ident: 10.1124/pharmrev.120.000020_bib82 article-title: Synergistic action of polysorbate 80 and polymyxin B sulphate on Pseudomonas aeruginosa publication-title: J Gen Microbiol – volume: 39 start-page: 961 year: 2011 ident: 10.1124/pharmrev.120.000020_bib458 article-title: The role of intestinal colonization with Gram-negative bacteria as a source for intensive care unit-acquired bacteremia publication-title: Crit Care Med doi: 10.1097/CCM.0b013e318208ee26 – year: 2018 ident: 10.1124/pharmrev.120.000020_bib78 – volume: 60 start-page: 1029 year: 2015 ident: 10.1124/pharmrev.120.000020_bib394 article-title: Characterization of polymyxin B biodistribution and disposition in an animal model publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.02445-15 – volume: 30 start-page: 143 year: 2008 ident: 10.1124/pharmrev.120.000020_bib397 article-title: Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, Gram-negative bacilli infections: a prospective, open-label, uncontrolled study publication-title: Clin Ther doi: 10.1016/j.clinthera.2008.01.015 – year: 1976 ident: 10.1124/pharmrev.120.000020_bib441 – volume: 1145 start-page: 133 year: 2019 ident: 10.1124/pharmrev.120.000020_bib347 article-title: Labelling conventions and product package insert of parenteral polymyxins: factors causing potential medication errors and impeding optimal clinical use publication-title: Adv Exp Med Biol doi: 10.1007/978-3-030-16373-0_10 – volume: 59 start-page: 2051 year: 2015 ident: 10.1124/pharmrev.120.000020_bib507 article-title: PmrD is required for modifications to escherichia coli endotoxin that promote antimicrobial resistance publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.05052-14 – volume: 47 start-page: 1298 year: 2008 ident: 10.1124/pharmrev.120.000020_bib650 article-title: Pharmacokinetics of intravenous polymyxin B in critically ill patients publication-title: Clin Infect Dis doi: 10.1086/592577 – volume: 65 start-page: 80 year: 2012 ident: 10.1124/pharmrev.120.000020_bib320 article-title: Incidence and predictors of acute kidney injury associated with intravenous polymyxin B therapy publication-title: J Infect doi: 10.1016/j.jinf.2012.01.015 – volume: 24 start-page: 249 year: 2019 ident: 10.1124/pharmrev.120.000020_bib584 article-title: Polymyxin derivatives that sensitize Gram-negative bacteria to other antibiotics publication-title: Molecules doi: 10.3390/molecules24020249 – volume: 28 start-page: 1783 year: 2017 ident: 10.1124/pharmrev.120.000020_bib264 article-title: Megalin blockade with cilastatin suppresses drug-induced nephrotoxicity publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2016060606 – volume: 360 start-page: 20 year: 2009 ident: 10.1124/pharmrev.120.000020_bib168 article-title: Decontamination of the digestive tract and oropharynx in ICU patients publication-title: N Engl J Med doi: 10.1056/NEJMoa0800394 – volume: 56 start-page: 4241 year: 2012 ident: 10.1124/pharmrev.120.000020_bib423 article-title: Application of a loading dose of colistin methanesulfonate in critically ill patients: population pharmacokinetics, protein binding, and prediction of bacterial kill publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.06426-11 – volume: 23 start-page: 400 year: 2005 ident: 10.1124/pharmrev.120.000020_bib607 article-title: A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection publication-title: Shock doi: 10.1097/01.shk.0000159930.87737.8a – volume: 42 start-page: 199 year: 2014 ident: 10.1124/pharmrev.120.000020_bib218 article-title: Colistin bladder instillation, an alternative way of treating multi-resistant Acinetobacter urinary tract infection: a case series and review of literature publication-title: Infection doi: 10.1007/s15010-013-0507-y – volume: 31 start-page: 404 year: 2015 ident: 10.1124/pharmrev.120.000020_bib128 article-title: Effect of divalent cation removal on the structure of Gram-negative bacterial outer membrane models publication-title: Langmuir doi: 10.1021/la504407v – volume: 57 start-page: 3224 year: 2013 ident: 10.1124/pharmrev.120.000020_bib237 article-title: Emergence of colistin resistance in Enterobacteriaceae after the introduction of selective digestive tract decontamination in an intensive care unit publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.02634-12 – volume: 181 start-page: 85 year: 2018 ident: 10.1124/pharmrev.120.000020_bib598 article-title: Polymyxins for CNS infections: pharmacology and neurotoxicity publication-title: Pharmacol Ther doi: 10.1016/j.pharmthera.2017.07.012 – ident: 10.1124/pharmrev.120.000020_bib39 – volume: 11 start-page: 193 year: 1980 ident: 10.1124/pharmrev.120.000020_bib175 article-title: Branhamella (Neisseria) catarrhalis: criteria for laboratory identification publication-title: J Clin Microbiol doi: 10.1128/jcm.11.2.193-195.1980 – volume: 1145 start-page: 289 year: 2019 ident: 10.1124/pharmrev.120.000020_bib484 article-title: Toxicity in patients publication-title: Adv Exp Med Biol doi: 10.1007/978-3-030-16373-0_17 – volume: 61 start-page: e01268-16 year: 2017 ident: 10.1124/pharmrev.120.000020_bib341 article-title: High-dose ampicillin-sulbactam combinations combat polymyxin-resistant Acinetobacter baumannii in a hollow-fiber infection model publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.01268-16 – volume: 5 start-page: 1645 year: 2019 ident: 10.1124/pharmrev.120.000020_bib83 article-title: Design of next generation polymyxins with lower toxicity: the discovery of SPR206 publication-title: ACS Infect Dis doi: 10.1021/acsinfecdis.9b00217 – volume: 24 start-page: 175 year: 2018 ident: 10.1124/pharmrev.120.000020_bib275 article-title: Comparison of methods for detection of plasmid-mediated and chromosomally encoded colistin resistance in Enterobacteriaceae publication-title: Clin Microbiol Infect doi: 10.1016/j.cmi.2017.06.002 – volume: 55 start-page: 421 year: 2018 ident: 10.1124/pharmrev.120.000020_bib143 article-title: Curcumin attenuates colistin-induced neurotoxicity in N2a cells via anti-inflammatory activity, suppression of oxidative stress, and apoptosis publication-title: Mol Neurobiol doi: 10.1007/s12035-016-0276-6 – volume: 51 start-page: 3726 year: 2007 ident: 10.1124/pharmrev.120.000020_bib375 article-title: Comparative evaluation of the VITEK 2, disk diffusion, etest, broth microdilution, and agar dilution susceptibility testing methods for colistin in clinical isolates, including heteroresistant Enterobacter cloacae and Acinetobacter baumannii strains publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.01406-06 – volume: 43 start-page: 874 year: 2008 ident: 10.1124/pharmrev.120.000020_bib429 article-title: Shifting patterns of inhaled antibiotic use in cystic fibrosis publication-title: Pediatr Pulmonol doi: 10.1002/ppul.20873 – volume: 62 start-page: e01254-17 year: 2017 ident: 10.1124/pharmrev.120.000020_bib36 article-title: Methionine ameliorates polymyxin-induced nephrotoxicity by attenuating cellular oxidative stress publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.01254-17 – volume: 58 start-page: 1195 year: 2014 ident: 10.1124/pharmrev.120.000020_bib457 article-title: In vitro responses of Acinetobacter baumannii to two- and three-drug combinations following exposure to colistin and doripenem publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.01779-13 – volume: 9 start-page: 824 year: 2018 ident: 10.1124/pharmrev.120.000020_bib144 article-title: Rapamycin confers neuroprotection against colistin-induced oxidative stress, mitochondria dysfunction, and apoptosis through the activation of autophagy and mTOR/Akt/CREB signaling pathways publication-title: ACS Chem Neurosci doi: 10.1021/acschemneuro.7b00323 – volume: 73 start-page: 462 year: 2018 ident: 10.1124/pharmrev.120.000020_bib330 article-title: Pharmacokinetics/pharmacodynamics of systemically administered polymyxin B against Klebsiella pneumoniae in mouse thigh and lung infection models publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkx409 – volume: 39 start-page: 10 year: 2019 ident: 10.1124/pharmrev.120.000020_bib577 publication-title: Pharmacotherapy doi: 10.1002/phar.2209 – volume: 16 start-page: 1087 year: 1988 ident: 10.1124/pharmrev.120.000020_bib303 article-title: Prevention of colonization and infection in critically ill patients: a prospective randomized study publication-title: Crit Care Med doi: 10.1097/00003246-198811000-00001 – volume: 59 start-page: 473 year: 2007 ident: 10.1124/pharmrev.120.000020_bib461 article-title: In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkl512 – volume: 35 start-page: 49 year: 2014 ident: 10.1124/pharmrev.120.000020_bib444 article-title: A multicenter case-case control study for risk factors and outcomes of extensively drug-resistant Acinetobacter baumannii bacteremia publication-title: Infect Control Hosp Epidemiol doi: 10.1086/674387 – volume: 54 start-page: 5316 year: 2010 ident: 10.1124/pharmrev.120.000020_bib224 article-title: Potent synergy and sustained bactericidal activity of a vancomycin-colistin combination versus multidrug-resistant strains of Acinetobacter baumannii publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00922-10 – volume: 10 start-page: 491 year: 1954 ident: 10.1124/pharmrev.120.000020_bib443 article-title: Site of action of polymyxin on Pseudomonas aeruginosa: antagonism by cations publication-title: J Gen Microbiol doi: 10.1099/00221287-10-3-491 – volume: 130 start-page: 797 year: 2007 ident: 10.1124/pharmrev.120.000020_bib314 article-title: A common mechanism of cellular death induced by bactericidal antibiotics publication-title: Cell doi: 10.1016/j.cell.2007.06.049 – volume: 29 start-page: 388 year: 2016 ident: 10.1124/pharmrev.120.000020_bib404 article-title: Acquired skin hyperpigmentation following intravenous polymyxin B treatment: a cohort study publication-title: Pigment Cell Melanoma Res doi: 10.1111/pcmr.12468 – volume: 37 start-page: 314 year: 2014 ident: 10.1124/pharmrev.120.000020_bib116 article-title: Influencing factors of successful eradication of multidrug-resistant Acinetobacter baumannii in the respiratory tract with aerosolized colistin publication-title: Biomed J doi: 10.4103/2319-4170.132879 – volume: 98 year: 2019 ident: 10.1124/pharmrev.120.000020_bib660 article-title: Risk factors for acquisition and mortality of multidrug-resistant Acinetobacter baumannii bacteremia: a retrospective study from a Chinese hospital publication-title: Medicine (Baltimore) – volume: 35 start-page: 1609 year: 2009 ident: 10.1124/pharmrev.120.000020_bib166 article-title: Decontamination of the digestive tract and oropharynx: hospital acquired infections after discharge from the intensive care unit publication-title: Intensive Care Med doi: 10.1007/s00134-009-1554-9 – volume: 65 start-page: 1416 year: 2010 ident: 10.1124/pharmrev.120.000020_bib428 article-title: Colistin susceptibility testing: evaluation of reliability for cystic fibrosis isolates of Pseudomonas aeruginosa and Stenotrophomonas maltophilia publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkq131 – volume: 55 start-page: 502 year: 2011 ident: 10.1124/pharmrev.120.000020_bib282 article-title: Impact of p-glycoprotein inhibition and lipopolysaccharide administration on blood-brain barrier transport of colistin in mice publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.01273-10 – volume: 912 start-page: 369 year: 2001 ident: 10.1124/pharmrev.120.000020_bib460 article-title: Isolation and structural characterization of polymyxin B components publication-title: J Chromatogr A doi: 10.1016/S0021-9673(01)00585-4 – volume: 281 start-page: 61 year: 1999 ident: 10.1124/pharmrev.120.000020_bib25 article-title: Trends in infectious disease mortality in the United States during the 20th century publication-title: JAMA doi: 10.1001/jama.281.1.61 – volume: 55 start-page: 3743 year: 2011 ident: 10.1124/pharmrev.120.000020_bib27 article-title: The pmrCAB operon mediates polymyxin resistance in Acinetobacter baumannii ATCC 17978 and clinical isolates through phosphoethanolamine modification of lipid A publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00256-11 – volume: 16 start-page: R148 year: 2012 ident: 10.1124/pharmrev.120.000020_bib266 article-title: Endotoxemia and mortality prediction in ICU and other settings: underlying risk and co-detection of gram negative bacteremia are confounders publication-title: Crit Care doi: 10.1186/cc11462 – volume: 16 start-page: 271 year: 1995 ident: 10.1124/pharmrev.120.000020_bib452 article-title: Lipopolysaccharides of polymyxin B-resistant mutants of Escherichia coli are extensively substituted by 2-aminoethyl pyrophosphate and contain aminoarabinose in lipid A publication-title: Mol Microbiol doi: 10.1111/j.1365-2958.1995.tb02299.x – volume: 70 start-page: 3357 year: 2015 ident: 10.1124/pharmrev.120.000020_bib498 article-title: Osteoarticular infection caused by MDR Pseudomonas aeruginosa: the benefits of combination therapy with colistin plus β-lactams publication-title: J Antimicrob Chemother – volume: 57 start-page: 3738 year: 2013 ident: 10.1124/pharmrev.120.000020_bib337 article-title: Synergistic activity of colistin and rifampin combination against multidrug-resistant Acinetobacter baumannii in an in vitro pharmacokinetic/pharmacodynamic model publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00703-13 – volume: 49 start-page: 1171 year: 2015 ident: 10.1124/pharmrev.120.000020_bib651 article-title: Head and neck hyperpigmentation probably associated with polymyxin B therapy publication-title: Ann Pharmacother doi: 10.1177/1060028015595643 – volume: 210 start-page: 746 year: 1995 ident: 10.1124/pharmrev.120.000020_bib97 article-title: Direct vesicle-vesicle exchange of phospholipids mediated by polymyxin B publication-title: Biochem Biophys Res Commun doi: 10.1006/bbrc.1995.1722 – volume: 57 start-page: 1421 year: 2013 ident: 10.1124/pharmrev.120.000020_bib138 article-title: Activities of fosfomycin, tigecycline, colistin, and gentamicin against extended-spectrum-β-lactamase-producing Escherichia coli in a foreign-body infection model publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.01718-12 – ident: 10.1124/pharmrev.120.000020_bib302 – volume: 69 start-page: 2434 year: 2014 ident: 10.1124/pharmrev.120.000020_bib374 article-title: Activity of colistin combined with doripenem at clinically relevant concentrations against multidrug-resistant Pseudomonas aeruginosa in an in vitro dynamic biofilm model publication-title: J Antimicrob Chemother doi: 10.1093/jac/dku151 – volume: 16 start-page: 485 year: 2018 ident: 10.1124/pharmrev.120.000020_bib69 article-title: Can octapeptin antibiotics combat extensively drug-resistant (XDR) bacteria? publication-title: Expert Rev Anti Infect Ther doi: 10.1080/14787210.2018.1483240 – volume: 47 start-page: 621 year: 2006 ident: 10.1124/pharmrev.120.000020_bib561 article-title: The in-vitro activity of colistin in Gram-negative bacteria publication-title: Singapore Med J – volume: 1 start-page: 922 year: 1963 ident: 10.1124/pharmrev.120.000020_bib625 article-title: Identity of colistin and polymyxin E publication-title: Lancet doi: 10.1016/S0140-6736(63)91694-5 – volume: 1 start-page: e00119 year: 2016 ident: 10.1124/pharmrev.120.000020_bib657 article-title: Transcriptomic analysis of the activity of a novel polymyxin against Staphylococcus aureus publication-title: mSphere doi: 10.1128/mSphere.00119-16 – volume: 72 start-page: 3577 year: 2004 ident: 10.1124/pharmrev.120.000020_bib402 article-title: The Vibrio cholerae ToxR-regulated porin OmpU confers resistance to antimicrobial peptides publication-title: Infect Immun doi: 10.1128/IAI.72.6.3577-3583.2004 – volume: 166 start-page: 1029 year: 2002 ident: 10.1124/pharmrev.120.000020_bib318 publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.2105141 – volume: 51 start-page: 952 year: 1949 ident: 10.1124/pharmrev.120.000020_bib88 article-title: The pharmacology of polymyxin A, B, and D publication-title: Ann N Y Acad Sci doi: 10.1111/j.1749-6632.1949.tb27322.x – volume: 79 start-page: 425 year: 2017 ident: 10.1124/pharmrev.120.000020_bib188 article-title: Receptor-mediated endocytosis in the proximal tubule publication-title: Annu Rev Physiol doi: 10.1146/annurev-physiol-022516-034234 – volume: 61 start-page: e01735-17 year: 2017 ident: 10.1124/pharmrev.120.000020_bib40 article-title: Evaluation of urinary KIM-1 for prediction of polymyxin B-induced nephrotoxicity publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.01735-17 – volume: 7 start-page: 170 year: 1952 ident: 10.1124/pharmrev.120.000020_bib89 article-title: The chemotherapy and pharmacology of the polymyxins publication-title: Br J Pharmacol Chemother doi: 10.1111/j.1476-5381.1952.tb00702.x – volume: 74 start-page: 377 year: 2014 ident: 10.1124/pharmrev.120.000020_bib134 article-title: Colistimethate sodium dry powder for inhalation: a review of its use in the treatment of chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis publication-title: Drugs doi: 10.1007/s40265-014-0181-0 – volume: 59 start-page: 2136 year: 2015 ident: 10.1124/pharmrev.120.000020_bib31 article-title: Major pathways of polymyxin-induced apoptosis in rat kidney proximal tubular cells publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.04869-14 – year: 2019 ident: 10.1124/pharmrev.120.000020_bib667 – volume: 59 start-page: 3224 year: 2015 ident: 10.1124/pharmrev.120.000020_bib537 article-title: Preliminary clinical study of the effect of ascorbic acid on colistin-associated nephrotoxicity publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00280-15 – volume: 1 start-page: 127 year: 1948 ident: 10.1124/pharmrev.120.000020_bib86 article-title: Chemotherapy and pharmacology of aerosporin; a selective Gram-negative antibiotic publication-title: Lancet doi: 10.1016/S0140-6736(48)90090-7 – volume: 30 start-page: 427 year: 1977 ident: 10.1124/pharmrev.120.000020_bib536 article-title: The structures of two new polymyxin group antibiotics publication-title: J Antibiot (Tokyo) doi: 10.7164/antibiotics.30.427 – volume: 104 start-page: 623 year: 1984 ident: 10.1124/pharmrev.120.000020_bib217 article-title: Efficacy of topical antibiotic therapy in acute conjunctivitis in children publication-title: J Pediatr doi: 10.1016/S0022-3476(84)80566-1 – volume: 58 start-page: 154 year: 2009 ident: 10.1124/pharmrev.120.000020_bib110 article-title: [Antibiotic resistance and biofilm formation in Pseudomonas aeruginosa strains isolated from patients with urinary tract infections] publication-title: Epidemiol Mikrobiol Imunol – volume: 59 start-page: 1802 year: 2015 ident: 10.1124/pharmrev.120.000020_bib1 article-title: Activity of eravacycline against Enterobacteriaceae and Acinetobacter baumannii, including multidrug-resistant isolates, from New York City publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.04809-14 – volume: 32 start-page: 1569 year: 2006 ident: 10.1124/pharmrev.120.000020_bib253 article-title: Effects of long-term routine use of selective digestive decontamination on antimicrobial resistance publication-title: Intensive Care Med doi: 10.1007/s00134-006-0304-5 – volume: 64 start-page: e01699-19 year: 2020 ident: 10.1124/pharmrev.120.000020_bib425 article-title: In vitro activity of eravacycline against Gram-negative bacilli isolated in clinical laboratories worldwide from 2013 to 2017 publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.01699-19 – volume: 72 start-page: 381 year: 2011 ident: 10.1124/pharmrev.120.000020_bib230 article-title: Neurotoxic effects associated with antibiotic use: management considerations publication-title: Br J Clin Pharmacol doi: 10.1111/j.1365-2125.2011.03991.x – volume: 12 start-page: 555 year: 2010 ident: 10.1124/pharmrev.120.000020_bib553 article-title: A novel combination regimen for the treatment of refractory bacteremia due to multidrug-resistant Pseudomonas aeruginosa in a liver transplant recipient publication-title: Transpl Infect Dis doi: 10.1111/j.1399-3062.2010.00543.x – volume: 38 start-page: 1779 year: 2012 ident: 10.1124/pharmrev.120.000020_bib28 article-title: Pharmacokinetics of inhaled colistimethate sodium (CMS) in mechanically ventilated critically ill patients publication-title: Intensive Care Med doi: 10.1007/s00134-012-2628-7 – volume: 68 start-page: 344 year: 2013 ident: 10.1124/pharmrev.120.000020_bib525 article-title: Safety, efficacy and convenience of colistimethate sodium dry powder for inhalation (Colobreathe DPI) in patients with cystic fibrosis: a randomised study publication-title: Thorax doi: 10.1136/thoraxjnl-2012-202059 – volume: 2 start-page: 341 year: 2016 ident: 10.1124/pharmrev.120.000020_bib605 article-title: A novel chemical biology approach for mapping of polymyxin lipopeptide antibody binding epitopes publication-title: ACS Infect Dis doi: 10.1021/acsinfecdis.6b00031 – volume: 7 start-page: 2000704 year: 2020 ident: 10.1124/pharmrev.120.000020_bib664 article-title: Polymyxins bind to the cell surface of unculturable Acinetobacter baumannii and cause unique dependent resistance publication-title: Adv Sci (Weinh) doi: 10.1002/advs.202000704 – volume: 31 start-page: 168 year: 1979 ident: 10.1124/pharmrev.120.000020_bib81 article-title: Additivity of action between polysorbate 80 and polymyxin B towards spheroplasts of Pseudomonas aeruginosa NCTC 6750 publication-title: J Pharm Pharmacol doi: 10.1111/j.2042-7158.1979.tb13463.x – volume: 40 start-page: 1333 year: 2005 ident: 10.1124/pharmrev.120.000020_bib195 article-title: Colistin: the revival of polymyxins for the management of multidrug-resistant Gram-negative bacterial infections [published correction appears in Clin Infect Dis (2006) 42:1819] publication-title: Clin Infect Dis doi: 10.1086/429323 – ident: 10.1124/pharmrev.120.000020_bib339 – start-page: 171 year: 2016 ident: 10.1124/pharmrev.120.000020_bib517 article-title: Antibiotics and preservatives – year: 2010 ident: 10.1124/pharmrev.120.000020_bib189 – volume: 24 start-page: 113 year: 2013 ident: 10.1124/pharmrev.120.000020_bib554 article-title: p53 is renoprotective after ischemic kidney injury by reducing inflammation publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2012050469 – volume: 320 start-page: 1455 year: 2018 ident: 10.1124/pharmrev.120.000020_bib160 article-title: Effect of targeted polymyxin B hemoperfusion on 28-day mortality in patients with septic shock and elevated endotoxin level: the EUPHRATES randomized clinical trial publication-title: JAMA doi: 10.1001/jama.2018.14618 – volume: 19 start-page: 501 year: 2013 ident: 10.1124/pharmrev.120.000020_bib226 article-title: Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe publication-title: Clin Microbiol Infect doi: 10.1111/1469-0691.12195 – volume: 6 start-page: 26 year: 2016 ident: 10.1124/pharmrev.120.000020_bib2 article-title: Efficacy and toxicity of aerosolised colistin in ventilator-associated pneumonia: a prospective, randomised trial publication-title: Ann Intensive Care doi: 10.1186/s13613-016-0127-7 – volume: 49 start-page: 526 year: 2017 ident: 10.1124/pharmrev.120.000020_bib277 article-title: Resistance to polymyxins in Gram-negative organisms publication-title: Int J Antimicrob Agents doi: 10.1016/j.ijantimicag.2016.11.029 – volume: 90 start-page: 637 year: 2001 ident: 10.1124/pharmrev.120.000020_bib30 article-title: The isolation and characterization of Campylobacter jejuni subsp. jejuni from domestic geese (Anser anser) publication-title: J Appl Microbiol doi: 10.1046/j.1365-2672.2001.01293.x – volume: 41 start-page: 754 year: 2005 ident: 10.1124/pharmrev.120.000020_bib326 article-title: Nebulized colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa publication-title: Clin Infect Dis doi: 10.1086/432583 – volume: 57 start-page: 226 year: 1965 ident: 10.1124/pharmrev.120.000020_bib555 article-title: The chemical structure of polymyxin E: the identities of polymyxin E1 with colistin A and of polymyxin E2 with colistin B publication-title: J Biochem doi: 10.1093/oxfordjournals.jbchem.a128082 – volume: 47 start-page: 1766 year: 2003 ident: 10.1124/pharmrev.120.000020_bib348 article-title: Use of high-performance liquid chromatography to study the pharmacokinetics of colistin sulfate in rats following intravenous administration publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.47.5.1766-1770.2003 – volume: 54 start-page: 3372 year: 2010 ident: 10.1124/pharmrev.120.000020_bib199 article-title: Adaptive resistance to the “last hope” antibiotics polymyxin B and colistin in Pseudomonas aeruginosa is mediated by the novel two-component regulatory system ParR-ParS publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00242-10 – volume: 45 start-page: 131 year: 2019 ident: 10.1124/pharmrev.120.000020_bib436 article-title: The rise and spread of mcr plasmid-mediated polymyxin resistance publication-title: Crit Rev Microbiol doi: 10.1080/1040841X.2018.1492902 – volume: 57 start-page: 524 year: 2013 ident: 10.1124/pharmrev.120.000020_bib518 article-title: Population pharmacokinetics of intravenous polymyxin B in critically ill patients: implications for selection of dosage regimens publication-title: Clin Infect Dis doi: 10.1093/cid/cit334 – volume: 70 start-page: 380 year: 2011 ident: 10.1124/pharmrev.120.000020_bib529 article-title: Comparative in vitro antimicrobial susceptibilities and synergistic activities of antimicrobial combinations against carbapenem-resistant Acinetobacter species: Acinetobacter baumannii versus Acinetobacter genospecies 3 and 13TU publication-title: Diagn Microbiol Infect Dis doi: 10.1016/j.diagmicrobio.2011.03.003 – volume: 51 start-page: 909 year: 1949 ident: 10.1124/pharmrev.120.000020_bib288 article-title: Chemical evidence for the multiplicity of the antibiotics produced by Bacillus polymyxa publication-title: Ann N Y Acad Sci doi: 10.1111/j.1749-6632.1949.tb27317.x – volume: 1145 start-page: 89 year: 2019 ident: 10.1124/pharmrev.120.000020_bib395 article-title: Pharmacokinetics of polymyxins in animals publication-title: Adv Exp Med Biol doi: 10.1007/978-3-030-16373-0_7 – volume: 25 start-page: 380 year: 2018 ident: 10.1124/pharmrev.120.000020_bib599 article-title: Structure, function, and biosynthetic origin of octapeptin antibiotics active against extensively drug-resistant Gram-negative bacteria publication-title: Cell Chem Biol doi: 10.1016/j.chembiol.2018.01.005 – volume: 53 start-page: 4685 year: 2016 ident: 10.1124/pharmrev.120.000020_bib146 article-title: Colistin-induced apoptosis of neuroblastoma-2a cells involves the generation of reactive oxygen species, mitochondrial dysfunction, and autophagy publication-title: Mol Neurobiol doi: 10.1007/s12035-015-9396-7 – volume: 12 start-page: 315 year: 2006 ident: 10.1124/pharmrev.120.000020_bib207 article-title: Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004) publication-title: Clin Microbiol Infect doi: 10.1111/j.1469-0691.2005.01351.x – volume: 9 start-page: 445 year: 1969 ident: 10.1124/pharmrev.120.000020_bib403 article-title: Evaluation of the Bauer-Kirby-Sherris-Turck single-disc diffusion method of antibiotic susceptibility testing publication-title: Antimicrob Agents Chemother – volume: 9 year: 2014 ident: 10.1124/pharmrev.120.000020_bib252 article-title: Impact of Acinetobacter baumannii superoxide dismutase on motility, virulence, oxidative stress resistance and susceptibility to antibiotics publication-title: PLoS One doi: 10.1371/journal.pone.0101033 – volume: 57 start-page: 419 year: 2007 ident: 10.1124/pharmrev.120.000020_bib480 article-title: In vitro postantibiotic effect of colistin on multidrug-resistant Acinetobacter baumannii publication-title: Diagn Microbiol Infect Dis doi: 10.1016/j.diagmicrobio.2006.10.006 – volume: 51 start-page: 714 year: 2018 ident: 10.1124/pharmrev.120.000020_bib658 article-title: Pharmacokinetics of colistin methanesulfonate (CMS) in healthy Chinese subjects after single and multiple intravenous doses publication-title: Int J Antimicrob Agents doi: 10.1016/j.ijantimicag.2017.12.025 – volume: 61 start-page: 1771 year: 2015 ident: 10.1124/pharmrev.120.000020_bib150 article-title: Colistin-associated acute kidney injury in severely ill patients: a step toward a better renal care? A prospective cohort study publication-title: Clin Infect Dis doi: 10.1093/cid/civ717 – volume: 58 start-page: 7331 year: 2014 ident: 10.1124/pharmrev.120.000020_bib71 article-title: Comparison of intrapulmonary and systemic pharmacokinetics of colistin methanesulfonate (CMS) and colistin after aerosol delivery and intravenous administration of CMS in critically ill patients publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.03510-14 – volume: 62 start-page: e01790-17 year: 2018 ident: 10.1124/pharmrev.120.000020_bib369 article-title: Elucidating the pharmacokinetics/pharmacodynamics of aerosolized colistin against multidrug-resistant Acinetobacter baumannii and Klebsiella pneumoniae in a mouse lung infection model publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.01790-17 – volume: 54 start-page: 3341 year: 2010 ident: 10.1124/pharmrev.120.000020_bib588 article-title: A novel polymyxin derivative that lacks the fatty acid tail and carries only three positive charges has strong synergism with agents excluded by the intact outer membrane publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.01439-09 – volume: 7 start-page: 544 year: 1989 ident: 10.1124/pharmrev.120.000020_bib210 article-title: [In vitro activity of 16 antimicrobial agents against Helicobacter (Campylobacter) pylori] publication-title: Enferm Infecc Microbiol Clin – volume: 270 start-page: 1030 year: 1964 ident: 10.1124/pharmrev.120.000020_bib450 article-title: Polymyxin B and colistin. A critical comparison publication-title: N Engl J Med doi: 10.1056/NEJM196405142702002 – volume: 38 start-page: 241 year: 2010 ident: 10.1124/pharmrev.120.000020_bib462 article-title: Successful treatment of three children with post-neurosurgical multidrug-resistant Acinetobacter baumannii meningitis publication-title: Infection doi: 10.1007/s15010-010-0018-z – volume: 49 start-page: 4814 year: 2005 ident: 10.1124/pharmrev.120.000020_bib354 article-title: Pharmacokinetics of colistin methanesulfonate and colistin in a critically ill patient receiving continuous venovenous hemodiafiltration publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.49.11.4814-4815.2005 – volume: 139 start-page: 1740 year: 2011 ident: 10.1124/pharmrev.120.000020_bib578 article-title: Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality publication-title: Epidemiol Infect doi: 10.1017/S0950268810003055 – volume: 51 start-page: 897 year: 1949 ident: 10.1124/pharmrev.120.000020_bib50 article-title: Chemical studies on polymyxin; comparison with aerosporin publication-title: Ann N Y Acad Sci doi: 10.1111/j.1749-6632.1949.tb27316.x – volume: 49 start-page: 609 year: 2017 ident: 10.1124/pharmrev.120.000020_bib96 article-title: Pharmacodynamics of tigecycline alone and in combination with colistin against clinical isolates of multidrug-resistant Acinetobacter baumannii in an in vitro pharmacodynamic model publication-title: Int J Antimicrob Agents doi: 10.1016/j.ijantimicag.2017.01.007 – volume: 6 start-page: 589 year: 2006 ident: 10.1124/pharmrev.120.000020_bib353 article-title: Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(06)70580-1 – volume: 62 start-page: B5128 year: 2015 ident: 10.1124/pharmrev.120.000020_bib445 article-title: The incidence and prognosis of patients with bacteremia publication-title: Dan Med J – volume: 29 start-page: 9 year: 2007 ident: 10.1124/pharmrev.120.000020_bib194 article-title: Intraventricular or intrathecal use of polymyxins in patients with Gram-negative meningitis: a systematic review of the available evidence publication-title: Int J Antimicrob Agents doi: 10.1016/j.ijantimicag.2006.08.024 – volume: 37 start-page: 67 year: 2000 ident: 10.1124/pharmrev.120.000020_bib52 article-title: Temperature-regulated efflux pump/potassium antiporter system mediates resistance to cationic antimicrobial peptides in Yersinia publication-title: Mol Microbiol doi: 10.1046/j.1365-2958.2000.01956.x – volume: 132 start-page: 277 year: 1986 ident: 10.1124/pharmrev.120.000020_bib574 article-title: Decreased particulate NADH oxidase activity in Bacillus subtilis spores after polymyxin B treatment publication-title: J Gen Microbiol – volume: 58 start-page: 3541 year: 2014 ident: 10.1124/pharmrev.120.000020_bib64 article-title: In vitro and in vivo activities of tigecycline-colistin combination therapies against carbapenem-resistant Enterobacteriaceae publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.02449-14 – volume: 59 start-page: 2780 year: 2015 ident: 10.1124/pharmrev.120.000020_bib274 article-title: Heteroresistance to colistin in Klebsiella pneumoniae associated with alterations in the PhoPQ regulatory system publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.05055-14 – volume: 51 start-page: 3413 year: 2007 ident: 10.1124/pharmrev.120.000020_bib559 article-title: Activity of colistin against heteroresistant Acinetobacter baumannii and emergence of resistance in an in vitro pharmacokinetic/pharmacodynamic model publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.01571-06 – volume: 60 start-page: 3709 year: 2016 ident: 10.1124/pharmrev.120.000020_bib118 article-title: Amino acid substitutions of CrrB responsible for resistance to colistin through CrrC in Klebsiella pneumoniae publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00009-16 – volume: 6 start-page: 2698 year: 2020 ident: 10.1124/pharmrev.120.000020_bib278 article-title: Outer membranes of polymyxin-resistant Acinetobacter baumannii with phosphoethanolamine-modified lipid A and lipopolysaccharide loss display different atomic-scale interactions with polymyxins publication-title: ACS Infect Dis doi: 10.1021/acsinfecdis.0c00330 – volume: 54 start-page: 2732 year: 2010 ident: 10.1124/pharmrev.120.000020_bib582 article-title: In vitro double and triple bactericidal activities of doripenem, polymyxin B, and rifampin against multidrug-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.01768-09 – volume: 23 start-page: 187 year: 1997 ident: 10.1124/pharmrev.120.000020_bib7 article-title: Decrease in nosocomial pneumonia in ventilated patients by selective oropharyngeal decontamination (SOD) publication-title: Intensive Care Med doi: 10.1007/s001340050314 – volume: 33 start-page: 307 year: 2005 ident: 10.1124/pharmrev.120.000020_bib100 article-title: Prevention of acquired infections in intubated patients with the combination of two decontamination regimens publication-title: Crit Care Med doi: 10.1097/01.CCM.0000152224.01949.01 – volume: 55 start-page: 32 year: 2016 ident: 10.1124/pharmrev.120.000020_bib617 article-title: Effects of colistin on amino acid neurotransmitters and blood-brain barrier in the mouse brain publication-title: Neurotoxicol Teratol doi: 10.1016/j.ntt.2016.03.004 – volume: 13 start-page: 541 year: 2007 ident: 10.1124/pharmrev.120.000020_bib562 article-title: Comparison of Etest, Vitek and agar dilution for susceptibility testing of colistin publication-title: Clin Microbiol Infect doi: 10.1111/j.1469-0691.2007.01708.x – volume: 7 year: 2019 ident: 10.1124/pharmrev.120.000020_bib20 article-title: FDA approved antibacterial drugs: 2018-2019 publication-title: Discoveries (Craiova) doi: 10.15190/d.2019.15 – ident: 10.1124/pharmrev.120.000020_bib510 – year: 2018 ident: 10.1124/pharmrev.120.000020_bib581 – volume: 46 start-page: 1 year: 1997 ident: 10.1124/pharmrev.120.000020_bib242 article-title: Antibacterial peptides and the outer membranes of Gram-negative bacilli publication-title: J Med Microbiol doi: 10.1099/00222615-46-1-1 – volume: 53 start-page: 546 year: 2011 ident: 10.1124/pharmrev.120.000020_bib384 article-title: Comparison of disc diffusion, Etest and agar dilution for susceptibility testing of colistin against Enterobacteriaceae publication-title: Lett Appl Microbiol doi: 10.1111/j.1472-765X.2011.03145.x – volume: 4 start-page: e00157-18 year: 2019 ident: 10.1124/pharmrev.120.000020_bib665 article-title: Metabolic responses to polymyxin treatment in Acinetobacter baumannii ATCC 19606: integrating transcriptomics and metabolomics with genome-scale metabolic modeling publication-title: mSystems doi: 10.1128/msystems.00157-18 – volume: 5 start-page: 88 year: 2017 ident: 10.1124/pharmrev.120.000020_bib90 article-title: Comparative gut microbiota and resistome profiling of intensive care patients receiving selective digestive tract decontamination and healthy subjects publication-title: Microbiome doi: 10.1186/s40168-017-0309-z – year: 2020 ident: 10.1124/pharmrev.120.000020_bib192 – volume: 52 start-page: 351 year: 2008 ident: 10.1124/pharmrev.120.000020_bib246 article-title: Colistin heteroresistance in Acinetobacter and its association with previous colistin therapy publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00766-07 – volume: 43 start-page: 323 year: 2010 ident: 10.1124/pharmrev.120.000020_bib362 article-title: Aerosolized colistin for the treatment of multidrug-resistant Acinetobacter baumannii pneumonia: experience in a tertiary care hospital in northern Taiwan publication-title: J Microbiol Immunol Infect doi: 10.1016/S1684-1182(10)60050-3 – volume: 62 start-page: 221 year: 2010 ident: 10.1124/pharmrev.120.000020_bib70 article-title: [Occurrence and susceptibility to antibiotics of carbapenem-resistant Pseudomonas aeruginosa strains between 1998 and 2009] publication-title: Med Dosw Mikrobiol – year: 2020 ident: 10.1124/pharmrev.120.000020_bib132 – volume: 37 start-page: 174 year: 2011 ident: 10.1124/pharmrev.120.000020_bib512 article-title: Susceptibility of Klebsiella spp. to colistin and polymyxin B: results from the SENTRY Antimicrobial Surveillance Program (2006-2009) publication-title: Int J Antimicrob Agents doi: 10.1016/j.ijantimicag.2010.10.005 – volume: 37 start-page: 204 year: 2014 ident: 10.1124/pharmrev.120.000020_bib93 article-title: Application of emerging biomarkers of acute kidney injury in development of kidney-sparing polypeptide-based antibiotics publication-title: Drug Chem Toxicol doi: 10.3109/01480545.2013.834360 – volume: 167 start-page: 412 year: 1994 ident: 10.1124/pharmrev.120.000020_bib23 article-title: Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B-immobilized fiber publication-title: Am J Surg doi: 10.1016/0002-9610(94)90126-0 – volume: 53 start-page: 1898 year: 2010 ident: 10.1124/pharmrev.120.000020_bib604 article-title: Structure--activity relationships of polymyxin antibiotics publication-title: J Med Chem doi: 10.1021/jm900999h – volume: 18 start-page: 391 year: 2018 ident: 10.1124/pharmrev.120.000020_bib473 article-title: Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(18)30099-9 – volume: 48 start-page: 3558 year: 2010 ident: 10.1124/pharmrev.120.000020_bib185 article-title: In vitro evaluation of antibiotic synergy for polymyxin B-resistant carbapenemase-producing Klebsiella pneumoniae publication-title: J Clin Microbiol doi: 10.1128/JCM.01106-10 – volume: 61 start-page: e00973-17 year: 2017 ident: 10.1124/pharmrev.120.000020_bib370 article-title: Pulmonary pharmacokinetics of colistin following administration of dry powder aerosols in rats publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00973-17 – volume: 4 start-page: 296 year: 1976 ident: 10.1124/pharmrev.120.000020_bib506 article-title: Polyacrylic bone cement containing erythromycin and colistin. I. In vitro bacteriological activity and diffusion properties of erythromycin, colistin and erythromycin/colistin comibination publication-title: J Int Med Res doi: 10.1177/030006057600400503 – volume: 56 start-page: 59 year: 2012 ident: 10.1124/pharmrev.120.000020_bib258 article-title: Colistin-resistant, lipopolysaccharide-deficient Acinetobacter baumannii responds to lipopolysaccharide loss through increased expression of genes involved in the synthesis and transport of lipoproteins, phospholipids, and poly-β-1,6-N-acetylglucosamine publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.05191-11 – volume: 36 start-page: 717 year: 1992 ident: 10.1124/pharmrev.120.000020_bib307 article-title: In vitro susceptibilities of aerotolerant Campylobacter isolates to 22 antimicrobial agents publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.36.4.717 – volume: 222 start-page: 57 year: 1995 ident: 10.1124/pharmrev.120.000020_bib380 article-title: Controlled clinical trial of selective decontamination for the treatment of severe acute pancreatitis publication-title: Ann Surg doi: 10.1097/00000658-199507000-00010 – volume: 25 start-page: 141 year: 1971 ident: 10.1124/pharmrev.120.000020_bib157 article-title: Respiratory arrest in myasthenia gravis with colistimethate therapy publication-title: Arch Neurol doi: 10.1001/archneur.1971.00490020059006 – volume: 206 start-page: 563 year: 1981 ident: 10.1124/pharmrev.120.000020_bib310 article-title: Analytical and preparative methods for polymyxin antibiotics using high-performance liquid-chromatography with a porous styrene-divinylbenzene co-polymer packing publication-title: J Chromatogr A doi: 10.1016/S0021-9673(00)88926-8 – volume: 276 start-page: 43122 year: 2001 ident: 10.1124/pharmrev.120.000020_bib576 article-title: An inner membrane enzyme in Salmonella and Escherichia coli that transfers 4-amino-4-deoxy-L-arabinose to lipid A: induction on polymyxin-resistant mutants and role of a novel lipid-linked donor publication-title: J Biol Chem doi: 10.1074/jbc.M106961200 – volume: 104 start-page: 534 year: 2018 ident: 10.1124/pharmrev.120.000020_bib392 article-title: Population pharmacokinetics of polymyxin B publication-title: Clin Pharmacol Ther doi: 10.1002/cpt.981 – volume: 75 start-page: 3 year: 2014 ident: 10.1124/pharmrev.120.000020_bib662 article-title: Emerging inhalation aerosol devices and strategies: where are we headed? publication-title: Adv Drug Deliv Rev doi: 10.1016/j.addr.2014.03.006 – volume: 9 start-page: 8781 year: 2019 ident: 10.1124/pharmrev.120.000020_bib289 article-title: Differences in colistin administration and bacterial and treatment outcomes in critically ill patients publication-title: Sci Rep doi: 10.1038/s41598-019-44965-y – volume: 11 start-page: 481 year: 1994 ident: 10.1124/pharmrev.120.000020_bib254 article-title: Increased substitution of phosphate groups in lipopolysaccharides and lipid A of the polymyxin-resistant pmrA mutants of Salmonella typhimurium: a 31P-NMR study publication-title: Mol Microbiol doi: 10.1111/j.1365-2958.1994.tb00329.x – volume: 9 start-page: 1172 year: 2014 ident: 10.1124/pharmrev.120.000020_bib602 article-title: Teaching ‘old’ polymyxins new tricks: new-generation lipopeptides targeting Gram-negative ‘superbugs’ publication-title: ACS Chem Biol doi: 10.1021/cb500080r – volume: 81 start-page: 4 year: 1969 ident: 10.1124/pharmrev.120.000020_bib381 article-title: Colistin sulfate ophthalmic in the treatment of ocular infections publication-title: Arch Ophthalmol doi: 10.1001/archopht.1969.00990010006002 – volume: 19 start-page: 1861 year: 2000 ident: 10.1124/pharmrev.120.000020_bib316 article-title: A small protein that mediates the activation of a two-component system by another two-component system publication-title: EMBO J doi: 10.1093/emboj/19.8.1861 – volume: 27 start-page: 2261 year: 2011 ident: 10.1124/pharmrev.120.000020_bib419 article-title: Safety and pharmacokinetic evaluation of intravenous colistin methanesulfonate sodium in Japanese healthy male subjects publication-title: Curr Med Res Opin doi: 10.1185/03007995.2011.626557 – volume: 71 start-page: e523 year: 2020 ident: 10.1124/pharmrev.120.000020_bib521 article-title: Clinical and Laboratory Standards Institute and European Committee on Antimicrobial Susceptibility Testing position statements on polymyxin B and colistin clinical breakpoints publication-title: Clin Infect Dis doi: 10.1093/cid/ciaa121 – volume: 28 start-page: 432 year: 2002 ident: 10.1124/pharmrev.120.000020_bib482 article-title: Selective decontamination of subglottic area in mechanically ventilated patients with multiple trauma publication-title: Intensive Care Med doi: 10.1007/s00134-002-1238-1 – volume: 36 start-page: 124 year: 2016 ident: 10.1124/pharmrev.120.000020_bib469 article-title: In vitro interactions of antibiotic combinations of colistin, tigecycline, and doripenem against extensively drug-resistant and multidrug-resistant Acinetobacter baumannii publication-title: Ann Lab Med doi: 10.3343/alm.2016.36.2.124 – volume: 12 start-page: 951 year: 2010 ident: 10.1124/pharmrev.120.000020_bib182 article-title: The major outer membrane protein OmpU of Vibrio splendidus contributes to host antimicrobial peptide resistance and is required for virulence in the oyster Crassostrea gigas publication-title: Environ Microbiol doi: 10.1111/j.1462-2920.2009.02138.x – volume: 70 start-page: 1303 year: 2015 ident: 10.1124/pharmrev.120.000020_bib257 article-title: The transcriptomic response of Acinetobacter baumannii to colistin and doripenem alone and in combination in an in vitro pharmacokinetics/pharmacodynamics model publication-title: J Antimicrob Chemother doi: 10.1093/jac/dku536 – volume: 91 start-page: 133 year: 1994 ident: 10.1124/pharmrev.120.000020_bib272 article-title: Expression cloning of a rat liver Na(+)-independent organic anion transporter publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.91.1.133 – volume: 29 start-page: 141 year: 2009 ident: 10.1124/pharmrev.120.000020_bib151 article-title: Successful treatment of multidrug-resistant Acinetobacter baumannii ventriculitis with intravenous and intraventricular colistin publication-title: Ann Trop Paediatr doi: 10.1179/146532809X440761 – volume: 48 start-page: 579 year: 2016 ident: 10.1124/pharmrev.120.000020_bib653 article-title: Histopathological findings of pigmented lesion and recovery of natural skin colour in a patient with polymyxin B-associated diffuse hyperpigmentation publication-title: Int J Antimicrob Agents doi: 10.1016/j.ijantimicag.2016.08.010 – volume: 58 start-page: 1757 year: 2014 ident: 10.1124/pharmrev.120.000020_bib564 article-title: Evaluation of double- and triple-antibiotic combinations for VIM- and NDM-producing Klebsiella pneumoniae by in vitro time-kill experiments publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00741-13 – volume: 55 start-page: 943 year: 2012 ident: 10.1124/pharmrev.120.000020_bib579 article-title: Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy publication-title: Clin Infect Dis doi: 10.1093/cid/cis588 – volume: 39 start-page: 183 year: 2001 ident: 10.1124/pharmrev.120.000020_bib209 article-title: Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines publication-title: J Clin Microbiol doi: 10.1128/JCM.39.1.183-190.2001 – volume: 152 start-page: 657 year: 2006 ident: 10.1124/pharmrev.120.000020_bib309 article-title: Phosphoethanolamine substitution in the lipid A of Escherichia coli O157: H7 and its association with PmrC publication-title: Microbiology (Reading) doi: 10.1099/mic.0.28692-0 – volume: 57 start-page: 5258 year: 2013 ident: 10.1124/pharmrev.120.000020_bib125 article-title: Mutations of the ompK36 porin gene and promoter impact responses of sequence type 258, KPC-2-producing Klebsiella pneumoniae strains to doripenem and doripenem-colistin publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.01069-13 – volume: 4 start-page: 154 year: 1988 ident: 10.1124/pharmrev.120.000020_bib220 article-title: Susceptibility of clinical isolates of Campylobacter pylori to 24 antimicrobial and anti-ulcer agents publication-title: Eur J Epidemiol doi: 10.1007/BF00144743 – volume: 46 start-page: 616 year: 2015 ident: 10.1124/pharmrev.120.000020_bib503 article-title: In vitro activity of the next-generation aminoglycoside plazomicin alone and in combination with colistin, meropenem, fosfomycin or tigecycline against carbapenemase-producing Enterobacteriaceae strains publication-title: Int J Antimicrob Agents doi: 10.1016/j.ijantimicag.2015.07.021 – volume: 271 start-page: 633 year: 1964 ident: 10.1124/pharmrev.120.000020_bib263 article-title: Toxicity of colistin and polymixin B publication-title: N Engl J Med doi: 10.1056/NEJM196409172711225 – volume: 148 start-page: 247 year: 2016 ident: 10.1124/pharmrev.120.000020_bib42 article-title: Diclofenac pretreatment effects on the toll-like receptor 4/nuclear factor kappa B-mediated inflammatory response to eccentric exercise in rat liver publication-title: Life Sci doi: 10.1016/j.lfs.2016.02.006 – volume: 11 start-page: 227 year: 1988 ident: 10.1124/pharmrev.120.000020_bib49 article-title: Trimethoprim-polymyxin B sulphate ophthalmic ointment in the treatment of bacterial conjunctivitis: a double-blind study versus chloramphenicol ophthalmic ointment publication-title: Curr Med Res Opin doi: 10.1185/03007998809114240 – volume: 357 start-page: 2310 year: 2007 ident: 10.1124/pharmrev.120.000020_bib408 article-title: Compounded colistimethate as possible cause of fatal acute respiratory distress syndrome publication-title: N Engl J Med doi: 10.1056/NEJMc071717 – volume: 22 start-page: 67 year: 2018 ident: 10.1124/pharmrev.120.000020_bib389 article-title: Colistin versus colistin combined with ampicillin-sulbactam for multiresistant Acinetobacter baumannii ventilator-associated pneumonia treatment: an open-label prospective study publication-title: Indian J Crit Care Med doi: 10.4103/ijccm.IJCCM_302_17 – volume: 28 start-page: 916 year: 1999 ident: 10.1124/pharmrev.120.000020_bib201 article-title: Successful treatment of ventriculitis due to carbapenem-resistant Acinetobacter baumannii with intraventricular colistin sulfomethate sodium publication-title: Clin Infect Dis doi: 10.1086/517243 – volume: 22 start-page: 354 year: 1966 ident: 10.1124/pharmrev.120.000020_bib249 article-title: Chemical structure of polymyxin D1 publication-title: Experientia doi: 10.1007/BF01901128 – volume: 56 start-page: 5082 year: 2012 ident: 10.1124/pharmrev.120.000020_bib171 article-title: Role of heme oxygenase-1 in polymyxin B-induced nephrotoxicity in rats publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00925-12 – volume: 54 start-page: 24 year: 1947 ident: 10.1124/pharmrev.120.000020_bib51 article-title: Antibiotic activity of Bacillus polymyxa publication-title: J Bacteriol – volume: 42 start-page: 1177 year: 2008 ident: 10.1124/pharmrev.120.000020_bib472 article-title: Parenteral polymyxin B use in patients with multidrug-resistant Gram-negative bacteremia and urinary tract infections: a retrospective case series publication-title: Ann Pharmacother doi: 10.1345/aph.1K346 – volume: 124 start-page: 610 year: 1971 ident: 10.1124/pharmrev.120.000020_bib156 article-title: Activity of colistin against Pseudomonas aeruginosa: inhibition by calcium publication-title: J Infect Dis doi: 10.1093/infdis/124.6.610 – volume: 5 start-page: 811 year: 2007 ident: 10.1124/pharmrev.120.000020_bib324 article-title: Polymyxin B: similarities to and differences from colistin (polymyxin E) publication-title: Expert Rev Anti Infect Ther doi: 10.1586/14787210.5.5.811 – volume: 18 start-page: 398 year: 1992 ident: 10.1124/pharmrev.120.000020_bib502 article-title: Prevention of nosocomial infection in critically ill patients by selective decontamination of the digestive tract. A randomized, double blind, placebo-controlled study publication-title: Intensive Care Med doi: 10.1007/BF01694341 – volume: 7 start-page: 61 year: 1959 ident: 10.1124/pharmrev.120.000020_bib632 article-title: Chemical, biological and clinical observations on colistin publication-title: Antibiot Annu – volume: 20 start-page: 1125 year: 2020 ident: 10.1124/pharmrev.120.000020_bib656 article-title: Use of polymyxins in Chinese hospitals publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(20)30696-4 – volume: 51 start-page: 879 year: 1949 ident: 10.1124/pharmrev.120.000020_bib623 article-title: Comparative biological studies of polymyxin and aerosporin publication-title: Ann N Y Acad Sci doi: 10.1111/j.1749-6632.1949.tb27314.x – volume: 23 start-page: 13 year: 2011 ident: 10.1124/pharmrev.120.000020_bib17 article-title: Emergence of tigecycline and colistin resistance in Acinetobacter species isolated from patients in Kuwait hospitals publication-title: J Chemother doi: 10.1179/joc.2011.23.1.13 – volume: 62 start-page: 140 year: 1988 ident: 10.1124/pharmrev.120.000020_bib475 article-title: Comparison of the efficacy of “Trisdine” and kanamycin-colistin bladder instillations in reducing bacteriuria during intermittent catheterisation of patients with acute spinal cord trauma publication-title: Br J Urol doi: 10.1111/j.1464-410X.1988.tb04293.x – volume: 16 start-page: 307 year: 1990 ident: 10.1124/pharmrev.120.000020_bib221 article-title: Intestinal decontamination in a polyvalent ICU. A double-blind study publication-title: Intensive Care Med doi: 10.1007/BF01706355 – volume: 60 start-page: 1163 year: 2007 ident: 10.1124/pharmrev.120.000020_bib311 article-title: High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkm305 – volume: 26 start-page: 276 year: 2014 ident: 10.1124/pharmrev.120.000020_bib162 article-title: Carbapenem-resistant Klebsiella pneumoniae sepsis in corticosteroid receipt mice: tigecycline or colistin monotherapy versus tigecycline/colistin combination publication-title: J Chemother doi: 10.1179/1973947813Y.0000000143 – volume: 36 start-page: 1111 year: 2003 ident: 10.1124/pharmrev.120.000020_bib211 article-title: Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP publication-title: Clin Infect Dis doi: 10.1086/374337 – volume: 33 start-page: 1162 year: 2007 ident: 10.1124/pharmrev.120.000020_bib291 article-title: Safety and efficacy of colistin compared with imipenem in the treatment of ventilator-associated pneumonia: a matched case-control study publication-title: Intensive Care Med doi: 10.1007/s00134-007-0675-2 – volume: 58 start-page: 4075 year: 2014 ident: 10.1124/pharmrev.120.000020_bib145 article-title: Colistin-induced nephrotoxicity in mice involves the mitochondrial, death receptor, and endoplasmic reticulum pathways publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00070-14 – volume: 53 start-page: 4247 year: 2009 ident: 10.1124/pharmrev.120.000020_bib281 article-title: Brain penetration of colistin in mice assessed by a novel high-performance liquid chromatographic technique publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00485-09 – volume: 280 start-page: 21202 year: 2005 ident: 10.1124/pharmrev.120.000020_bib497 article-title: A phosphoethanolamine transferase specific for the outer 3-deoxy-D-manno-octulosonic acid residue of Escherichia coli lipopolysaccharide. Identification of the eptB gene and Ca2+ hypersensitivity of an eptB deletion mutant publication-title: J Biol Chem doi: 10.1074/jbc.M500964200 – volume: 18 start-page: 1239 year: 1990 ident: 10.1124/pharmrev.120.000020_bib504 article-title: Prevention of nosocomial lung infection in ventilated patients: use of an antimicrobial pharyngeal nonabsorbable paste publication-title: Crit Care Med doi: 10.1097/00003246-199011000-00011 – volume: 10 start-page: 120 year: 2019 ident: 10.1124/pharmrev.120.000020_bib147 article-title: Molecular mechanisms of neurotoxicity induced by polymyxins and chemoprevention publication-title: ACS Chem Neurosci doi: 10.1021/acschemneuro.8b00300 – volume: 79 start-page: 253 year: 2019 ident: 10.1124/pharmrev.120.000020_bib543 article-title: Colistin for the treatment of urinary tract infections caused by extremely drug-resistant Pseudomonas aeruginosa: dose is critical publication-title: J Infect doi: 10.1016/j.jinf.2019.06.011 – volume: 25 start-page: 1168 year: 1991 ident: 10.1124/pharmrev.120.000020_bib73 article-title: Toxicity of colistin in cystic fibrosis patients publication-title: DICP doi: 10.1177/106002809102501101 – start-page: 343 year: 2019 ident: 10.1124/pharmrev.120.000020_bib600 article-title: Discovery of novel polymyxin-like antibiotics – volume: 33 start-page: 1565 year: 2014 ident: 10.1124/pharmrev.120.000020_bib65 article-title: Activity of colistin in combination with tigecycline or rifampicin against multidrug-resistant Stenotrophomonas maltophilia publication-title: Eur J Clin Microbiol Infect Dis doi: 10.1007/s10096-014-2101-3 – volume: 8 start-page: 1444 year: 2019 ident: 10.1124/pharmrev.120.000020_bib119 article-title: Colistin heteroresistance in Klebsiella pneumoniae isolates and diverse mutations of PmrAB and PhoPQ in resistant subpopulations publication-title: J Clin Med doi: 10.3390/jcm8091444 – volume: 51 start-page: 1678 year: 2013 ident: 10.1124/pharmrev.120.000020_bib260 article-title: Colistin MIC variability by method for contemporary clinical isolates of multidrug-resistant Gram-negative bacilli publication-title: J Clin Microbiol doi: 10.1128/JCM.03385-12 – volume: 18 start-page: 1640 year: 2011 ident: 10.1124/pharmrev.120.000020_bib527 article-title: Paenibacillus polymyxa PKB1 produces variants of polymyxin B-type antibiotics publication-title: Chem Biol doi: 10.1016/j.chembiol.2011.09.017 – volume: 113 start-page: 544 year: 2009 ident: 10.1124/pharmrev.120.000020_bib411 article-title: Comparison of the structure and dynamics of the antibiotic peptide polymyxin B and the inactive nonapeptide in aqueous trifluoroethanol by NMR spectroscopy publication-title: J Phys Chem B doi: 10.1021/jp808379x – volume: 62 start-page: e00788-18 year: 2018 ident: 10.1124/pharmrev.120.000020_bib111 article-title: Colistin heteroresistance and involvement of the PmrAB regulatory system in Acinetobacter baumannii publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00788-18 – volume: 54 start-page: 25 year: 2002 ident: 10.1124/pharmrev.120.000020_bib333 article-title: Dry powder inhalation of antibiotics in cystic fibrosis therapy: part 2. Inhalation of a novel colistin dry powder formulation: a feasibility study in healthy volunteers and patients publication-title: Eur J Pharm Biopharm doi: 10.1016/S0939-6411(02)00044-9 – volume: 58 start-page: 874 year: 2014 ident: 10.1124/pharmrev.120.000020_bib236 article-title: In vitro pharmacodynamics of polymyxin B and tigecycline alone and in combination against carbapenem-resistant Acinetobacter baumannii publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.01624-13 – volume: 70 start-page: 2589 year: 2015 ident: 10.1124/pharmrev.120.000020_bib4 article-title: Synergistic killing of NDM-producing MDR Klebsiella pneumoniae by two ‘old’ antibiotics-polymyxin B and chloramphenicol publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkv135 – volume: 9 start-page: Doc14 year: 2014 ident: 10.1124/pharmrev.120.000020_bib476 article-title: In vitro synergism of combinations of colistin with selected antibiotics against colistin-resistant Acinetobacter baumannii publication-title: GMS Hyg Infect Control – volume: 48 start-page: 559 year: 2016 ident: 10.1124/pharmrev.120.000020_bib371 article-title: Synergistic killing by meropenem and colistin combination of carbapenem-resistant Acinetobacter baumannii isolates from Chinese patients in an in vitro pharmacokinetic/pharmacodynamic model publication-title: Int J Antimicrob Agents doi: 10.1016/j.ijantimicag.2016.07.018 – volume: 55 start-page: 1306 year: 1993 ident: 10.1124/pharmrev.120.000020_bib541 article-title: Selective decontamination in pediatric liver transplants. A randomized prospective study publication-title: Transplantation doi: 10.1097/00007890-199306000-00018 – volume: 2 start-page: 923 year: 1970 ident: 10.1124/pharmrev.120.000020_bib80 article-title: Acute renal failure due to overdosage of colistin publication-title: Med J Aust doi: 10.5694/j.1326-5377.1970.tb63262.x – volume: 51 start-page: 875 year: 1949 ident: 10.1124/pharmrev.120.000020_bib85 article-title: Antibiotics derived from bacillus polymyxa publication-title: Ann N Y Acad Sci doi: 10.1111/j.1749-6632.1949.tb27313.x – volume: 21 start-page: 1692 year: 1993 ident: 10.1124/pharmrev.120.000020_bib569 article-title: Decreased mortality rate and length of hospital stay in surgical intensive care unit patients with successful selective decontamination of the gut publication-title: Crit Care Med doi: 10.1097/00003246-199311000-00018 – volume: 362 start-page: 1011 year: 2003 ident: 10.1124/pharmrev.120.000020_bib159 article-title: Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial publication-title: Lancet doi: 10.1016/S0140-6736(03)14409-1 – volume: 70 start-page: 3291 year: 2015 ident: 10.1124/pharmrev.120.000020_bib113 article-title: New pharmacokinetic/pharmacodynamic studies of systemically administered colistin against Pseudomonas aeruginosa and Acinetobacter baumannii in mouse thigh and lung infection models: smaller response in lung infection publication-title: J Antimicrob Chemother – volume: 276 start-page: 43111 year: 2001 ident: 10.1124/pharmrev.120.000020_bib663 article-title: Lipid A modifications in polymyxin-resistant Salmonella typhimurium: PmrA-dependent 4-amino-4-deoxy-L-arabinose, and phosphoethanolamine incorporation publication-title: J Biol Chem doi: 10.1074/jbc.M106960200 – volume: 54 start-page: 1720 year: 2012 ident: 10.1124/pharmrev.120.000020_bib149 article-title: High-dose, extended-interval colistin administration in critically ill patients: is this the right dosing strategy? A preliminary study publication-title: Clin Infect Dis doi: 10.1093/cid/cis286 – volume: 91 start-page: 194 year: 2018 ident: 10.1124/pharmrev.120.000020_bib545 article-title: Detection of colistin heteroresistance in Acinetobacter baumannii from blood and respiratory isolates publication-title: Diagn Microbiol Infect Dis doi: 10.1016/j.diagmicrobio.2018.01.028 – volume: 5 start-page: 643 year: 2014 ident: 10.1124/pharmrev.120.000020_bib456 article-title: Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria publication-title: Front Microbiol doi: 10.3389/fmicb.2014.00643 – volume: 41 start-page: 292 year: 2013 ident: 10.1124/pharmrev.120.000020_bib591 article-title: The novel polymyxin derivative NAB739 is remarkably less cytotoxic than polymyxin B and colistin to human kidney proximal tubular cells publication-title: Int J Antimicrob Agents doi: 10.1016/j.ijantimicag.2012.10.005 – ident: 10.1124/pharmrev.120.000020_bib32 – volume: 33 start-page: 108313 year: 2020 ident: 10.1124/pharmrev.120.000020_bib407 article-title: CrrB positively regulates high-level polymyxin resistance and virulence in Klebsiella pneumoniae publication-title: Cell Rep doi: 10.1016/j.celrep.2020.108313 – volume: 207 start-page: 2099 year: 1969 ident: 10.1124/pharmrev.120.000020_bib509 article-title: Colistimethate toxicity. Report of a fatal case in a previously healthy child publication-title: JAMA doi: 10.1001/jama.1969.03150240119022 – volume: 25 start-page: 11 year: 2005 ident: 10.1124/pharmrev.120.000020_bib350 article-title: Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria publication-title: Int J Antimicrob Agents doi: 10.1016/j.ijantimicag.2004.10.001 – start-page: 89 year: 1984 ident: 10.1124/pharmrev.120.000020_bib432 article-title: Use of antibiotic-containing bone cement publication-title: Clin Orthop Relat Res – volume: 56 start-page: 5642 year: 2012 ident: 10.1124/pharmrev.120.000020_bib515 article-title: Rapid killing of Acinetobacter baumannii by polymyxins is mediated by a hydroxyl radical death pathway publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00756-12 – volume: 24 start-page: 3531 year: 2008 ident: 10.1124/pharmrev.120.000020_bib177 article-title: Comparison of efficacy and safety of ciprofloxacin otic solution 0.2% versus polymyxin B-neomycin-hydrocortisone in the treatment of acute diffuse otitis externa publication-title: Curr Med Res Opin doi: 10.1185/03007990802583845 – volume: 43 start-page: xxvi year: 1948 ident: 10.1124/pharmrev.120.000020_bib287 article-title: The chemical basis for the classification of the polymyxins publication-title: Biochem J – volume: 45 start-page: 199 year: 2015 ident: 10.1124/pharmrev.120.000020_bib400 article-title: Inhaled colistimethate sodium in ventilator-associated tracheobronchitis due to multidrug-resistant Gram-negative bacteria publication-title: Int J Antimicrob Agents doi: 10.1016/j.ijantimicag.2014.09.010 – volume: 30 start-page: 315 year: 2007 ident: 10.1124/pharmrev.120.000020_bib204 article-title: Intravenous polymyxin B for the treatment of nosocomial pneumonia caused by multidrug-resistant Pseudomonas aeruginosa publication-title: Int J Antimicrob Agents doi: 10.1016/j.ijantimicag.2007.05.017 – volume: 68 start-page: 1213 year: 2013 ident: 10.1124/pharmrev.120.000020_bib583 article-title: Novel derivatives of polymyxins publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkt039 – volume: 29 start-page: 1950 year: 2007 ident: 10.1124/pharmrev.120.000020_bib494 article-title: Pooled analysis of two clinical trials comparing the clinical outcomes of topical ciprofloxacin/dexamethasone otic suspension and polymyxin B/neomycin/hydrocortisone otic suspension for the treatment of acute otitis externa in adults and children publication-title: Clin Ther doi: 10.1016/j.clinthera.2007.09.005 – volume: 58 start-page: 4762 year: 2014 ident: 10.1124/pharmrev.120.000020_bib276 article-title: Resistance to colistin associated with a single amino acid change in protein PmrB among Klebsiella pneumoniae isolates of worldwide origin publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00084-14 – volume: 265 start-page: 2704 year: 1991 ident: 10.1124/pharmrev.120.000020_bib489 article-title: Oropharyngeal decontamination decreases incidence of ventilator-associated pneumonia. A randomized, placebo-controlled, double-blind clinical trial publication-title: JAMA doi: 10.1001/jama.1991.03460200084041 – volume: 70 start-page: 3771 year: 1948 ident: 10.1124/pharmrev.120.000020_bib530 article-title: Chemical studies on polymyxin; isolation and preliminary purification publication-title: J Am Chem Soc doi: 10.1021/ja01191a068 – volume: 56 start-page: 432 year: 2008 ident: 10.1124/pharmrev.120.000020_bib63 article-title: Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia publication-title: J Infect doi: 10.1016/j.jinf.2008.04.002 – volume: 271 start-page: 32599 year: 1996 ident: 10.1124/pharmrev.120.000020_bib94 article-title: Electrogenic properties and substrate specificity of the polyspecific rat cation transporter rOCT1 publication-title: J Biol Chem doi: 10.1074/jbc.271.51.32599 – volume: 1 start-page: 568 year: 2015 ident: 10.1124/pharmrev.120.000020_bib501 article-title: Antimicrobial activity and toxicity of the major lipopeptide components of polymyxin B and colistin: last-line antibiotics against multidrug-resistant Gram-negative bacteria publication-title: ACS Infect Dis doi: 10.1021/acsinfecdis.5b00085 – volume: 68 start-page: 60 year: 2019 ident: 10.1124/pharmrev.120.000020_bib235 article-title: Comparison of susceptibility testing methods for determining the activity of colistin against Gram-negative bacilli of clinical origin publication-title: J Med Microbiol doi: 10.1099/jmm.0.000879 – volume: 66 start-page: 1047 year: 2011 ident: 10.1124/pharmrev.120.000020_bib619 article-title: In vitro activity of teicoplanin combined with colistin versus multidrug-resistant strains of Acinetobacter baumannii publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkr069 – ident: 10.1124/pharmrev.120.000020_bib222 – year: 2004 ident: 10.1124/pharmrev.120.000020_bib269 – volume: 62 start-page: e02442-17 year: 2018 ident: 10.1124/pharmrev.120.000020_bib169 article-title: Emergence of high-level colistin resistance in an Acinetobacter baumannii clinical isolate mediated by inactivation of the global regulator H-NS publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.02442-17 – volume: 56 start-page: 5240 year: 2012 ident: 10.1124/pharmrev.120.000020_bib283 article-title: Effect of systemic infection induced by Pseudomonas aeruginosa on the brain uptake of colistin in mice publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00713-12 – volume: 54 start-page: 560 year: 2010 ident: 10.1124/pharmrev.120.000020_bib552 article-title: Nonclonal emergence of colistin-resistant Klebsiella pneumoniae isolates from blood samples in South Korea publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00762-09 – volume: 65 start-page: 942 year: 2010 ident: 10.1124/pharmrev.120.000020_bib589 article-title: Susceptibility of carbapenemase-producing strains of Klebsiella pneumoniae and Escherichia coli to the direct antibacterial activity of NAB739 and to the synergistic activity of NAB7061 with rifampicin and clarithromycin publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkq040 – volume: 54 start-page: 2051 year: 2010 ident: 10.1124/pharmrev.120.000020_bib92 article-title: Attenuation of colistin bactericidal activity by high inoculum of Pseudomonas aeruginosa characterized by a new mechanism-based population pharmacodynamic model publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00881-09 – volume: 273 start-page: 22395 year: 1998 ident: 10.1124/pharmrev.120.000020_bib6 article-title: Molecular characterization and tissue distribution of a new organic anion transporter subtype (oatp3) that transports thyroid hormones and taurocholate and comparison with oatp2 publication-title: J Biol Chem doi: 10.1074/jbc.273.35.22395 – volume: 61 start-page: e00857-17 year: 2017 ident: 10.1124/pharmrev.120.000020_bib296 article-title: Colistin is extensively lost during standard in vitro experimental conditions publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00857-17 – volume: 109 start-page: 8722 year: 2012 ident: 10.1124/pharmrev.120.000020_bib243 article-title: Amino acid addition to Vibrio cholerae LPS establishes a link between surface remodeling in Gram-positive and Gram-negative bacteria publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1201313109 – volume: 38 start-page: 3523 year: 2000 ident: 10.1124/pharmrev.120.000020_bib595 article-title: Intrathecal use of colistin publication-title: J Clin Microbiol doi: 10.1128/JCM.38.9.3523-3523.2000 – volume: 57 start-page: 1938 year: 2013 ident: 10.1124/pharmrev.120.000020_bib666 article-title: Combined intravenous and intraventricular administration of colistin methanesulfonate in critically ill patients with central nervous system infection publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.01461-12 – volume: 7 start-page: 246 year: 2017 ident: 10.1124/pharmrev.120.000020_bib641 article-title: In vitro pharmacokinetics/pharmacodynamics evaluation of fosfomycin combined with amikacin or colistin against KPC2-producing Klebsiella pneumoniae publication-title: Front Cell Infect Microbiol doi: 10.3389/fcimb.2017.00246 – volume: 10 start-page: 1146 year: 2019 ident: 10.1124/pharmrev.120.000020_bib366 article-title: Synergistic combination of polymyxin B and enrofloxacin induced metabolic perturbations in extensive drug-resistant Pseudomonas aeruginosa publication-title: Front Pharmacol doi: 10.3389/fphar.2019.01146 – volume: 66 start-page: 207 year: 2012 ident: 10.1124/pharmrev.120.000020_bib122 article-title: Kojic acid-induced IL-6 production in human keratinocytes plays a role in its anti-melanogenic activity in skin publication-title: J Dermatol Sci doi: 10.1016/j.jdermsci.2012.03.002 – volume: 51 start-page: 2005 year: 2007 ident: 10.1124/pharmrev.120.000020_bib124 article-title: Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.01576-06 – volume: 55 start-page: 118 year: 2014 ident: 10.1124/pharmrev.120.000020_bib123 article-title: Inhaled colistin for treatment of pneumonia due to colistin-only-susceptible Acinetobacter baumannii publication-title: Yonsei Med J doi: 10.3349/ymj.2014.55.1.118 – volume: 84 start-page: 432 year: 2001 ident: 10.1124/pharmrev.120.000020_bib142 article-title: Bronchoconstriction following nebulised colistin in cystic fibrosis publication-title: Arch Dis Child doi: 10.1136/adc.84.5.432 – volume: 51 start-page: 4106 year: 2013 ident: 10.1124/pharmrev.120.000020_bib332 article-title: Irreproducible and uninterpretable polymyxin B MICs for Enterobacter cloacae and Enterobacter aerogenes publication-title: J Clin Microbiol doi: 10.1128/JCM.02129-13 – volume: 60 start-page: 3921 year: 2016 ident: 10.1124/pharmrev.120.000020_bib112 article-title: Colistin and polymyxin B dosage regimens against Acinetobacter baumannii: differences in activity and the emergence of resistance publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.02927-15 – volume: 41 start-page: 480 year: 2013 ident: 10.1124/pharmrev.120.000020_bib294 article-title: Successful treatment of extensively drug-resistant Acinetobacter baumannii ventriculitis and meningitis with intraventricular colistin after application of a loading dose: a case series publication-title: Int J Antimicrob Agents doi: 10.1016/j.ijantimicag.2013.02.010 – volume: 13 start-page: 328 year: 2013 ident: 10.1124/pharmrev.120.000020_bib154 article-title: Effect of selective decontamination on antimicrobial resistance in intensive care units: a systematic review and meta-analysis publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(12)70322-5 – volume: 55 start-page: 3284 year: 2011 ident: 10.1124/pharmrev.120.000020_bib212 article-title: Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.01733-10 – volume: 186 start-page: 4124 year: 2004 ident: 10.1124/pharmrev.120.000020_bib336 article-title: The PmrA-regulated pmrC gene mediates phosphoethanolamine modification of lipid A and polymyxin resistance in Salmonella enterica publication-title: J Bacteriol doi: 10.1128/JB.186.13.4124-4133.2004 – volume: 61 start-page: 908 year: 2008 ident: 10.1124/pharmrev.120.000020_bib505 article-title: Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkn018 – volume: 15 start-page: 274 year: 2007 ident: 10.1124/pharmrev.120.000020_bib187 article-title: Treatment with intrathecal colistin of a resistant extended-spectrum β-lactamase-producing Klebsiella pneumoniae in the cerebrospinal fluid publication-title: Infect Dis Clin Pract doi: 10.1097/IPC.0b013e31802df0d7 – volume: 141 start-page: 515 year: 2012 ident: 10.1124/pharmrev.120.000020_bib633 article-title: Polymyxin use associated with respiratory arrest publication-title: Chest doi: 10.1378/chest.11-1483 – volume: 61 start-page: e00356-17 year: 2017 ident: 10.1124/pharmrev.120.000020_bib43 article-title: Deciphering heteroresistance to colistin in a Klebsiella pneumoniae isolate from Marseille, France publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00356-17 – volume: 89 start-page: 875 year: 2011 ident: 10.1124/pharmrev.120.000020_bib139 article-title: Pharmacokinetics of colistin and colistimethate sodium after a single 80-mg intravenous dose of CMS in young healthy volunteers publication-title: Clin Pharmacol Ther doi: 10.1038/clpt.2011.48 – volume: 276 start-page: F658 year: 1999 ident: 10.1124/pharmrev.120.000020_bib528 article-title: Localization of PEPT1 and PEPT2 proton-coupled oligopeptide transporter mRNA and protein in rat kidney publication-title: Am J Physiol – volume: 67 start-page: 452 year: 2012 ident: 10.1124/pharmrev.120.000020_bib640 article-title: Ascorbic acid protects against the nephrotoxicity and apoptosis caused by colistin and affects its pharmacokinetics publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkr483 – volume: 189 start-page: 975 year: 2014 ident: 10.1124/pharmrev.120.000020_bib247 article-title: Inhaled colistin in patients with bronchiectasis and chronic Pseudomonas aeruginosa infection publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.201312-2208OC – volume: 63 start-page: e00965-19 year: 2019 ident: 10.1124/pharmrev.120.000020_bib306 article-title: mcr-9, an inducible gene encoding an acquired phosphoethanolamine transferase in Escherichia coli, and its origin publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00965-19 – volume: 67 start-page: 191 year: 2010 ident: 10.1124/pharmrev.120.000020_bib466 article-title: Activity of doripenem with and without levofloxacin, amikacin, and colistin against Pseudomonas aeruginosa and Acinetobacter baumannii publication-title: Diagn Microbiol Infect Dis doi: 10.1016/j.diagmicrobio.2010.01.004 – volume: 41 start-page: 256 year: 2012 ident: 10.1124/pharmrev.120.000020_bib620 article-title: The elution of colistimethate sodium from polymethylmethacrylate and calcium phosphate cement beads publication-title: Am J Orthop – volume: 2 start-page: 331 year: 1972 ident: 10.1124/pharmrev.120.000020_bib114 article-title: Locus of divalent cation inhibition of the bactericidal action of polymyxin B publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.2.5.331 – volume: 271 start-page: 67 year: 2017 ident: 10.1124/pharmrev.120.000020_bib378 article-title: Salidroside attenuates colistin-induced neurotoxicity in RSC96 Schwann cells through PI3K/Akt pathway publication-title: Chem Biol Interact doi: 10.1016/j.cbi.2017.04.027 – volume: 59 start-page: 7316 year: 2015 ident: 10.1124/pharmrev.120.000020_bib136 article-title: In vitro activities of novel antimicrobial combinations against extensively drug-resistant Acinetobacter baumannii publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00493-15 – volume: 19 start-page: 60 year: 2019 ident: 10.1124/pharmrev.120.000020_bib44 article-title: Comparative evaluation of the UMIC Colistine kit to assess MIC of colistin of Gram-negative rods publication-title: BMC Microbiol doi: 10.1186/s12866-019-1424-8 – volume: 22 start-page: 30589 year: 2017 ident: 10.1124/pharmrev.120.000020_bib102 article-title: Novel plasmid-mediated colistin resistance mcr-4 gene in Salmonella and Escherichia coli, Italy 2013, Spain and Belgium, 2015 to 2016 publication-title: Euro Surveill doi: 10.2807/1560-7917.ES.2017.22.31.30589 – volume: 61 start-page: e02319-16 year: 2017 ident: 10.1124/pharmrev.120.000020_bib652 article-title: Nephrotoxicity of polymyxins: is there any difference between colistimethate and polymyxin B? publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.02319-16 – year: 1980 ident: 10.1124/pharmrev.120.000020_bib442 – volume: 56 start-page: 3441 year: 2012 ident: 10.1124/pharmrev.120.000020_bib12 article-title: Bactericidal activity of multiple combinations of tigecycline and colistin against NDM-1-producing Enterobacteriaceae publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.05682-11 – volume: 52 start-page: 2940 year: 2008 ident: 10.1124/pharmrev.120.000020_bib424 article-title: In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii and selection of tigecycline-amikacin synergy publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.01581-07 – volume: 47 start-page: 5977 year: 2019 ident: 10.1124/pharmrev.120.000020_bib470 article-title: Survival of carbapenem-resistant Acinetobacter baumannii bacteremia: colistin monotherapy versus colistin plus meropenem publication-title: J Int Med Res doi: 10.1177/0300060519879336 – volume: 4 start-page: 521 year: 1973 ident: 10.1124/pharmrev.120.000020_bib434 article-title: Natural colistin resistance in Edwardsiella tarda publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.4.5.521 – volume: 26 start-page: 656 year: 2005 ident: 10.1124/pharmrev.120.000020_bib91 article-title: Treatment of nosocomial meningitis due to a multidrug resistant Acinetobacter baumannii with intraventricular colistin publication-title: Saudi Med J – volume: 92 start-page: 2259 year: 2018 ident: 10.1124/pharmrev.120.000020_bib646 article-title: Polymyxin B causes DNA damage in HK-2 cells and mice publication-title: Arch Toxicol doi: 10.1007/s00204-018-2192-1 – volume: 39 start-page: 949 year: 2005 ident: 10.1124/pharmrev.120.000020_bib491 article-title: Intrathecal colistin and sterilization of resistant Pseudomonas aeruginosa shunt infection publication-title: Ann Pharmacother doi: 10.1345/aph.1E485 – volume: 68 start-page: 674 year: 2013 ident: 10.1124/pharmrev.120.000020_bib519 article-title: Pharmacokinetics of polymyxin B in patients on continuous venovenous haemodialysis publication-title: J Antimicrob Chemother doi: 10.1093/jac/dks437 – volume: 80 start-page: 225 year: 2017 ident: 10.1124/pharmrev.120.000020_bib539 article-title: Pharmacokinetics of the individual major components of polymyxin B and colistin in rats publication-title: J Nat Prod doi: 10.1021/acs.jnatprod.6b01176 – volume: 62 start-page: e00483-18 year: 2018 ident: 10.1124/pharmrev.120.000020_bib329 article-title: Personalizing polymyxin B dosing using an adaptive feedback control algorithm publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00483-18 – volume: 163 start-page: 611 year: 1949 ident: 10.1124/pharmrev.120.000020_bib548 article-title: Nomenclature of polymyxin antibiotics publication-title: Nature doi: 10.1038/163611a0 – volume: 74 start-page: 412 year: 2012 ident: 10.1124/pharmrev.120.000020_bib513 article-title: Use of a surfactant (polysorbate 80) to improve MIC susceptibility testing results for polymyxin B and colistin publication-title: Diagn Microbiol Infect Dis doi: 10.1016/j.diagmicrobio.2012.08.025 – volume: 14 start-page: e1018 year: 2010 ident: 10.1124/pharmrev.120.000020_bib343 article-title: Hypersensitivity pneumonitis due to high-dose colistin aerosol therapy publication-title: Int J Infect Dis doi: 10.1016/j.ijid.2010.08.001 – volume: 9 start-page: 430 year: 2017 ident: 10.1124/pharmrev.120.000020_bib305 article-title: A Klebsiella pneumoniae antibiotic resistance mechanism that subdues host defences and promotes virulence publication-title: EMBO Mol Med doi: 10.15252/emmm.201607336 – volume: 61 start-page: e02690-16 year: 2017 ident: 10.1124/pharmrev.120.000020_bib9 article-title: Potential toxicity of polymyxins in human lung epithelial cells publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.02690-16 – year: 2021 ident: 10.1124/pharmrev.120.000020_bib191 – volume: 7 start-page: 391 year: 2008 ident: 10.1124/pharmrev.120.000020_bib285 article-title: Spread of colistin resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients publication-title: J Cyst Fibros doi: 10.1016/j.jcf.2008.02.003 – volume: 1 start-page: 105 year: 2017 ident: 10.1124/pharmrev.120.000020_bib532 article-title: History and current status of polymyxin B-immobilized fiber column for treatment of severe sepsis and septic shock publication-title: Ann Gastroenterol Surg doi: 10.1002/ags3.12015 – volume: 58 start-page: 5181 year: 2014 ident: 10.1124/pharmrev.120.000020_bib364 article-title: Serratia marcescens arn, a PhoP-regulated locus necessary for polymyxin B resistance publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00013-14 – volume: 51 start-page: 554 year: 2018 ident: 10.1124/pharmrev.120.000020_bib573 article-title: Impact of the colistin resistance gene mcr-1 on bacterial fitness publication-title: Int J Antimicrob Agents doi: 10.1016/j.ijantimicag.2017.11.011 – volume: 72 start-page: 7107 year: 2004 ident: 10.1124/pharmrev.120.000020_bib99 article-title: Capsule polysaccharide mediates bacterial resistance to antimicrobial peptides publication-title: Infect Immun doi: 10.1128/IAI.72.12.7107-7114.2004 – volume: 8 start-page: 711 year: 2013 ident: 10.1124/pharmrev.120.000020_bib601 article-title: Pharmacology of polymyxins: new insights into an ‘old’ class of antibiotics publication-title: Future Microbiol doi: 10.2217/fmb.13.39 – volume: 71 start-page: 403 year: 2016 ident: 10.1124/pharmrev.120.000020_bib377 article-title: Human oligopeptide transporter 2 (PEPT2) mediates cellular uptake of polymyxins publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkv340 – volume: 61 start-page: e02025-16 year: 2017 ident: 10.1124/pharmrev.120.000020_bib368 article-title: Pharmacokinetics/Pharmacodynamics of pulmonary delivery of colistin against Pseudomonas aeruginosa in a mouse lung infection model publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.02025-16 – volume: 125 start-page: 502 year: 2004 ident: 10.1124/pharmrev.120.000020_bib496 article-title: Comparison of lung deposition in two types of nebulization: intrapulmonary percussive ventilation vs jet nebulization publication-title: Chest doi: 10.1378/chest.125.2.502 – volume: 9 start-page: 508 year: 2020 ident: 10.1124/pharmrev.120.000020_bib616 article-title: Identification of novel mobile colistin resistance gene mcr-10 publication-title: Emerg Microbes Infect doi: 10.1080/22221751.2020.1732231 – start-page: 321 year: 2019 ident: 10.1124/pharmrev.120.000020_bib566 article-title: Anti-endotoxin properties of polymyxin B-immobilized fibers – volume: 9 start-page: e00440-18 year: 2018 ident: 10.1124/pharmrev.120.000020_bib161 article-title: Genomic analysis of a pan-resistant isolate of Klebsiella pneumoniae, United States 2016 publication-title: MBio doi: 10.1128/mBio.00440-18 – volume: 58 start-page: 864 year: 2006 ident: 10.1124/pharmrev.120.000020_bib560 article-title: Comparison of three standardized disc susceptibility testing methods for colistin publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkl330 – volume: 71 start-page: 2321 year: 2016 ident: 10.1124/pharmrev.120.000020_bib327 article-title: Evaluation of antibacterial activities of colistin, rifampicin and meropenem combinations against NDM-1-producing Klebsiella pneumoniae in 24 h in vitro time-kill experiments publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkw213 – volume: 8 start-page: 1017 year: 2016 ident: 10.1124/pharmrev.120.000020_bib603 article-title: Polymyxins: a new hope in combating Gram-negative superbugs? publication-title: Future Med Chem doi: 10.4155/fmc-2016-0091 – volume: 338 start-page: 2431 year: 2003 ident: 10.1124/pharmrev.120.000020_bib103 article-title: Structure of bacterial lipopolysaccharides publication-title: Carbohydr Res doi: 10.1016/j.carres.2003.07.010 – volume: 43 start-page: 903 year: 2005 ident: 10.1124/pharmrev.120.000020_bib26 article-title: Reliability of the E-test method for detection of colistin resistance in clinical isolates of Acinetobacter baumannii publication-title: J Clin Microbiol doi: 10.1128/JCM.43.2.903-905.2005 – volume: 23 start-page: 552 year: 1964 ident: 10.1124/pharmrev.120.000020_bib45 article-title: Sodium sulphomethyl derivatives of polymyxins publication-title: Br J Pharmacol Chemother doi: 10.1111/j.1476-5381.1964.tb01610.x – volume: 11 start-page: 287 year: 2005 ident: 10.1124/pharmrev.120.000020_bib297 article-title: Cure of multidrug-resistant Acinetobacter baumannii fixation device-related orthopedic infections in two patients with intravenous colistin publication-title: Microb Drug Resist doi: 10.1089/mdr.2005.11.287 – volume: 620 start-page: 28 year: 2017 ident: 10.1124/pharmrev.120.000020_bib514 article-title: Phosphoethanolamine addition to the heptose I of the lipopolysaccharide modifies the inner core structure and has an impact on the binding of polymyxin B to the Escherichia coli outer membrane publication-title: Arch Biochem Biophys doi: 10.1016/j.abb.2017.03.008 – volume: 5 start-page: 97 year: 2013 ident: 10.1124/pharmrev.120.000020_bib335 article-title: Polymyxins and doripenem combination against KPC-producing Klebsiella pneumoniae publication-title: J Clin Med Res – volume: 16 start-page: 888 year: 2010 ident: 10.1124/pharmrev.120.000020_bib304 article-title: Intrathecal colistin for drug-resistant Acinetobacter baumannii central nervous system infection: a case series and systematic review publication-title: Clin Microbiol Infect doi: 10.1111/j.1469-0691.2009.03019.x – volume: 7 start-page: 122 year: 2018 ident: 10.1124/pharmrev.120.000020_bib618 article-title: Emergence of a novel mobile colistin resistance gene, mcr-8, in NDM-producing Klebsiella pneumoniae publication-title: Emerg Microbes Infect doi: 10.1038/s41426-018-0124-z – volume: 59 start-page: 786 year: 2007 ident: 10.1124/pharmrev.120.000020_bib21 article-title: Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkl562 – volume: 48 start-page: 753 year: 2004 ident: 10.1124/pharmrev.120.000020_bib638 article-title: In vitro double and triple synergistic activities of polymyxin B, imipenem, and rifampin against multidrug-resistant Acinetobacter baumannii publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.48.3.753-757.2004 – year: 1996 ident: 10.1124/pharmrev.120.000020_bib478 article-title: Bacterial pathogenesis – volume: 73 start-page: 354 year: 2012 ident: 10.1124/pharmrev.120.000020_bib206 article-title: Antimicrobial resistance among Gram-negative bacilli isolated from Latin America: results from SENTRY Antimicrobial Surveillance Program (Latin America, 2008-2010) publication-title: Diagn Microbiol Infect Dis doi: 10.1016/j.diagmicrobio.2012.04.007 – volume: 67 start-page: 565 year: 1980 ident: 10.1124/pharmrev.120.000020_bib270 article-title: The value of polymixin B in endotoxaemia due to experimental obstructive jaundice and mesenteric ischaemia publication-title: Br J Surg doi: 10.1002/bjs.1800670812 – volume: 42 start-page: 645 year: 1989 ident: 10.1124/pharmrev.120.000020_bib153 article-title: Identification of Pseudomonas pseudomallei in clinical practice: use of simple screening tests and API 20NE publication-title: J Clin Pathol doi: 10.1136/jcp.42.6.645 – volume: 73 start-page: 1791 year: 2018 ident: 10.1124/pharmrev.120.000020_bib636 article-title: Novel plasmid-mediated colistin resistance gene mcr-7.1 in Klebsiella pneumoniae publication-title: J Antimicrob Chemother doi: 10.1093/jac/dky111 – volume: 154 start-page: 3877 year: 2008 ident: 10.1124/pharmrev.120.000020_bib373 article-title: Capsule polysaccharide is a bacterial decoy for antimicrobial peptides publication-title: Microbiology (Reading) doi: 10.1099/mic.0.2008/022301-0 – volume: 51 start-page: 891 year: 1949 ident: 10.1124/pharmrev.120.000020_bib87 article-title: Comparative biological studies of polymyxin A and polymyxin D publication-title: Ann N Y Acad Sci doi: 10.1111/j.1749-6632.1949.tb27315.x – volume: 65 start-page: 2231 year: 2010 ident: 10.1124/pharmrev.120.000020_bib186 article-title: The impact of polymyxin B dosage on in-hospital mortality of patients treated with this antibiotic publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkq285 – volume: 7 start-page: 41 year: 1959 ident: 10.1124/pharmrev.120.000020_bib526 article-title: Microbiological and pharmacological studies of colistin sulfate and sodium colistinmethanesulfonate publication-title: Antibiot Annu – volume: 52 start-page: 987 year: 2003 ident: 10.1124/pharmrev.120.000020_bib346 article-title: Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkg468 – volume: 150 start-page: 159 year: 1968 ident: 10.1124/pharmrev.120.000020_bib418 article-title: Separation by density gradient centrifugation of two types of membranes from spheroplast membrane of Escherichia coli K12 publication-title: Biochim Biophys Acta doi: 10.1016/0005-2736(68)90020-5 – volume: 57 start-page: 4336 year: 2013 ident: 10.1124/pharmrev.120.000020_bib284 article-title: Species-dependent blood-brain barrier disruption of lipopolysaccharide: amelioration by colistin in vitro and in vivo publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00765-13 – volume: 10 start-page: 428 year: 2006 ident: 10.1124/pharmrev.120.000020_bib634 article-title: Intrathecal colistin for treatment of Pseudomonas aeruginosa ventriculitis: report of a case with successful outcome publication-title: Crit Care doi: 10.1186/cc5088 – volume: 164 start-page: 622 year: 1949 ident: 10.1124/pharmrev.120.000020_bib624 article-title: Crystalline derivatives of the polymyxins and the identification of the fatty acid component publication-title: Nature doi: 10.1038/164622a0 – volume: 56 start-page: 6212 year: 2012 ident: 10.1124/pharmrev.120.000020_bib200 article-title: The two-component system CprRS senses cationic peptides and triggers adaptive resistance in Pseudomonas aeruginosa independently of ParRS publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.01530-12 – volume: 66 start-page: 175 year: 2011 ident: 10.1124/pharmrev.120.000020_bib323 article-title: Polymyxin B versus other antimicrobials for the treatment of pseudomonas aeruginosa bacteraemia publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkq390 – volume: 137 start-page: 278 year: 2014 ident: 10.1124/pharmrev.120.000020_bib301 article-title: Early prediction of polymyxin-induced nephrotoxicity with next-generation urinary kidney injury biomarkers publication-title: Toxicol Sci doi: 10.1093/toxsci/kft247 – volume: 183 start-page: S1 issue: Suppl 1 year: 2001 ident: 10.1124/pharmrev.120.000020_bib547 article-title: Urinary tract infections: disease panorama and challenges publication-title: J Infect Dis doi: 10.1086/318850 – volume: 46 start-page: 723 year: 1977 ident: 10.1124/pharmrev.120.000020_bib550 article-title: Polymyxin and related peptide antibiotics publication-title: Annu Rev Biochem doi: 10.1146/annurev.bi.46.070177.003451 – volume: 22 start-page: 457 year: 2007 ident: 10.1124/pharmrev.120.000020_bib468 article-title: Management of a multidrug-resistant Pseudomonas aeruginosa infected total knee arthroplasty using colistin. A case report and review of the literature publication-title: J Arthroplasty doi: 10.1016/j.arth.2006.05.006 – volume: 10 start-page: 1689 year: 2019 ident: 10.1124/pharmrev.120.000020_bib585 article-title: Polymyxins and their potential next generation as therapeutic antibiotics publication-title: Front Microbiol doi: 10.3389/fmicb.2019.01689 – volume: 162 start-page: 857 year: 2013 ident: 10.1124/pharmrev.120.000020_bib628 article-title: A single-blinded randomized clinical trial comparing polymyxin B-trimethoprim and moxifloxacin for treatment of acute conjunctivitis in children publication-title: J Pediatr doi: 10.1016/j.jpeds.2012.09.013 – ident: 10.1124/pharmrev.120.000020_bib34 – volume: 13 start-page: 78 year: 1978 ident: 10.1124/pharmrev.120.000020_bib571 article-title: In vitro activity of antimicrobial agents on Legionnaires disease bacterium publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.13.1.78 – volume: 85 start-page: 83 year: 2015 ident: 10.1124/pharmrev.120.000020_bib661 article-title: Inhaled formulations and pulmonary drug delivery systems for respiratory infections publication-title: Adv Drug Deliv Rev doi: 10.1016/j.addr.2014.10.022 – volume: 22 year: 2020 ident: 10.1124/pharmrev.120.000020_bib358 article-title: Polymyxin B-induced skin hyperpigmentation publication-title: Transpl Infect Dis doi: 10.1111/tid.13312 – volume: 56 start-page: 5103 year: 2012 ident: 10.1124/pharmrev.120.000020_bib165 article-title: The combination of colistin and doripenem is synergistic against Klebsiella pneumoniae at multiple inocula and suppresses colistin resistance in an in vitro pharmacokinetic/pharmacodynamic model publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.01064-12 – volume: 9 start-page: 333 year: 2012 ident: 10.1124/pharmrev.120.000020_bib22 article-title: Inhaled colistin for lower respiratory tract infections publication-title: Expert Opin Drug Deliv doi: 10.1517/17425247.2012.660480 – volume: 7 start-page: 596 year: 1975 ident: 10.1124/pharmrev.120.000020_bib152 article-title: Effect of calcium and magnesium ions on the susceptibility of Pseudomonas species to tetracycline, gentamicin polymyxin B, and carbenicillin publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.7.5.596 – volume: 46 start-page: 47 year: 1993 ident: 10.1124/pharmrev.120.000020_bib198 article-title: Inhibition of melanogenesis in human melanoma cells by novel analogues of the partial histamine (H2) agonist nordimaprit publication-title: Biochem Pharmacol doi: 10.1016/0006-2952(93)90346-X – volume: 9 start-page: 2776 year: 2018 ident: 10.1124/pharmrev.120.000020_bib238 article-title: Metabolic analyses revealed time-dependent synergistic killing by colistin and aztreonam combination against multidrug-resistant Acinetobacter baumannii publication-title: Front Microbiol doi: 10.3389/fmicb.2018.02776 – volume: 56 start-page: 398 year: 2013 ident: 10.1124/pharmrev.120.000020_bib606 article-title: Association between colistin dose and microbiologic outcomes in patients with multidrug-resistant Gram-negative bacteremia publication-title: Clin Infect Dis doi: 10.1093/cid/cis909 – volume: 41 start-page: 321 year: 2013 ident: 10.1124/pharmrev.120.000020_bib499 article-title: Comparison of polymyxin B with other antimicrobials in the treatment of ventilator-associated pneumonia and tracheobronchitis caused by Pseudomonas aeruginosa or Acinetobacter baumannii publication-title: Infection doi: 10.1007/s15010-012-0349-z – volume: 72 start-page: 2528 year: 2017 ident: 10.1124/pharmrev.120.000020_bib612 article-title: Evaluation of two automated systems for colistin susceptibility testing of carbapenem-resistant Acinetobacter baumannii clinical isolates publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkx186 – volume: 65 start-page: 2645 year: 2010 ident: 10.1124/pharmrev.120.000020_bib495 article-title: Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkq360 – volume: 30 start-page: 307 year: 2007 ident: 10.1124/pharmrev.120.000020_bib500 article-title: Ventilator-associated pneumonia due to colistin susceptible-only microorganisms publication-title: Eur Respir J doi: 10.1183/09031936.00156906 – volume: 72 start-page: 2745 year: 2017 ident: 10.1124/pharmrev.120.000020_bib8 article-title: mcr-1 and mcr-2 variant genes identified in Moraxella species isolated from pigs in Great Britain from 2014 to 2015 publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkx286 – volume: 55 start-page: 5685 year: 2011 ident: 10.1124/pharmrev.120.000020_bib60 article-title: Synergistic killing of multidrug-resistant Pseudomonas aeruginosa at multiple inocula by colistin combined with doripenem in an in vitro pharmacokinetic/pharmacodynamic model publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.05298-11 – volume: 49 start-page: 523 year: 2016 ident: 10.1124/pharmrev.120.000020_bib265 article-title: Role of aerosolized colistin methanesulfonate therapy for extensively-drug-resistant Acinetobacter baumannii complex pneumonia and airway colonization publication-title: J Microbiol Immunol Infect doi: 10.1016/j.jmii.2014.08.009 – volume: 45 start-page: 877 year: 2013 ident: 10.1124/pharmrev.120.000020_bib183 article-title: Cell cycle arrest in a model of colistin nephrotoxicity publication-title: Physiol Genomics doi: 10.1152/physiolgenomics.00076.2013 – volume: 69 start-page: 1856 year: 2014 ident: 10.1124/pharmrev.120.000020_bib205 article-title: In vitro activity and post-antibiotic effects of colistin in combination with other antimicrobials against colistin-resistant KPC-producing Klebsiella pneumoniae bloodstream isolates publication-title: J Antimicrob Chemother doi: 10.1093/jac/dku065 – volume: 2017 start-page: 5437139 year: 2017 ident: 10.1124/pharmrev.120.000020_bib643 article-title: Oxidative stress induced by polymyxin E is involved in rapid killing of Paenibacillus polymyxa publication-title: BioMed Res Int doi: 10.1155/2017/5437139 – volume: 9 year: 2014 ident: 10.1124/pharmrev.120.000020_bib546 article-title: Role of novel multidrug efflux pump involved in drug resistance in Klebsiella pneumoniae publication-title: PLoS One doi: 10.1371/journal.pone.0096288 – volume: 51 start-page: 917 year: 1949 ident: 10.1124/pharmrev.120.000020_bib106 article-title: The chemistry of polymyxin A publication-title: Ann N Y Acad Sci doi: 10.1111/j.1749-6632.1949.tb27318.x – volume: 32 start-page: 450 year: 2008 ident: 10.1124/pharmrev.120.000020_bib197 article-title: Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii infections: characteristics and outcome in a series of 28 patients publication-title: Int J Antimicrob Agents doi: 10.1016/j.ijantimicag.2008.05.016 – volume: 33 start-page: 1551 year: 1980 ident: 10.1124/pharmrev.120.000020_bib271 article-title: Selective cleavage of a peptide antibiotic, colistin by colistinase publication-title: J Antibiot (Tokyo) doi: 10.7164/antibiotics.33.1551 – volume: 39 start-page: 272 year: 2014 ident: 10.1124/pharmrev.120.000020_bib647 article-title: Efficacy and safety of low-dose colistin in the treatment for infections caused by multidrug-resistant Gram-negative bacteria publication-title: J Clin Pharm Ther doi: 10.1111/jcpt.12138 – volume: 8 start-page: 31 year: 2019 ident: 10.1124/pharmrev.120.000020_bib29 article-title: A review of the clinical pharmacokinetics of polymyxin B publication-title: Antibiotics (Basel) doi: 10.3390/antibiotics8010031 – volume: 71 start-page: 2218 year: 2016 ident: 10.1124/pharmrev.120.000020_bib615 article-title: Clinically relevant concentrations of fosfomycin combined with polymyxin B, tobramycin or ciprofloxacin enhance bacterial killing of Pseudomonas aeruginosa, but do not suppress the emergence of fosfomycin resistance publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkw115 – volume: 55 start-page: 5134 year: 2011 ident: 10.1124/pharmrev.120.000020_bib56 article-title: Clinically relevant plasma concentrations of colistin in combination with imipenem enhance pharmacodynamic activity against multidrug-resistant Pseudomonas aeruginosa at multiple inocula publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.05028-11 – volume: 53 start-page: 3430 year: 2009 ident: 10.1124/pharmrev.120.000020_bib481 article-title: Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by Gram-negative bacteria publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.01361-08 – volume: 48 start-page: 85 year: 1973 ident: 10.1124/pharmrev.120.000020_bib359 article-title: The second international standard for polymyxin B publication-title: Bull World Health Organ – volume: 68 start-page: i7 issue: Suppl 1 year: 2013 ident: 10.1124/pharmrev.120.000020_bib655 article-title: Antimicrobial susceptibility of 22746 pathogens from Canadian hospitals: results of the CANWARD 2007-11 study publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkt022 – volume: 27 start-page: 357 year: 1987 ident: 10.1124/pharmrev.120.000020_bib551 article-title: The effect of oropharyngeal decontamination using topical nonabsorbable antibiotics on the incidence of nosocomial respiratory tract infections in multiple trauma patients publication-title: J Trauma doi: 10.1097/00005373-198704000-00003 – volume: 60 start-page: 431 year: 2015 ident: 10.1124/pharmrev.120.000020_bib215 article-title: Influence of colistin dose on global cure in patients with bacteremia due to carbapenem-resistant Gram-negative bacilli publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.01414-15 – volume: 57 start-page: 222 year: 2013 ident: 10.1124/pharmrev.120.000020_bib376 article-title: Efficacy of high-dose nebulized colistin in ventilator-associated pneumonia caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii publication-title: Anesthesiology – year: 2016 ident: 10.1124/pharmrev.120.000020_bib453 – volume: 50 start-page: 931 year: 2017 ident: 10.1124/pharmrev.120.000020_bib319 article-title: Comparison of synergism between colistin, fosfomycin and tigecycline against extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates or with carbapenem resistance publication-title: J Microbiol Immunol Infect doi: 10.1016/j.jmii.2016.12.008 – volume: 54 start-page: 595 year: 2001 ident: 10.1124/pharmrev.120.000020_bib459 article-title: Isolation and structural characterization of colistin components publication-title: J Antibiot (Tokyo) doi: 10.7164/antibiotics.54.595 – volume: 50 start-page: 1953 year: 2006 ident: 10.1124/pharmrev.120.000020_bib59 article-title: Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00035-06 – volume: 2015 start-page: 679109 year: 2015 ident: 10.1124/pharmrev.120.000020_bib642 article-title: Antibacterial mechanisms of polymyxin and bacterial resistance publication-title: BioMed Res Int doi: 10.1155/2015/679109 – volume: 65 start-page: 981 year: 2010 ident: 10.1124/pharmrev.120.000020_bib608 article-title: Novel polymyxin derivatives are effective in treating experimental Escherichia coli peritoneal infection in mice publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkq072 – volume: 146 start-page: 491 year: 2009 ident: 10.1124/pharmrev.120.000020_bib422 article-title: Polymyxin B identified as an inhibitor of alternative NADH dehydrogenase and malate: quinone oxidoreductase from the Gram-positive bacterium Mycobacterium smegmatis publication-title: J Biochem doi: 10.1093/jb/mvp096 – volume: 31 start-page: 2318 year: 2010 ident: 10.1124/pharmrev.120.000020_bib590 article-title: Structure-activity studies on novel polymyxin derivatives that carry only three positive charges publication-title: Peptides doi: 10.1016/j.peptides.2010.09.010 – volume: 68 start-page: 636 year: 2013 ident: 10.1124/pharmrev.120.000020_bib587 article-title: Antimicrobial activity of the novel polymyxin derivative NAB739 tested against Gram-negative pathogens publication-title: J Antimicrob Chemother doi: 10.1093/jac/dks438 – volume: 8 start-page: 45 year: 2002 ident: 10.1124/pharmrev.120.000020_bib227 article-title: Characterization of polypeptide antibiotics of the polymyxin series by liquid chromatography electrospray ionization ion trap tandem mass spectrometry publication-title: J Pept Sci doi: 10.1002/psc.367 – volume: 55 start-page: 3022 year: 2011 ident: 10.1124/pharmrev.120.000020_bib420 article-title: Insertion sequence ISAba11 is involved in colistin resistance and loss of lipopolysaccharide in Acinetobacter baumannii publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.01732-10 – volume: 41 start-page: 975 year: 2015 ident: 10.1124/pharmrev.120.000020_bib474 article-title: Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial publication-title: Intensive Care Med doi: 10.1007/s00134-015-3751-z – year: 2013 ident: 10.1124/pharmrev.120.000020_bib108 – volume: 76 start-page: 4892 year: 1954 ident: 10.1124/pharmrev.120.000020_bib245 article-title: Polymyxin-B1 - fractionation, molecular weight determination, amino acid and fatty acid composition publication-title: J Am Chem Soc doi: 10.1021/ja01648a039 – volume: 18 start-page: 182 year: 2010 ident: 10.1124/pharmrev.120.000020_bib41 article-title: Intrathecal colistin for treatment of multidrug resistant (MDR) Pseudomonas aeruginosa after neurosurgical ventriculitis publication-title: Infez Med – volume: 13 start-page: 48 year: 1979 ident: 10.1124/pharmrev.120.000020_bib137 article-title: Effect of polymyxin B sulfate on endotoxin activity in a Gram-negative septicemia model publication-title: Pediatr Res doi: 10.1203/00006450-197901000-00011 – volume: 16 start-page: 161 year: 2016 ident: 10.1124/pharmrev.120.000020_bib372 article-title: Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(15)00424-7 – volume: 35 start-page: 593 year: 1989 ident: 10.1124/pharmrev.120.000020_bib557 article-title: [Clinical effects of intravesical instillation of polymyxin B in patients with acute cystitis] publication-title: Hinyokika Kiyo – volume: 53 start-page: 837 year: 2004 ident: 10.1124/pharmrev.120.000020_bib349 article-title: Pharmacokinetics of colistin methanesulphonate and colistin in rats following an intravenous dose of colistin methanesulphonate publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkh167 – volume: 59 start-page: 536 year: 2015 ident: 10.1124/pharmrev.120.000020_bib631 article-title: Genomic and transcriptomic analyses of colistin-resistant clinical isolates of Klebsiella pneumoniae reveal multiple pathways of resistance publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.04037-14 – volume: 2 start-page: 3 year: 1998 ident: 10.1124/pharmrev.120.000020_bib534 article-title: Extracorporeal endotoxin removal by polymyxin B immobilized fiber cartridge: designing and antiendotoxin efficacy in the clinical application publication-title: Ther Apher doi: 10.1111/j.1744-9987.1998.tb00066.x – volume: 54 start-page: 4971 year: 2010 ident: 10.1124/pharmrev.120.000020_bib421 article-title: Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00834-10 – volume: 64 start-page: e01587-19 year: 2019 ident: 10.1124/pharmrev.120.000020_bib267 article-title: Metabolomics study of the synergistic killing of polymyxin B in combination with amikacin against polymyxin-susceptible and -resistant Pseudomonas aeruginosa publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.01587-19 – volume: 63 start-page: 848 year: 2007 ident: 10.1124/pharmrev.120.000020_bib401 article-title: Antimicrobial peptides activate the Vibrio cholerae sigmaE regulon through an OmpU-dependent signalling pathway publication-title: Mol Microbiol doi: 10.1111/j.1365-2958.2006.05544.x – volume: 70 start-page: 827 year: 2015 ident: 10.1124/pharmrev.120.000020_bib644 article-title: Imaging the distribution of polymyxins in the kidney publication-title: J Antimicrob Chemother doi: 10.1093/jac/dku441 – volume: 57 start-page: 332 year: 2009 ident: 10.1124/pharmrev.120.000020_bib299 article-title: Development of des-fatty acyl-polymyxin B decapeptide analogs with Pseudomonas aeruginosa-specific antimicrobial activity publication-title: Chem Pharm Bull (Tokyo) doi: 10.1248/cpb.57.332 – volume: 13 start-page: 813 year: 1976 ident: 10.1124/pharmrev.120.000020_bib426 article-title: Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides publication-title: Immunochemistry doi: 10.1016/0019-2791(76)90181-6 – volume: 74 start-page: 144 year: 1971 ident: 10.1124/pharmrev.120.000020_bib399 article-title: Polymyxin inhalation therapeutic hazard publication-title: Ann Intern Med doi: 10.7326/0003-4819-74-1-144 – volume: 4 start-page: 525 year: 1970 ident: 10.1124/pharmrev.120.000020_bib488 article-title: Effects of large doses of colistin sulphomethate sodium on renal function publication-title: BMJ doi: 10.1136/bmj.4.5734.525 – volume: 68 start-page: 551 year: 2015 ident: 10.1124/pharmrev.120.000020_bib172 article-title: In vitro activity of fosfomycin in combination with colistin against clinical isolates of carbapenem-resistant Pseudomas aeruginosa publication-title: J Antibiot (Tokyo) doi: 10.1038/ja.2015.27 – year: 2017 ident: 10.1124/pharmrev.120.000020_bib630 – volume: 45 start-page: 594 year: 2007 ident: 10.1124/pharmrev.120.000020_bib351 article-title: Antibiograms of multidrug-resistant clinical Acinetobacter baumannii: promising therapeutic options for treatment of infection with colistin-resistant strains publication-title: Clin Infect Dis doi: 10.1086/520658 – volume: 50 start-page: 1715 year: 2006 ident: 10.1124/pharmrev.120.000020_bib19 article-title: Predictors of mortality in patients with bloodstream infection due to ceftazidime-resistant Klebsiella pneumoniae publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.50.5.1715-1720.2006 – volume: 1 start-page: 512 year: 2015 ident: 10.1124/pharmrev.120.000020_bib654 article-title: Permeability barrier of Gram-negative cell envelopes and approaches to bypass it publication-title: ACS Infect Dis doi: 10.1021/acsinfecdis.5b00097 – volume: 44 start-page: 1308 year: 2014 ident: 10.1124/pharmrev.120.000020_bib572 article-title: Inhaled antibiotics: dry or wet? publication-title: Eur Respir J doi: 10.1183/09031936.00090314 – volume: 23 start-page: e78 year: 2016 ident: 10.1124/pharmrev.120.000020_bib648 article-title: Treatment of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia: retrospective comparison between intravenous colistin and intravenous ampicillin-sulbactam publication-title: Am J Ther doi: 10.1097/MJT.0b013e3182a32df3 – volume: 20 start-page: 550 year: 2014 ident: 10.1124/pharmrev.120.000020_bib178 article-title: In vitro synergistic activity of colistin and ceftazidime or ciprofloxacin against multidrug-resistant clinical strains of Pseudomonas aeruginosa publication-title: Microb Drug Resist doi: 10.1089/mdr.2014.0006 – volume: 56 start-page: 2108 year: 2012 ident: 10.1124/pharmrev.120.000020_bib493 article-title: Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.06268-11 – volume: 46 start-page: 560 year: 2015 ident: 10.1124/pharmrev.120.000020_bib14 article-title: The combination of colistin and fosfomycin is synergistic against NDM-1-producing Enterobacteriaceae in in vitro pharmacokinetic/pharmacodynamic model experiments publication-title: Int J Antimicrob Agents doi: 10.1016/j.ijantimicag.2015.07.019 – volume: 27 start-page: 439 year: 2001 ident: 10.1124/pharmrev.120.000020_bib47 article-title: Selective decontamination of the digestive tract in severely burned pediatric patients publication-title: Burns doi: 10.1016/S0305-4179(00)00147-9 – volume: 57 start-page: 3990 year: 2013 ident: 10.1124/pharmrev.120.000020_bib568 article-title: Synergistic activity of colistin plus rifampin against colistin-resistant KPC-producing Klebsiella pneumoniae publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00179-13 – volume: 58 start-page: 5696 year: 2014 ident: 10.1124/pharmrev.120.000020_bib101 article-title: MgrB inactivation is a common mechanism of colistin resistance in KPC-producing Klebsiella pneumoniae of clinical origin publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.03110-14 – volume: 30 start-page: 391 year: 2016 ident: 10.1124/pharmrev.120.000020_bib300 article-title: Agents of last resort: polymyxin resistance publication-title: Infect Dis Clin North Am doi: 10.1016/j.idc.2016.02.005 – volume: 40 start-page: 332 year: 2012 ident: 10.1124/pharmrev.120.000020_bib433 article-title: Efficacy of tigecycline/colistin combination in a pneumonia model caused by extensively drug-resistant Acinetobacter baumannii publication-title: Int J Antimicrob Agents doi: 10.1016/j.ijantimicag.2012.06.003 – ident: 10.1124/pharmrev.120.000020_bib219 – volume: 68 start-page: 223 year: 2008 ident: 10.1124/pharmrev.120.000020_bib465 article-title: Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes publication-title: Mol Microbiol doi: 10.1111/j.1365-2958.2008.06152.x – volume: 83 start-page: 179 year: 2016 ident: 10.1124/pharmrev.120.000020_bib225 article-title: Polymyxin B induced generalized hyperpigmentation in neonates publication-title: Indian J Pediatr doi: 10.1007/s12098-015-1798-z – volume: 117 start-page: 545 year: 1992 ident: 10.1124/pharmrev.120.000020_bib133 article-title: Prevention of infection in critically ill patients by selective decontamination of the digestive tract publication-title: Ann Intern Med doi: 10.7326/0003-4819-117-7-545 – volume: 49 start-page: 3624 year: 2005 ident: 10.1124/pharmrev.120.000020_bib558 article-title: Pharmacodynamics of polymyxin B against Pseudomonas aeruginosa publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.49.9.3624-3630.2005 – volume: 55 start-page: 4044 year: 2011 ident: 10.1124/pharmrev.120.000020_bib639 article-title: Melatonin attenuates colistin-induced nephrotoxicity in rats publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00328-11 – volume: 127 start-page: 522 year: 2005 ident: 10.1124/pharmrev.120.000020_bib16 article-title: Bronchial constriction and inhaled colistin in cystic fibrosis publication-title: Chest doi: 10.1378/chest.127.2.522 – volume: 55 start-page: 5893 year: 2011 ident: 10.1124/pharmrev.120.000020_bib520 article-title: Comparative effectiveness of aminoglycosides, polymyxin B, and tigecycline for clearance of carbapenem-resistant Klebsiella pneumoniae from urine publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00387-11 – volume: 20 start-page: 48 year: 2014 ident: 10.1124/pharmrev.120.000020_bib435 article-title: Susceptibility of various oral antibacterial agents against extended spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae publication-title: J Infect Chemother doi: 10.1016/j.jiac.2013.08.004 – volume: 16 start-page: 282 year: 2004 ident: 10.1124/pharmrev.120.000020_bib567 article-title: Microbiological activity and clinical efficacy of a colistin and rifampin combination in multidrug-resistant Pseudomonas aeruginosa infections publication-title: J Chemother doi: 10.1179/joc.2004.16.3.282 – volume: 30 start-page: 1042 year: 1977 ident: 10.1124/pharmrev.120.000020_bib535 article-title: The structure of polymyxin T1. (Studies on antibiotics from the genus Bacillus. XXII) publication-title: J Antibiot (Tokyo) doi: 10.7164/antibiotics.30.1042 – volume: 17 start-page: 1798 year: 2011 ident: 10.1124/pharmrev.120.000020_bib649 article-title: Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment publication-title: Clin Microbiol Infect doi: 10.1111/j.1469-0691.2011.03514.x – volume: 976 start-page: 65 year: 2002 ident: 10.1124/pharmrev.120.000020_bib228 article-title: Liquid chromatography-ion trap tandem mass spectrometry for the characterization of polypeptide antibiotics of the colistin series in commercial samples publication-title: J Chromatogr A doi: 10.1016/S0021-9673(02)00375-8 – volume: 52 start-page: 656 year: 1997 ident: 10.1124/pharmrev.120.000020_bib174 article-title: Effect of tonicity of nebulised colistin on chest tightness and pulmonary function in adults with cystic fibrosis publication-title: Thorax doi: 10.1136/thx.52.7.656 – volume: 282 start-page: 15569 year: 2007 ident: 10.1124/pharmrev.120.000020_bib127 article-title: Secondary acylation of Klebsiella pneumoniae lipopolysaccharide contributes to sensitivity to antibacterial peptides publication-title: J Biol Chem doi: 10.1074/jbc.M701454200 – volume: 62 start-page: e01475-17 year: 2018 ident: 10.1124/pharmrev.120.000020_bib414 article-title: Population pharmacokinetics of polymyxin B in acutely ill adult patients publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.01475-17 – volume: 73 start-page: 1217 year: 2018 ident: 10.1124/pharmrev.120.000020_bib184 article-title: Identification of novel variants of the colistin resistance gene mcr-3 in Aeromonas spp. from the national resistance monitoring programme GERM-Vet and from diagnostic submissions publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkx538 – volume: 42 start-page: 565 year: 2013 ident: 10.1124/pharmrev.120.000020_bib379 article-title: Rapid emergence of secondary resistance to gentamicin and colistin following selective digestive decontamination in patients with KPC-2-producing Klebsiella pneumoniae: a single-centre experience publication-title: Int J Antimicrob Agents doi: 10.1016/j.ijantimicag.2013.08.008 – volume: 19 start-page: 41 year: 2018 ident: 10.1124/pharmrev.120.000020_bib659 article-title: Polymyxin B-induced skin hyperpigmentation: a rare case report and literature review publication-title: BMC Pharmacol Toxicol doi: 10.1186/s40360-018-0226-1 – volume: 9 start-page: 493 year: 1976 ident: 10.1124/pharmrev.120.000020_bib321 article-title: In vitro and in vivo activities of minocycline and other antibiotics against Acinetobacter (Herellea-Mima) publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.9.3.493 – volume: 29 start-page: 159 year: 1976 ident: 10.1124/pharmrev.120.000020_bib315 article-title: [Distribution and changes of antibiotic susceptibility of genus Haemophilus (author’s transl)] publication-title: Jpn J Antibiot – volume: 97 start-page: 166 year: 2015 ident: 10.1124/pharmrev.120.000020_bib451 article-title: Extracellular zinc induces phosphoethanolamine addition to Pseudomonas aeruginosa lipid A via the ColRS two-component system publication-title: Mol Microbiol doi: 10.1111/mmi.13018 – volume: 57 start-page: 3463 year: 2013 ident: 10.1124/pharmrev.120.000020_bib463 article-title: How does colistin-induced nephropathy develop and can it be treated? publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00343-13 – volume: 35 start-page: 308 year: 2010 ident: 10.1124/pharmrev.120.000020_bib251 article-title: Variability of polymyxin B major components in commercial formulations publication-title: Int J Antimicrob Agents doi: 10.1016/j.ijantimicag.2009.11.005 – volume: 56 start-page: 106061 year: 2020 ident: 10.1124/pharmrev.120.000020_bib5 article-title: Transcriptomic responses of a New Delhi metallo-β-lactamase-producing Klebsiella pneumoniae isolate to the combination of polymyxin B and chloramphenicol publication-title: Int J Antimicrob Agents doi: 10.1016/j.ijantimicag.2020.106061 – volume: 184 start-page: 92 year: 1982 ident: 10.1124/pharmrev.120.000020_bib213 article-title: Trimethoprim-polymyxin eye drops versus neomycin-polymyxin-gramicidin eye drops in the treatment of presumptive bacterial conjunctivitis - a double-blind study publication-title: Ophthalmologica doi: 10.1159/000309190 – volume: 61 start-page: e01337-16 year: 2016 ident: 10.1124/pharmrev.120.000020_bib570 article-title: Dosing and pharmacokinetics of polymyxin B in patients with renal insufficiency publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.01337-16 – volume: 63 start-page: 534 year: 2009 ident: 10.1124/pharmrev.120.000020_bib24 article-title: Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkn530 – volume: 70 start-page: 75 year: 2015 ident: 10.1124/pharmrev.120.000020_bib485 article-title: The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae publication-title: J Antimicrob Chemother doi: 10.1093/jac/dku323 – volume: 56 start-page: 4416 year: 2012 ident: 10.1124/pharmrev.120.000020_bib268 article-title: Pharmacokinetics of colistin in cerebrospinal fluid after intraventricular administration of colistin methanesulfonate publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00231-12 – year: 2018 ident: 10.1124/pharmrev.120.000020_bib131 – volume: 66 start-page: 946 year: 2011 ident: 10.1124/pharmrev.120.000020_bib409 article-title: Colistin heteroresistance in carbapenemase-producing Klebsiella pneumoniae publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkr007 – volume: 11 year: 2016 ident: 10.1124/pharmrev.120.000020_bib596 article-title: Polymyxin B nephrotoxicity: from organ to cell damage publication-title: PLoS One doi: 10.1371/journal.pone.0161057 – volume: 19 start-page: 5071 year: 2000 ident: 10.1124/pharmrev.120.000020_bib68 article-title: Transfer of palmitate from phospholipids to lipid A in outer membranes of Gram-negative bacteria publication-title: EMBO J doi: 10.1093/emboj/19.19.5071 – volume: 282 start-page: 36077 year: 2007 ident: 10.1124/pharmrev.120.000020_bib635 article-title: An undecaprenyl phosphate-aminoarabinose flippase required for polymyxin resistance in Escherichia coli publication-title: J Biol Chem doi: 10.1074/jbc.M706172200 – volume: 69 start-page: 1432 year: 2014 ident: 10.1124/pharmrev.120.000020_bib13 article-title: Colistin susceptibility testing: time for a review publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkt503 – volume: 43 start-page: 91 year: 2002 ident: 10.1124/pharmrev.120.000020_bib345 article-title: Spectrum of Vibrio species associated with acute diarrhea in North Jakarta, Indonesia publication-title: Diagn Microbiol Infect Dis doi: 10.1016/S0732-8893(02)00373-5 – volume: 121 start-page: 555 year: 1970 ident: 10.1124/pharmrev.120.000020_bib229 article-title: The synergistic action of the sulfonamides and the polymyxins against Serratia marcescens publication-title: J Infect Dis doi: 10.1093/infdis/121.5.555 – volume: 55 start-page: 954 year: 2005 ident: 10.1124/pharmrev.120.000020_bib331 article-title: Citywide emergence of Pseudomonas aeruginosa strains with reduced susceptibility to polymyxin B publication-title: J Antimicrob Chemother doi: 10.1093/jac/dki153 – volume: 41 start-page: 197 year: 2013 ident: 10.1124/pharmrev.120.000020_bib593 article-title: Difficult-to-treat Gram-negative bone and joint infections: efficacy and safety of prolonged intravenous colistin publication-title: Int J Antimicrob Agents doi: 10.1016/j.ijantimicag.2012.09.016 – volume: 55 start-page: 2609 year: 2017 ident: 10.1124/pharmrev.120.000020_bib120 article-title: Colistin and polymyxin B susceptibility testing for carbapenem-resistant and mcr-positive Enterobacteriaceae: comparison of Sensititre, Microscan, Vitek 2, and Etest with broth microdilution publication-title: J Clin Microbiol doi: 10.1128/JCM.00268-17 – year: 2019 ident: 10.1124/pharmrev.120.000020_bib109 – volume: 212 start-page: 311 year: 1966 ident: 10.1124/pharmrev.120.000020_bib626 article-title: Structures of the polymyxins A and the question of identity with the polymyxins M publication-title: Nature doi: 10.1038/212311a0 – volume: 10 start-page: 124 year: 2004 ident: 10.1124/pharmrev.120.000020_bib447 article-title: [Multiresistant nosocomial bacterial strains and their “in vitro” susceptibility to chloramphenicol and colistin] publication-title: Klin Mikrobiol Infekc Lek – volume: 11 start-page: 372 year: 2011 ident: 10.1124/pharmrev.120.000020_bib167 article-title: Selective digestive tract decontamination and selective oropharyngeal decontamination and antibiotic resistance in patients in intensive-care units: an open-label, clustered group-randomised, crossover study publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(11)70035-4 – volume: 87 start-page: 1590 year: 2015 ident: 10.1124/pharmrev.120.000020_bib35 article-title: Significant accumulation of polymyxin in single renal tubular cells: a medicinal chemistry and triple correlative microscopy approach publication-title: Anal Chem doi: 10.1021/ac504516k – volume: 57 start-page: 2310 year: 2013 ident: 10.1124/pharmrev.120.000020_bib95 article-title: Pharmacodynamic evaluation of the intracellular activity of antibiotics towards Pseudomonas aeruginosa PAO1 in a model of THP-1 human monocytes publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.02609-12 – volume: 54 start-page: 3783 year: 2010 ident: 10.1124/pharmrev.120.000020_bib55 article-title: Pharmacokinetic/pharmacodynamic investigation of colistin against Pseudomonas aeruginosa using an in vitro model publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00903-09 – volume: 13 start-page: 137 year: 2013 ident: 10.1124/pharmrev.120.000020_bib449 article-title: Polymyxin P is the active principle in suppressing phytopathogenic Erwinia spp. by the biocontrol rhizobacterium Paenibacillus polymyxa M-1 publication-title: BMC Microbiol doi: 10.1186/1471-2180-13-137 – volume: 7 start-page: 22 year: 2018 ident: 10.1124/pharmrev.120.000020_bib233 article-title: Successful treatment of extensively drug-resistant Acinetobacter baumannii ventriculitis with polymyxin B and tigecycline- a case report publication-title: Antimicrob Resist Infect Control doi: 10.1186/s13756-018-0313-5 – volume: 61 start-page: e02391-16 year: 2017 ident: 10.1124/pharmrev.120.000020_bib393 article-title: Role of renal drug exposure in polymyxin B-induced nephrotoxicity publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.02391-16 – volume: 37 start-page: 1458 year: 2011 ident: 10.1124/pharmrev.120.000020_bib454 article-title: Long-term use of selective decontamination of the digestive tract does not increase antibiotic resistance: a 5-year prospective cohort study publication-title: Intensive Care Med doi: 10.1007/s00134-011-2307-0 – volume: 29 start-page: 51 year: 2007 ident: 10.1124/pharmrev.120.000020_bib467 article-title: Colistin offers prolonged survival in experimental infection by multidrug-resistant Acinetobacter baumannii: the significance of co-administration of rifampicin publication-title: Int J Antimicrob Agents doi: 10.1016/j.ijantimicag.2006.09.009 – volume: 59 start-page: 597 year: 2011 ident: 10.1124/pharmrev.120.000020_bib522 article-title: Novel des-fatty acyl-polymyxin B derivatives with Pseudomonas aeruginosa-specific antimicrobial activity publication-title: Chem Pharm Bull (Tokyo) doi: 10.1248/cpb.59.597 – volume: 52 start-page: 1280 year: 2011 ident: 10.1124/pharmrev.120.000020_bib325 article-title: Pharmacokinetics of polymyxin B in a patient with renal insufficiency: a case report publication-title: Clin Infect Dis doi: 10.1093/cid/cir137 – volume: 53 start-page: 2133 year: 2009 ident: 10.1124/pharmrev.120.000020_bib544 article-title: Does the activity of the combination of imipenem and colistin in vitro exceed the problem of resistance in metallo-beta-lactamase-producing Klebsiella pneumoniae isolates? publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.01271-08 – volume: 2014 start-page: 249856 year: 2014 ident: 10.1124/pharmrev.120.000020_bib176 article-title: Worldwide dissemination of the NDM-type carbapenemases in Gram-negative bacteria publication-title: BioMed Res Int doi: 10.1155/2014/249856 – volume: 30 start-page: 34 year: 2012 ident: 10.1124/pharmrev.120.000020_bib74 article-title: In vitro pharmacodynamic properties of colistin methanesulfonate and amikacin against Pseudomonas aeruginosa publication-title: Indian J Med Microbiol doi: 10.4103/0255-0857.93020 – volume: 10 start-page: R27 year: 2006 ident: 10.1124/pharmrev.120.000020_bib196 article-title: Toxicity of polymyxins: a systematic review of the evidence from old and recent studies publication-title: Crit Care doi: 10.1186/cc3995 – volume: 30 start-page: 153 year: 1990 ident: 10.1124/pharmrev.120.000020_bib609 article-title: Relationship between structure and histamine releasing action of polymyxin B and its analogues publication-title: Agents Actions doi: 10.1007/BF01969025 – volume: 85 start-page: 65 year: 2015 ident: 10.1124/pharmrev.120.000020_bib597 article-title: Inhaled anti-infective chemotherapy for respiratory tract infections: successes, challenges and the road ahead publication-title: Adv Drug Deliv Rev doi: 10.1016/j.addr.2014.11.004 – volume: 266 start-page: 759 year: 1962 ident: 10.1124/pharmrev.120.000020_bib629 article-title: Neurotoxic and nephrotoxic effects of colistin in patients with renal disease publication-title: N Engl J Med doi: 10.1056/NEJM196204122661505 – volume: 68 start-page: 2311 year: 2013 ident: 10.1124/pharmrev.120.000020_bib250 article-title: Pharmacokinetics of four different brands of colistimethate and formed colistin in rats publication-title: J Antimicrob Chemother – volume: 158 start-page: 908 year: 1998 ident: 10.1124/pharmrev.120.000020_bib516 article-title: Effectiveness and cost of selective decontamination of the digestive tract in critically ill intubated patients. A randomized, double-blind, placebo-controlled, multicenter trial publication-title: Am J Respir Crit Care Med doi: 10.1164/ajrccm.158.3.9712079 – volume: 9 start-page: 11 year: 1976 ident: 10.1124/pharmrev.120.000020_bib202 article-title: Susceptibility of beta-hemolytic streptococci to 65 antibacterial agents publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.9.1.11 – volume: 17 start-page: 1444 year: 2011 ident: 10.1124/pharmrev.120.000020_bib412 article-title: Outbreak of KPC-3-producing, and colistin-resistant, Klebsiella pneumoniae infections in two Sicilian hospitals publication-title: Clin Microbiol Infect doi: 10.1111/j.1469-0691.2011.03572.x – volume: 280 start-page: 28186 year: 2005 ident: 10.1124/pharmrev.120.000020_bib575 article-title: Resistance to the antimicrobial peptide polymyxin requires myristoylation of Escherichia coli and Salmonella typhimurium lipid A publication-title: J Biol Chem doi: 10.1074/jbc.M505020200 – volume: 57 start-page: 2204 year: 2013 ident: 10.1124/pharmrev.120.000020_bib234 article-title: Polymyxin resistance of Pseudomonas aeruginosa phoQ mutants is dependent on additional two-component regulatory systems publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.02353-12 – volume: 36 start-page: 1394 year: 2010 ident: 10.1124/pharmrev.120.000020_bib54 article-title: Impact of digestive and oropharyngeal decontamination on the intestinal microbiota in ICU patients publication-title: Intensive Care Med doi: 10.1007/s00134-010-1826-4 – volume: 164 start-page: 382 year: 2001 ident: 10.1124/pharmrev.120.000020_bib61 article-title: Prevention of ventilator-associated pneumonia by oral decontamination: a prospective, randomized, double-blind, placebo-controlled study publication-title: Am J Respir Crit Care Med doi: 10.1164/ajrccm.164.3.2005003 – volume: 48 start-page: 1724 year: 2009 ident: 10.1124/pharmrev.120.000020_bib244 article-title: Nephrotoxicity associated with intravenous colistin (colistimethate sodium) treatment at a tertiary care medical center publication-title: Clin Infect Dis doi: 10.1086/599225 – volume: 278 start-page: 24731 year: 2003 ident: 10.1124/pharmrev.120.000020_bib77 article-title: Origin of lipid A species modified with 4-amino-4-deoxy-L-arabinose in polymyxin-resistant mutants of Escherichia coli. an aminotransferase (ArnB) that generates UDP-4-deoxyl-L-arabinose publication-title: J Biol Chem doi: 10.1074/jbc.M304043200 – volume: 58 start-page: 235 year: 2007 ident: 10.1124/pharmrev.120.000020_bib477 article-title: Salvage treatment of pneumonia and initial treatment of tracheobronchitis caused by multidrug-resistant Gram-negative bacilli with inhaled polymyxin B publication-title: Diagn Microbiol Infect Dis doi: 10.1016/j.diagmicrobio.2007.01.008 – volume: 57 start-page: 5394 year: 2013 ident: 10.1124/pharmrev.120.000020_bib179 article-title: Risk factors for treatment failure of polymyxin B monotherapy for carbapenem-resistant Klebsiella pneumoniae infections publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00510-13 – volume: 181 start-page: 623 year: 1979 ident: 10.1124/pharmrev.120.000020_bib273 article-title: Further studies on the structural requirements for polypeptide-mediated histamine release from rat mast cells publication-title: Biochem J doi: 10.1042/bj1810623 – volume: 72 start-page: 857 year: 1970 ident: 10.1124/pharmrev.120.000020_bib312 article-title: Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy publication-title: Ann Intern Med doi: 10.7326/0003-4819-72-6-857 – volume: 37 start-page: 244 year: 2011 ident: 10.1124/pharmrev.120.000020_bib487 article-title: Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay publication-title: Int J Antimicrob Agents doi: 10.1016/j.ijantimicag.2010.10.031 – volume: 2015 start-page: 568079 year: 2015 ident: 10.1124/pharmrev.120.000020_bib563 article-title: In vitro activity of imipenem and colistin against a carbapenem-resistant Klebsiella pneumoniae isolate coproducing SHV-31, CMY-2, and DHA-1 publication-title: BioMed Res Int doi: 10.1155/2015/568079 – volume: 35 start-page: 28 year: 2015 ident: 10.1124/pharmrev.120.000020_bib290 article-title: Adverse reactions associated with systemic polymyxin therapy publication-title: Pharmacotherapy doi: 10.1002/phar.1493 – volume: 55 start-page: 4469 year: 2011 ident: 10.1124/pharmrev.120.000020_bib255 article-title: Pharmacokinetics/pharmacodynamics of colistin and imipenem on mucoid and nonmucoid Pseudomonas aeruginosa biofilms publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00126-11 – volume: 74 start-page: 48 year: 2019 ident: 10.1124/pharmrev.120.000020_bib10 article-title: Intracellular localization of polymyxins in human alveolar epithelial cells publication-title: J Antimicrob Chemother – volume: 60 start-page: 6980 year: 2016 ident: 10.1124/pharmrev.120.000020_bib391 article-title: Comparative pharmacokinetic profiling of different polymyxin B components publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00702-16 – volume: 4 start-page: e00149-18 year: 2019 ident: 10.1124/pharmrev.120.000020_bib239 article-title: Comparative metabolomics and transcriptomics reveal multiple pathways associated with polymyxin killing in Pseudomonas aeruginosa publication-title: mSystems doi: 10.1128/msystems.00149-18 – volume: 12 start-page: 598 year: 1990 ident: 10.1124/pharmrev.120.000020_bib417 article-title: Flagellate dermatitis after bleomycin. A histological and immunohistochemical study publication-title: Am J Dermatopathol doi: 10.1097/00000372-199012000-00011 – volume: 38 start-page: e7 year: 2004 ident: 10.1124/pharmrev.120.000020_bib292 article-title: Colistin for Klebsiella pneumoniae-associated sepsis publication-title: Clin Infect Dis doi: 10.1086/380461 – volume: 36 start-page: 383 year: 2010 ident: 10.1124/pharmrev.120.000020_bib248 article-title: Susceptibility of Klebsiella pneumoniae clinical isolates from 2007 to 2009 to colistin and comparator antibiotics publication-title: Int J Antimicrob Agents doi: 10.1016/j.ijantimicag.2010.06.004 – volume: 17 start-page: 565 year: 2016 ident: 10.1124/pharmrev.120.000020_bib115 article-title: The role of galectin-3 in the kidneys publication-title: Int J Mol Sci doi: 10.3390/ijms17040565 – volume: 70 start-page: 386 year: 2017 ident: 10.1124/pharmrev.120.000020_bib84 article-title: Development of new polymyxin derivatives for multi-drug resistant Gram-negative infections publication-title: J Antibiot (Tokyo) doi: 10.1038/ja.2016.146 – volume: 187 start-page: 5387 year: 2005 ident: 10.1124/pharmrev.120.000020_bib580 article-title: Cationic antimicrobial peptide resistance in Neisseria meningitidis publication-title: J Bacteriol doi: 10.1128/JB.187.15.5387-5396.2005 – volume: 30 start-page: 179 year: 1977 ident: 10.1124/pharmrev.120.000020_bib170 article-title: Acute renal failure due to colistin intoxication publication-title: Acta Paediatr Belg – volume: 1145 start-page: 219 year: 2019 ident: 10.1124/pharmrev.120.000020_bib438 article-title: Clinical pharmacokinetics, pharmacodynamics and toxicodynamics of polymyxins: implications for therapeutic use publication-title: Adv Exp Med Biol doi: 10.1007/978-3-030-16373-0_15 – volume: 6 start-page: S319 year: 2019 ident: 10.1124/pharmrev.120.000020_bib511 article-title: 707. QPX9003: Pharmacology of a novel polymyxin in mice and rats publication-title: Open Forum Infect Dis doi: 10.1093/ofid/ofz360.775 – volume: 71 start-page: 5225 year: 2003 ident: 10.1124/pharmrev.120.000020_bib533 article-title: Unusual interaction of a lipopolysaccharide isolated from Burkholderia cepacia with polymyxin B publication-title: Infect Immun doi: 10.1128/IAI.71.9.5225-5230.2003 – volume: 62 start-page: 675 year: 2009 ident: 10.1124/pharmrev.120.000020_bib360 article-title: In vitro activity of various combinations of antimicrobials against carbapenem-resistant Acinetobacter species in Singapore publication-title: J Antibiot (Tokyo) doi: 10.1038/ja.2009.99 – volume: 64 start-page: 565 year: 2017 ident: 10.1124/pharmrev.120.000020_bib439 article-title: Dosing guidance for intravenous colistin in critically-ill patients publication-title: Clin Infect Dis doi: 10.1093/cid/ciw839 – volume: 17 start-page: 672 year: 2013 ident: 10.1124/pharmrev.120.000020_bib286 article-title: Susceptibility rates in Latin American nations: report from a regional resistance surveillance program (2011) publication-title: Braz J Infect Dis doi: 10.1016/j.bjid.2013.07.002 – volume: 53 start-page: 2857 year: 2009 ident: 10.1124/pharmrev.120.000020_bib383 article-title: Renal disposition of colistin in the isolated perfused rat kidney publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00030-09 – volume: 112 start-page: S83 issue: 4 Suppl year: 2003 ident: 10.1124/pharmrev.120.000020_bib398 article-title: The histamine-cytokine network in allergic inflammation publication-title: J Allergy Clin Immunol doi: 10.1016/S0091-6749(03)01881-5 – volume: 24 start-page: 865 year: 2018 ident: 10.1124/pharmrev.120.000020_bib406 article-title: Antimicrobial susceptibility testing of colistin - evaluation of seven commercial MIC products against standard broth microdilution for Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter spp publication-title: Clin Microbiol Infect doi: 10.1016/j.cmi.2017.11.020 – volume: 157 start-page: 142 year: 1972 ident: 10.1124/pharmrev.120.000020_bib611 article-title: Antimicrobial resistance of the genera Proteus, Providencia and Serratia with special reference to multiple resistance patterns publication-title: Med Microbiol Immunol (Berl) doi: 10.1007/BF02124474 – volume: 59 start-page: 7240 year: 2015 ident: 10.1124/pharmrev.120.000020_bib293 article-title: Colistin population pharmacokinetics after application of a loading dose of 9 MU colistin methanesulfonate in critically ill patients publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00554-15 – volume: 49 start-page: 403 year: 2002 ident: 10.1124/pharmrev.120.000020_bib524 article-title: In vitro activity of the aerosolized agents colistin and tobramycin and five intravenous agents against Pseudomonas aeruginosa isolated from cystic fibrosis patients in southwestern Germany publication-title: J Antimicrob Chemother doi: 10.1093/jac/49.2.403 – volume: 7 start-page: 45527 year: 2017 ident: 10.1124/pharmrev.120.000020_bib388 article-title: Untargeted metabolomics analysis reveals key pathways responsible for the synergistic killing of colistin and doripenem combination against Acinetobacter baumannii publication-title: Sci Rep doi: 10.1038/srep45527 – volume: 70 start-page: 1434 year: 2015 ident: 10.1124/pharmrev.120.000020_bib382 article-title: Colistin and doripenem combinations against Pseudomonas aeruginosa: profiling the time course of synergistic killing and prevention of resistance publication-title: J Antimicrob Chemother doi: 10.1093/jac/dku567 – volume: 6 start-page: S313 year: 2019 ident: 10.1124/pharmrev.120.000020_bib105 article-title: 690. Activity of a novel polymyxin analog, QPX9003, tested against resistant Gram-negative pathogens, including carbapenem-resistant Acinetobacter, Enterobacterales, and Pseudomonas publication-title: Open Forum Infect Dis doi: 10.1093/ofid/ofz360.758 – volume: 67 start-page: 147 year: 2014 ident: 10.1124/pharmrev.120.000020_bib163 article-title: A secondary mode of action of polymyxins against Gram-negative bacteria involves the inhibition of NADH-quinone oxidoreductase activity publication-title: J Antibiot (Tokyo) doi: 10.1038/ja.2013.111 – volume: 40 start-page: 537 year: 2007 ident: 10.1124/pharmrev.120.000020_bib261 article-title: Successful treatment of meningitis caused by multidrug-resistant Acinetobacter baumannii with intravenous and intrathecal colistin publication-title: J Microbiol Immunol Infect – volume: 1 start-page: 131 year: 2013 ident: 10.1124/pharmrev.120.000020_bib621 article-title: Global survey of polymyxin use: a call for international guidelines publication-title: J Glob Antimicrob Resist doi: 10.1016/j.jgar.2013.03.012 – volume: 47 start-page: 2814 year: 2008 ident: 10.1124/pharmrev.120.000020_bib214 article-title: An inner membrane dioxygenase that generates the 2-hydroxymyristate moiety of Salmonella lipid A publication-title: Biochemistry doi: 10.1021/bi702457c – volume: 6 year: 2011 ident: 10.1124/pharmrev.120.000020_bib361 article-title: In-vitro activity of polymyxin B, rifampicin, tigecycline alone and in combination against carbapenem-resistant Acinetobacter baumannii in Singapore publication-title: PLoS One doi: 10.1371/journal.pone.0018485 – volume: 99 start-page: 232 year: 2012 ident: 10.1124/pharmrev.120.000020_bib410 article-title: Selective decontamination of the oral and digestive tract in surgical versus non-surgical patients in intensive care in a cluster-randomized trial publication-title: Br J Surg doi: 10.1002/bjs.7703 – volume: 129 start-page: 145 year: 1981 ident: 10.1124/pharmrev.120.000020_bib592 article-title: Characterization of the lipopolysaccharide from the polymyxin-resistant pmrA mutants of Salmonella typhimurium publication-title: FEBS Lett doi: 10.1016/0014-5793(81)80777-6 – volume: 58 start-page: 6337 year: 2014 ident: 10.1124/pharmrev.120.000020_bib37 article-title: Measuring polymyxin uptake by renal tubular cells: is BODIPY-polymyxin B an appropriate probe? publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.03733-14 – volume: 50 start-page: 348 year: 2005 ident: 10.1124/pharmrev.120.000020_bib298 article-title: Cure of post-traumatic recurrent multiresistant Gram-negative rod meningitis with intraventricular colistin publication-title: J Infect doi: 10.1016/j.jinf.2004.05.008 – volume: 106 start-page: 8009 year: 2009 ident: 10.1124/pharmrev.120.000020_bib390 article-title: An ABC transport system that maintains lipid asymmetry in the Gram-negative outer membrane publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0903229106 – volume: 43 start-page: 140 year: 2014 ident: 10.1124/pharmrev.120.000020_bib79 article-title: Bactericidal effect of colistin on planktonic Pseudomonas aeruginosa is independent of hydroxyl radical formation publication-title: Int J Antimicrob Agents doi: 10.1016/j.ijantimicag.2013.10.015 – year: 2015 ident: 10.1124/pharmrev.120.000020_bib130 – volume: 35 start-page: 248 year: 2012 ident: 10.1124/pharmrev.120.000020_bib416 article-title: Novel polymyxin derivatives are less cytotoxic than polymyxin B to renal proximal tubular cells publication-title: Peptides doi: 10.1016/j.peptides.2012.03.033 – volume: 54 start-page: 566 year: 2004 ident: 10.1124/pharmrev.120.000020_bib542 article-title: Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infections publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkh369 – volume: 35 start-page: 557 year: 1997 ident: 10.1124/pharmrev.120.000020_bib158 article-title: Hyphenated liquid chromatographic method for the determination of colistin residues in bovine tissues publication-title: J Chromatogr Sci doi: 10.1093/chromsci/35.12.557 – volume: 61 start-page: 636 year: 2008 ident: 10.1124/pharmrev.120.000020_bib58 article-title: Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkm511 – volume: 25 start-page: 750 year: 2014 ident: 10.1124/pharmrev.120.000020_bib164 article-title: Probing the penetration of antimicrobial polymyxin lipopeptides into Gram-negative bacteria publication-title: Bioconjug Chem doi: 10.1021/bc500094d – volume: 62 start-page: e02101 year: 2018 ident: 10.1124/pharmrev.120.000020_bib216 article-title: Successive emergence of ceftazidime-avibactam resistance through distinct genomic adaptations in bla(KPC-2)-harboring Klebsiella pneumoniae sequence type 307 isolates publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.02101-17 – volume: 301 start-page: 2445 year: 2009 ident: 10.1124/pharmrev.120.000020_bib140 article-title: Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial publication-title: JAMA doi: 10.1001/jama.2009.856 – volume: 39 start-page: 255 year: 1997 ident: 10.1124/pharmrev.120.000020_bib107 article-title: A reassessment of the in-vitro activity of colistin sulphomethate sodium publication-title: J Antimicrob Chemother doi: 10.1093/jac/39.2.255 – volume: 59 start-page: 7489 year: 2015 ident: 10.1124/pharmrev.120.000020_bib645 article-title: Cellular uptake and localization of polymyxins in renal tubular cells using rationally designed fluorescent probes publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.01216-15 – volume: 15 start-page: 235 year: 2011 ident: 10.1124/pharmrev.120.000020_bib385 article-title: Intrathecal (intraventricular) polymyxin B in the treatment of patients with meningoencephalitis by Acinetobacter baumannii and Pseudomonas aeruginosa publication-title: Crit Care doi: 10.1186/cc9655 – volume: 48 start-page: 583 year: 2016 ident: 10.1124/pharmrev.120.000020_bib46 article-title: Molecular mechanisms of polymyxin resistance: knowns and unknowns publication-title: Int J Antimicrob Agents doi: 10.1016/j.ijantimicag.2016.06.023 – volume: 18 start-page: 870 year: 2012 ident: 10.1124/pharmrev.120.000020_bib322 article-title: Eradication of multidrug-resistant Acinetobacter baumannii from the respiratory tract with inhaled colistin methanesulfonate: a matched case-control study publication-title: Clin Microbiol Infect doi: 10.1111/j.1469-0691.2011.03682.x – volume: 52 start-page: 3229 year: 2008 ident: 10.1124/pharmrev.120.000020_bib586 article-title: Novel polymyxin derivatives carrying only three positive charges are effective antibacterial agents publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00405-08 – volume: 42 start-page: 573 year: 2017 ident: 10.1124/pharmrev.120.000020_bib405 article-title: Skin hyperpigmentation following intravenous polymyxin B treatment associated with melanocyte activation and inflammatory process publication-title: J Clin Pharm Ther doi: 10.1111/jcpt.12543 – volume: 156 start-page: 706 year: 1987 ident: 10.1124/pharmrev.120.000020_bib203 article-title: Polymyxin B moderates acidosis and hypotension in established, experimental Gram-negative septicemia publication-title: J Infect Dis doi: 10.1093/infdis/156.5.706 – volume: 173 start-page: 1348 year: 2006 ident: 10.1124/pharmrev.120.000020_bib313 article-title: Oral decontamination with chlorhexidine reduces the incidence of ventilator-associated pneumonia publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.200505-820OC – volume: 72 start-page: 1415 year: 2017 ident: 10.1124/pharmrev.120.000020_bib342 article-title: Polymyxin-resistant, carbapenem-resistant Acinetobacter baumannii is eradicated by a triple combination of agents that lack individual activity publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkx002 – volume: 35 start-page: 299 year: 1996 ident: 10.1124/pharmrev.120.000020_bib98 article-title: Intermembrane molecular contacts by polymyxin B mediate exchange of phospholipids publication-title: Biochemistry doi: 10.1021/bi9512408 – volume: 5 start-page: 551 year: 2014 ident: 10.1124/pharmrev.120.000020_bib104 article-title: A new strategy to fight antimicrobial resistance: the revival of old antibiotics publication-title: Front Microbiol doi: 10.3389/fmicb.2014.00551 – volume: 26 start-page: 211 year: 2014 ident: 10.1124/pharmrev.120.000020_bib437 article-title: Activity of the colistin-rifampicin combination against colistin-resistant, carbapenemase-producing Gram-negative bacteria publication-title: J Chemother doi: 10.1179/1973947813Y.0000000136 – volume: 57 start-page: 4329 year: 2013 ident: 10.1124/pharmrev.120.000020_bib33 article-title: Polymyxin B induces apoptosis in kidney proximal tubular cells publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.02587-12 – ident: 10.1124/pharmrev.120.000020_bib540 – volume: 16 start-page: 184 year: 2010 ident: 10.1124/pharmrev.120.000020_bib413 article-title: Intravenous fosfomycin for the treatment of nosocomial infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients: a prospective evaluation publication-title: Clin Microbiol Infect doi: 10.1111/j.1469-0691.2009.02921.x – volume: 50 start-page: 4231 year: 2006 ident: 10.1124/pharmrev.120.000020_bib352 article-title: Defining the dosage units for colistin methanesulfonate: urgent need for international harmonization publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00756-06 – volume: 45 start-page: 781 year: 2001 ident: 10.1124/pharmrev.120.000020_bib356 article-title: In vitro pharmacodynamic properties of colistin and colistin methanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.45.3.781-785.2001 – volume: 3 start-page: 23 year: 2004 ident: 10.1124/pharmrev.120.000020_bib622 article-title: Effect of nebulized colistin sulphate and colistin sulphomethate on lung function in patients with cystic fibrosis: a pilot study publication-title: J Cyst Fibros doi: 10.1016/j.jcf.2003.12.005 – volume: 54 start-page: 290 year: 2004 ident: 10.1124/pharmrev.120.000020_bib53 article-title: Successful treatment of Acinetobacter meningitis with intrathecal polymyxin E publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkh289 – volume: 280 start-page: 23000 year: 2005 ident: 10.1124/pharmrev.120.000020_bib627 article-title: Structure and function of both domains of ArnA, a dual function decarboxylase and a formyltransferase, involved in 4-amino-4-deoxy-L-arabinose biosynthesis publication-title: J Biol Chem doi: 10.1074/jbc.M501534200 – volume: 62 start-page: 39 year: 2005 ident: 10.1124/pharmrev.120.000020_bib62 article-title: Use of colistin in the treatment of multiple-drug-resistant Gram-negative infections publication-title: Am J Health Syst Pharm doi: 10.1093/ajhp/62.1.39 – volume: 186 start-page: 575 year: 2004 ident: 10.1124/pharmrev.120.000020_bib427 article-title: PmrAB, a two-component regulatory system of Pseudomonas aeruginosa that modulates resistance to cationic antimicrobial peptides and addition of aminoarabinose to lipid A publication-title: J Bacteriol doi: 10.1128/JB.186.2.575-579.2004 – volume: 58 start-page: 139 year: 2014 ident: 10.1124/pharmrev.120.000020_bib440 article-title: Consistent global approach on reporting of colistin doses to promote safe and effective use publication-title: Clin Infect Dis doi: 10.1093/cid/cit680 – volume: 57 start-page: 6319 year: 2013 ident: 10.1124/pharmrev.120.000020_bib556 article-title: Megalin contributes to kidney accumulation and nephrotoxicity of colistin publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00254-13 – volume: 111 start-page: 551 year: 2007 ident: 10.1124/pharmrev.120.000020_bib126 article-title: Gram-negative outer and inner membrane models: insertion of cyclic cationic lipopeptides publication-title: J Phys Chem B doi: 10.1021/jp064757+ – volume: 16 start-page: 327 year: 2020 ident: 10.1124/pharmrev.120.000020_bib357 article-title: Pan-transcriptomic analysis identified common differentially expressed genes of Acinetobacter baumannii in response to polymyxin treatments publication-title: Mol Omics doi: 10.1039/D0MO00015A – volume: 17 start-page: 60 year: 2010 ident: 10.1124/pharmrev.120.000020_bib117 article-title: Molecular characterization of the PhoPQ-PmrD-PmrAB mediated pathway regulating polymyxin B resistance in Klebsiella pneumoniae CG43 publication-title: J Biomed Sci doi: 10.1186/1423-0127-17-60 – volume: 64 start-page: 1067 year: 2009 ident: 10.1124/pharmrev.120.000020_bib15 article-title: Pharmacokinetics of novel antimicrobial cationic peptides NAB 7061 and NAB 739 in rats following intravenous administration publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkp331 – volume: 59 start-page: 7911 year: 2015 ident: 10.1124/pharmrev.120.000020_bib121 article-title: A PmrB-regulated deacetylase required for lipid A modification and polymyxin resistance in Acinetobacter baumannii publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00515-15 – volume: 60 start-page: 1295 year: 2015 ident: 10.1124/pharmrev.120.000020_bib492 article-title: Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistance publication-title: Clin Infect Dis doi: 10.1093/cid/civ048 – volume: 56 start-page: 5724 year: 2012 ident: 10.1124/pharmrev.120.000020_bib3 article-title: Pharmacokinetics and renal disposition of polymyxin B in an animal model publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.01333-12 – volume: 68 start-page: 83 year: 1991 ident: 10.1124/pharmrev.120.000020_bib387 article-title: Dexamethasone in the complex treatment of Chlamydial conjunctivitis publication-title: Rev Int Trach Pathol Ocul Trop Subtrop Sante Publique – volume: 61 start-page: e00985-17 year: 2017 ident: 10.1124/pharmrev.120.000020_bib538 article-title: Gelofusine ameliorates colistin-induced nephrotoxicity publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00985-17 – volume: 81 start-page: 43 year: 1947 ident: 10.1124/pharmrev.120.000020_bib549 article-title: Polymyxin: a new chemotherapeutic agent publication-title: Bull Johns Hopkins Hosp – volume: 64 start-page: e01495-19 year: 2020 ident: 10.1124/pharmrev.120.000020_bib483 article-title: Polymyxin susceptibility testing and interpretive breakpoints: recommendations from the United States Committee on Antimicrobial Susceptibility Testing (USCAST) publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.01495-19 – volume: 73 start-page: 267 year: 2012 ident: 10.1124/pharmrev.120.000020_bib490 article-title: Multidrug resistance among Acinetobacter spp. in the USA and activity profile of key agents: results from CAPITAL Surveillance 2010 publication-title: Diagn Microbiol Infect Dis doi: 10.1016/j.diagmicrobio.2012.04.002 – volume: 14 start-page: 719 year: 1998 ident: 10.1124/pharmrev.120.000020_bib508 article-title: Prevention of nosocomial infection in a pediatric intensive care unit (PICU) through the use of selective digestive decontamination publication-title: Eur J Epidemiol doi: 10.1023/A:1007487330893 – volume: 50 start-page: 2946 year: 2006 ident: 10.1124/pharmrev.120.000020_bib355 article-title: Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00103-06 – volume: 67 start-page: 593 year: 2003 ident: 10.1124/pharmrev.120.000020_bib446 article-title: Molecular basis of bacterial outer membrane permeability revisited publication-title: Microbiol Mol Biol Rev doi: 10.1128/MMBR.67.4.593-656.2003 – volume: 277 start-page: 2886 year: 2002 ident: 10.1124/pharmrev.120.000020_bib76 article-title: Oxidative decarboxylation of UDP-glucuronic acid in extracts of polymyxin-resistant Escherichia coli. Origin of lipid a species modified with 4-amino-4-deoxy-L-arabinose publication-title: J Biol Chem doi: 10.1074/jbc.M109377200 – volume: 56 start-page: 2683 year: 2012 ident: 10.1124/pharmrev.120.000020_bib256 article-title: In vivo pharmacokinetics/pharmacodynamics of colistin and imipenem in Pseudomonas aeruginosa biofilm infection publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.06486-11 – volume: 34 start-page: 305 year: 1999 ident: 10.1124/pharmrev.120.000020_bib386 article-title: PhoP-PhoQ homologues in Pseudomonas aeruginosa regulate expression of the outer-membrane protein OprH and polymyxin B resistance publication-title: Mol Microbiol doi: 10.1046/j.1365-2958.1999.01600.x – volume: 13 year: 2018 ident: 10.1124/pharmrev.120.000020_bib415 article-title: Risk factors of colistin safety according to administration routes: intravenous and aerosolized colistin publication-title: PLoS One doi: 10.1371/journal.pone.0207588 – volume: 168 start-page: 323 year: 1989 ident: 10.1124/pharmrev.120.000020_bib240 article-title: New approach to endotoxic and septic shock by means of polymyxin B immobilized fiber publication-title: Surg Gynecol Obstet – volume: 63 start-page: e00556-19 year: 2019 ident: 10.1124/pharmrev.120.000020_bib363 article-title: Resistance and heteroresistance to colistin in Pseudomonas aeruginosa isolates from Wenzhou, China publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00556-19 – volume: 30 start-page: 767 year: 1977 ident: 10.1124/pharmrev.120.000020_bib471 article-title: Polymyxin E, a new peptide antibiotic publication-title: J Antibiot (Tokyo) doi: 10.7164/antibiotics.30.767 – volume: 10 start-page: 178 year: 2006 ident: 10.1124/pharmrev.120.000020_bib523 article-title: Successful treatment of multidrug-resistant Pseudomonas aeruginosa meningitis with intravenous and intrathecal colistin publication-title: Int J Infect Dis doi: 10.1016/j.ijid.2005.03.005 – volume: 58 start-page: 2570 year: 2014 ident: 10.1124/pharmrev.120.000020_bib637 article-title: Pulmonary and systemic pharmacokinetics of inhaled and intravenous colistin methanesulfonate in cystic fibrosis patients: targeting advantage of inhalational administration publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.01705-13 – volume: 52 start-page: 987 year: 1997 ident: 10.1124/pharmrev.120.000020_bib135 article-title: Intravenous colistin sulphomethate in acute respiratory exacerbations in adult patients with cystic fibrosis publication-title: Thorax doi: 10.1136/thx.52.11.987 – volume: 6 start-page: 2110 year: 2020 ident: 10.1124/pharmrev.120.000020_bib280 article-title: Structure-interaction relationship of polymyxins with the membrane of human kidney proximal tubular cells publication-title: ACS Infect Dis doi: 10.1021/acsinfecdis.0c00190 – volume: 264 start-page: 337 year: 1988 ident: 10.1124/pharmrev.120.000020_bib241 article-title: Selective removal of endotoxin from the blood by extracorporeal hemoperfusion with polymyxin B immobilized fiber publication-title: Prog Clin Biol Res – volume: 51 start-page: 3431 year: 2007 ident: 10.1124/pharmrev.120.000020_bib317 article-title: Colistin methanesulfonate against multidrug-resistant Acinetobacter baumannii in an in vitro pharmacodynamic model publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.01433-06 – volume: 54 start-page: 1057 year: 2004 ident: 10.1124/pharmrev.120.000020_bib262 article-title: Pitfalls of polymyxin antimicrobial susceptibility testing of Pseudomonas aeruginosa isolated from cystic fibrosis patients publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkh470 – volume: 23 start-page: 281 year: 2013 ident: 10.1124/pharmrev.120.000020_bib148 article-title: Effect of colistin exposure on calcium homeostasis and mitochondria functions in chick cortex neurons publication-title: Toxicol Mech Methods doi: 10.3109/15376516.2012.754533 – volume: 33 start-page: 960 year: 1999 ident: 10.1124/pharmrev.120.000020_bib193 article-title: Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant Gram-negative bacteria publication-title: Ann Pharmacother doi: 10.1345/aph.18426 – volume: 49 start-page: 521 year: 2017 ident: 10.1124/pharmrev.120.000020_bib565 article-title: Assessment of early combination effects of colistin and meropenem against Pseudomonas aeruginosa and Acinetobacter baumannii in dynamic time-kill experiments publication-title: Infect Dis (Lond) doi: 10.1080/23744235.2017.1296183 – volume: 53 start-page: 274 year: 2006 ident: 10.1124/pharmrev.120.000020_bib431 article-title: Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii publication-title: J Infect doi: 10.1016/j.jinf.2005.11.019 – volume: 12 start-page: 592 year: 1998 ident: 10.1124/pharmrev.120.000020_bib334 article-title: Four years’ experience of intravenous colomycin in an adult cystic fibrosis unit publication-title: Eur Respir J doi: 10.1183/09031936.98.12030592 – volume: 62 start-page: 1311 year: 2008 ident: 10.1124/pharmrev.120.000020_bib486 article-title: In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkn425 – ident: 10.1124/pharmrev.120.000020_bib38 – volume: 67 start-page: 2459 year: 2012 ident: 10.1124/pharmrev.120.000020_bib396 article-title: Colistin pharmacokinetics in intensive care unit patients on continuous venovenous haemodiafiltration: an observational study publication-title: J Antimicrob Chemother doi: 10.1093/jac/dks257 – volume: 29 start-page: 125 year: 1967 ident: 10.1124/pharmrev.120.000020_bib66 article-title: Sodium sulphomethyl derivatives of polymyxins publication-title: Br J Pharmacol Chemother doi: 10.1111/j.1476-5381.1967.tb01946.x – volume: 68 start-page: 6139 year: 2000 ident: 10.1124/pharmrev.120.000020_bib232 article-title: Genetic and functional analysis of a PmrA-PmrB-regulated locus necessary for lipopolysaccharide modification, antimicrobial peptide resistance, and oral virulence of Salmonella enterica serovar typhimurium publication-title: Infect Immun doi: 10.1128/IAI.68.11.6139-6146.2000 – volume: 51 start-page: 1 year: 2018 ident: 10.1124/pharmrev.120.000020_bib594 article-title: Inhaled colistin monotherapy for respiratory tract infections in adults without cystic fibrosis: a systematic review and meta-analysis publication-title: Int J Antimicrob Agents doi: 10.1016/j.ijantimicag.2017.05.016 – volume: 8 start-page: 27 year: 2019 ident: 10.1124/pharmrev.120.000020_bib67 article-title: A breath of fresh air in the fog of antimicrobial resistance: inhaled polymyxins for Gram-negative pneumonia publication-title: Antibiotics (Basel) doi: 10.3390/antibiotics8010027 – volume: 53 start-page: 4924 year: 2009 ident: 10.1124/pharmrev.120.000020_bib614 article-title: In vitro activity of colistin (polymyxin E) against 3,480 isolates of Gram-negative bacilli obtained from patients in Canadian hospitals in the CANWARD study, 2007-2008 publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00786-09 – volume: 29 start-page: 217 year: 2006 ident: 10.1124/pharmrev.120.000020_bib613 article-title: Evaluation of 3 methods of bladder irrigation to treat bacteriuria in persons with neurogenic bladder publication-title: J Spinal Cord Med doi: 10.1080/10790268.2006.11753877 – volume: 11 start-page: R47 year: 2007 ident: 10.1124/pharmrev.120.000020_bib141 article-title: Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review publication-title: Crit Care doi: 10.1186/cc5780 – volume: 6 start-page: 426 year: 2012 ident: 10.1124/pharmrev.120.000020_bib610 article-title: Intravesical colistin irrigation to treat multidrug-resistant Acinetobacter baumannii urinary tract infection: a case report publication-title: J Med Case Reports doi: 10.1186/1752-1947-6-426 – volume: 62 start-page: e01018-18 year: 2018 ident: 10.1124/pharmrev.120.000020_bib531 article-title: Colistin does not potentiate ceftazidime-avibactam killing of carbapenem-resistant Enterobacteriaceae in vitro or suppress emergence of ceftazidime-avibactam resistance publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.01018-18 – volume: 280 start-page: 14154 year: 2005 ident: 10.1124/pharmrev.120.000020_bib75 article-title: A formyltransferase required for polymyxin resistance in Escherichia coli and the modification of lipid A with 4-Amino-4-deoxy-L-arabinose. Identification and function oF UDP-4-deoxy-4-formamido-L-arabinose publication-title: J Biol Chem doi: 10.1074/jbc.M414265200 – volume: 66 start-page: 2070 year: 2011 ident: 10.1124/pharmrev.120.000020_bib208 article-title: Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006-09) publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkr239 – volume: 75 start-page: 3534 year: 2020 ident: 10.1124/pharmrev.120.000020_bib279 article-title: Molecular dynamics simulations informed by membrane lipidomics reveal the structure-interaction relationship of polymyxins with the lipid A-based outer membrane of Acinetobacter baumannii publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkaa376 – volume: 111 start-page: 1750 year: 2016 ident: 10.1124/pharmrev.120.000020_bib308 article-title: Bilayer properties of lipid A from various Gram-negative bacteria publication-title: Biophys J doi: 10.1016/j.bpj.2016.09.001 – volume: 7 start-page: 151 year: 2019 ident: 10.1124/pharmrev.120.000020_bib295 article-title: The “old” and the “new” antibiotics for MDR Gram-negative pathogens: from whom, when, and how publication-title: Front Public Health doi: 10.3389/fpubh.2019.00151 – volume: 76 start-page: 1444 year: 2010 ident: 10.1124/pharmrev.120.000020_bib259 article-title: Activation of PmrA inhibits LpxT-dependent phosphorylation of lipid A promoting resistance to antimicrobial peptides publication-title: Mol Microbiol doi: 10.1111/j.1365-2958.2010.07150.x – volume: 51 start-page: 1924 year: 2013 ident: 10.1124/pharmrev.120.000020_bib338 article-title: Comparison of the Vitek 2, MicroScan, and Etest methods with the agar dilution method in assessing colistin susceptibility of bloodstream isolates of Acinetobacter species from a Korean university hospital publication-title: J Clin Microbiol doi: 10.1128/JCM.00427-13 – volume: 54 start-page: 548 year: 2012 ident: 10.1124/pharmrev.120.000020_bib479 article-title: Intraventricular polymyxin B for the treatment of neonatal meningo-ventriculitis caused by multi-resistant Acinetobacter baumannii--case report and review of literature publication-title: Turk J Pediatr – volume: 18 start-page: 554 year: 2006 ident: 10.1124/pharmrev.120.000020_bib18 article-title: Post-neurosurgical meningitis due to multidrug-resistant Acinetobacter baumanii treated with intrathecal colistin: case report and review of the literature publication-title: J Chemother doi: 10.1179/joc.2006.18.5.554 – volume: 57 start-page: 1442 year: 2013 ident: 10.1124/pharmrev.120.000020_bib430 article-title: Nephrotoxicity and efficacy assessment of polymyxin use in 92 transplant patients publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.01329-12 – volume: 72 start-page: 3317 year: 2017 ident: 10.1124/pharmrev.120.000020_bib72 article-title: Identification of a novel transposon-associated phosphoethanolamine transferase gene, mcr-5, conferring colistin resistance in d-tartrate fermenting Salmonella enterica subsp. enterica serovar Paratyphi B publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkx327 – volume: 61 start-page: e02121-16 year: 2017 ident: 10.1124/pharmrev.120.000020_bib173 article-title: Polymyxin B in combination with rifampin and meropenem against polymyxin B-resistant KPC-producing Klebsiella pneumoniae publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.02121-16 – year: 2013 ident: 10.1124/pharmrev.120.000020_bib129 – volume: 63 start-page: e02176-18 year: 2019 ident: 10.1124/pharmrev.120.000020_bib365 article-title: Novel polymyxin combination with the antiretroviral zidovudine exerts synergistic killing against NDM-producing multidrug-resistant Klebsiella pneumoniae publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.02176-18 – volume: 14 start-page: e596 year: 2010 ident: 10.1124/pharmrev.120.000020_bib48 article-title: Evaluation of susceptibility testing methods for polymyxin publication-title: Int J Infect Dis doi: 10.1016/j.ijid.2009.09.001 – volume: 74 start-page: 213 year: 2012 ident: 10.1124/pharmrev.120.000020_bib57 article-title: Pharmacokinetics and pharmacodynamics of ‘old’ polymyxins: what is new? publication-title: Diagn Microbiol Infect Dis doi: 10.1016/j.diagmicrobio.2012.07.010 |
| SSID | ssj0014585 |
| Score | 2.688847 |
| SecondaryResourceType | review_article |
| Snippet | Antibiotic resistance is a major global health challenge and, worryingly, several key Gram negative pathogens can become resistant to most currently available... |
| SourceID | pubmedcentral proquest pubmed crossref elsevier |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 679 |
| SubjectTerms | Anti-Bacterial Agents - adverse effects Colistin - adverse effects Drug Resistance, Multiple, Bacterial Gram-Negative Bacterial Infections - drug therapy Humans Polymyxin B Polymyxins - adverse effects Review |
| Title | Rescuing the Last-Line Polymyxins: Achievements and Challenges |
| URI | https://dx.doi.org/10.1124/pharmrev.120.000020 https://www.ncbi.nlm.nih.gov/pubmed/33627412 https://www.proquest.com/docview/2493456714 https://pubmed.ncbi.nlm.nih.gov/PMC7911091 |
| Volume | 73 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKeOEFcafcZCS0p2Ykjp0LD6Bp2phQGQOlqOLFchxHrdYmiCSI7tdznDiXsTINXqLqNGlSf19Ozjmxv4PQq8D2QidUicVcj-olObEVE2FbKlEiZh4VoahnW5x4xzP6Yc7mo9G7waylqoz35PnWdSX_gyrYAFe9SvYfkO1-FAzwGfCFLSAM22th_EUVsmrXO01FUVpTHTSe5qvNevNLV5J12U8ulqpWBS8bPeaDtn9KMYxMT3sN6xo3I1PaFYvbunKl-sLq_nlDkI_5QqzXIgEv01VNv6rVWf6zpkOedXX7b4u80rbPy95sag7EGUxVMW5S2-ym2cqe2mIzvrVpU2I4RAaO0mtayFx24ITqrsP6L-sePA6xa4VJYvfPq_Yd_cknfjSbTnl0OI9uoJsE8gTdwuL9vJvj41BW92TtLs3ITsFJXm85xd9Ck8upx58zaAchSXQH3Ta5BN5viHEXjVR2D-0aIDcTHPVr64oJ3sUDiDf30duWPRjYgzv24J49b_CQOxi4g3vuPECzo8Po4Ngy3TQsSVlYWinEIULJJKRafyf0pR9IImngpH6sUgWZb-rZQtkyTZgnWCAcKVnqB0zCwDkscR-inSzP1GOEYy-hBO7lIEgTmgihHw1-rMX5heu7wh0j0g4kl0ZqXnc8WfE65SSUt6PPYfR5M_pjNOkO-t4orVy9u9cixE2w2ASBHKh09YEvWzw5uFL9fkxkKq8KTmjoQj7hO3SMHjX4dlfiunWTKjJG_gXkux20TPvFb7LlopZr90Ot6us8ucZ5n6Jb_e32DO2UPyr1HILeMn5RE_s3Ob6vdQ |
| linkProvider | Geneva Foundation for Medical Education and Research |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Rescuing+the+Last-Line+Polymyxins%3A+Achievements+and+Challenges&rft.jtitle=Pharmacological+reviews&rft.au=Nang%2C+Sue+C&rft.au=Azad%2C+Mohammad+A+K&rft.au=Velkov%2C+Tony&rft.au=Zhou%2C+Qi+Tony&rft.date=2021-04-01&rft.issn=1521-0081&rft.eissn=1521-0081&rft.volume=73&rft.issue=2&rft.spage=679&rft_id=info:doi/10.1124%2Fpharmrev.120.000020&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0031-6997&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0031-6997&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0031-6997&client=summon |